CHOLESTEROL EFFLUX

1. Importance of different pathways of cellular cholesterol efflux
2. Transintestinal cholesterol efflux
3. Reverse cholesterol transport and cholesterol efflux in atherosclerosis
4. Cellular cholesterol efflux
5. Apolipoproteins, membrane cholesterol domains, and the regulation of cholesterol efflux.
6. Cell cholesterol efflux: integration of old and new observations provides new insights
7. cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis
8. Cellular cholesterol efflux mediated by cyclodextrins
9. High density lipoproteins and arteriosclerosis: role of cholesterol efflux and reverse cholesterol transport
10. The ABCs of cholesterol efflux
11. Cellular cholesterol efflux mediated by cyclodextrins: demonstration of kinetic pools and mechanism of efflux
12. Regulation and mechanisms of macrophage cholesterol efflux
13. Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXRα
14. ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation
15. cholesterol efflux pathways and other potential mechanisms involved in the athero‐protective effect of high density lipoproteins
16. Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes
17. Cellular physiology of cholesterol efflux in vascular endothelial cells
18. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux
19. Regulation of Cellular cholesterol efflux by Lecithin: cholesterol Acyltransferase Reaction through Nonspecific Lipid Exchange (∗)
20. The role of cholesterol efflux in regulating the fertilization potential of mammalian spermatozoa
21. Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses
22. A sensitive assay for ABCA1-mediated cholesterol efflux using BODIPY-cholesterol
23. cholesterol efflux from cultured adipose cells is mediated by LpAI particles but not by LpAI: AII particles
24. Effects of acceptor composition and mechanism of ABCG1-mediated cellular free cholesterol efflux
25. Serum amyloid A (SAA): influence on HDL-mediated cellular cholesterol efflux.
26. The role of microRNAs in cholesterol efflux and hepatic lipid metabolism
27. HDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis
28. Impaired expression of genes regulating cholesterol efflux in human osteoarthritic chondrocytes
29. cholesterol efflux from macrophages and other cells.
30. ABC1 gene expression and ApoA-I-mediated cholesterol efflux are regulated by LXR
31. cholesterol efflux mediated by apolipoproteins is an active cellular process distinct from efflux mediated by passive diffusion
32. Regulation of macrophage cholesterol efflux through hydroxymethylglutaryl-CoA reductase inhibition: a role for RhoA in ABCA1-mediated cholesterol efflux
33. Association between increased arterial-wall thickness and impairment in ABCA1-driven cholesterol efflux: an observational study
34. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins
35. A PPARγ-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis
36. Increased cholesterol efflux Potential of Sera From ApoA-IMilano Carriers and Transgenic Mice
37. Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1
38. Regulation and mechanisms of ATP-binding cassette transporter A1-mediated cellular cholesterol efflux
39. A new insight into resveratrol as an atheroprotective compound: inhibition of lipid peroxidation and enhancement of cholesterol efflux
40. … culture system for screening human serum for ability to promote cellular cholesterol efflux. Relations between serum components and efflux, esterification, and transfer …
41. Adiponectin prevents atherosclerosis by increasing cholesterol efflux from macrophages
42. ATP-binding cassette transporter A1 (ABCA1) functions as a cholesterol efflux regulatory protein
43. The correlation of ATP-binding cassette 1 mRNA levels with cholesterol efflux from various cell lines
44. Inhibition of cholesteryl ester transfer protein by torcetrapib modestly increases macrophage cholesterol efflux to HDL
45. Autophagy regulates cholesterol efflux from macrophage foam cells via lysosomal acid lipase
46. cholesterol efflux to apolipoprotein AI involves endocytosis and resecretion in a calcium-dependent pathway
47. Apolipoprotein M is required for preβ-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis
48. Stimulation of cholesterol efflux by LXR agonists in cholesterol-loaded human macrophages is ABCA1-dependent but ABCG1-independent
49. Role of apolipoproteins in cellular cholesterol efflux
50. ABCA1 and amphipathic apolipoproteins form high-affinity molecular complexes required for cholesterol efflux
51. Mutations in the ABC 1 gene in familial HDL deficiency with defective cholesterol efflux
52. Functional LCAT is not required for macrophage cholesterol efflux to human serum
53. cholesterol efflux potential and antiinflammatory properties of high-density lipoprotein after treatment with niacin or anacetrapib
54. cholesterol efflux-mediated signal transduction in mammalian sperm: cholesterol release signals an increase in protein tyrosine phosphorylation during mouse sperm …
55. HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE-and ABCG1-dependent pathway
56. Age-related impairment of HDL-mediated cholesterol efflux
57. Bovine oviductal fluid components and their potential role in sperm cholesterol efflux
58. … formation of pre-β high-density lipoprotein and improves high-density lipoprotein–mediated cholesterol efflux and reverse cholesterol transport from macrophages in …
59. cholesterol efflux alters lipid raft stability and distribution during capacitation of boar spermatozoa
60. Peroxisome proliferator-activated receptor delta activation leads to increased transintestinal cholesterol efflux
61. A novel model of cholesterol efflux from lipid-loaded cells
62. Sphingomyelin-dependence of cholesterol efflux mediated by ABCG1s⃞
63. Differential effects of HDL subpopulations on cellular ABCA1-and SR-BI-mediated cholesterol efflux
64. cholesterol efflux by acute-phase high density lipoprotein: role of lecithin: cholesterol acyltransferase 1
65. The effects of ABCA1 on cholesterol efflux and Aβ levels in vitro and in vivo
66. Perspective on plasma membrane cholesterol efflux and spermatozoal function
67. Recycling of apoprotein E is associated with cholesterol efflux and high density lipoprotein internalization
68. From blood to gut: Direct secretion of cholesterol via transintestinal cholesterol efflux
69. Multidrug resistance: a role for cholesterol efflux pathways?
70. HDL phospholipid content and composition as a major factor determining cholesterol efflux capacity from Fu5AH cells to human serum
71. Testosterone up-regulates scavenger receptor BI and stimulates cholesterol efflux from macrophages
72. Serum amyloid A promotes cholesterol efflux mediated by scavenger receptor BI
73. Apolipoprotein E produced by human monocyte-derived macrophages mediates cholesterol efflux that occurs in the absence of added cholesterol acceptors
74. Enhanced cholesterol efflux promotion in well-trained soccer players
75. Mechanism of cholesterol efflux from cells
76. Major proteins of bovine seminal plasma and high-density lipoprotein induce cholesterol efflux from epididymal sperm
77. Scavenger receptor class B type I as a mediator of cellular cholesterol efflux to lipoproteins and phospholipid acceptors
78. Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 …
79. cholesterol efflux via ATP-binding cassette transporter A1 (ABCA1) and cholesterol uptake via the LDL receptor influences cholesterol-induced impairment of …
80. Apolipoprotein-mediated cellular cholesterol efflux
81. Cellular cholesterol efflux to serum is impaired in diabetic nephropathy
82. ApoA-I cleaved by transthyretin has reduced ability to promote cholesterol efflux and increased amyloidogenicity
83. Coffee consumption enhances high-density lipoprotein-mediated cholesterol efflux in macrophages
84. Relative roles of various efflux pathways in net cholesterol efflux from macrophage foam cells in atherosclerotic lesions
85. MicroRNA-758 regulates cholesterol efflux through posttranscriptional repression of ATP-binding cassette transporter A1
86. Identification of sterol acceptors that stimulate cholesterol efflux from human spermatozoa during in vitro capacitation
87. Expression of heterologous human apolipoprotein E by J774 macrophages enhances cholesterol efflux to HDL3.
88. An analysis of the role of a retroendocytosis pathway in ABCA1-mediated cholesterol efflux from macrophagess⃞
89. cholesterol efflux regulatory protein, Tangier disease and familial high-density lipoprotein deficiency
90. Human apolipoprotein A-IV binds to apolipoprotein AI/A-II receptor sites and promotes cholesterol efflux from adipose cells.
91. Role of ABCG1 and ABCA1 in regulation of neuronal cholesterol efflux to apolipoprotein E discs and suppression of amyloid-β peptide generation
92. Nonenzymatic Glycosylation of HDL and Impaired HDL-Receptor–Mediated cholesterol efflux
93. Experimental models for the investigation of high-density lipoprotein–mediated cholesterol efflux
94. Scavenger receptor class B, type I-mediated [3H] cholesterol efflux to high and low density lipoproteins is dependent on lipoprotein binding to the receptor
95. Unsaturated fatty acids inhibit cholesterol efflux from macrophages by increasing degradation of ATP-binding cassette transporter A1
96. … peroxisome proliferator-activated receptor γ gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux
97. Regulation of human sperm capacitation by a cholesterol efflux-stimulated signal transduction pathway leading to protein kinase A-mediated up-regulation of protein …
98. Glycodelin-S in Human Seminal Plasma Reduces cholesterol efflux andInhibits Capacitation ofSpermatozoa
99. Expression of caveolin-1 enhances cholesterol efflux in hepatic cells
100. 5A apolipoprotein mimetic peptide promotes cholesterol efflux and reduces atherosclerosis in mice
101. Preferential ATP-binding cassette transporter A1-mediated cholesterol efflux from late endosomes/lysosomes
102. A new HDL mimetic peptide that stimulates cellular cholesterol efflux with high efficiency greatly reduces atherosclerosis in mice
103. Cathepsins F and S block HDL3-induced cholesterol efflux from macrophage foam cells
104. C-reactive protein inhibits cholesterol efflux from human macrophage-derived foam cells
105. Abca7 null mice retain normal macrophage phosphatidylcholine and cholesterol efflux activity despite alterations in adipose mass and serum cholesterol …
106. cAMP induces ABCA1 phosphorylation activity and promotes cholesterol efflux from fibroblasts
107. Leptin modulates ACAT1 expression and cholesterol efflux from human macrophages
108. Moderate alcohol consumption increases cholesterol efflux mediated by ABCA1
109. Involvement of Cdc42 signaling in apoA-I-induced cholesterol efflux
110. cholesterol efflux-mediated signal transduction in mammalian sperm: β-cyclodextrins initiate transmembrane signaling leading to an increase in protein …
111. cholesterol efflux as a critical component of Alzheimer’s disease pathogenesis
112. A potent synthetic LXR agonist is more effective than cholesterol loading at inducing ABCA1 mRNA and stimulating cholesterol efflux
113. Regulation of cholesterol efflux from macrophages
114. cholesterol efflux promotes acrosome reaction in goat spermatozoa
115. Enhancing apolipoprotein AI-dependent cholesterol efflux elevates cholesterol export from macrophages in vivo
116. Modification of the cholesterol efflux properties of human serum by enrichment with phospholipid
117. Human apolipoproteins AI and A-II in cell cholesterol efflux: studies with transgenic mice
118. … cholesterol efflux in heterozygotes for Tangier disease is markedly reduced and correlates with high density lipoprotein cholesterol concentration and particle …
119. Apolipoprotein E-dependent cholesterol efflux from macrophages: kinetic study and divergent mechanisms for endogenous versus exogenous apolipoprotein …
120. ACAT1 deficiency disrupts cholesterol efflux and alters cellular morphology in macrophages
121. Effect of tumor necrosis factor α on cholesterol efflux in adipocytes
122. SR-BI-mediated high density lipoprotein (HDL) endocytosis leads to HDL resecretion facilitating cholesterol efflux
123. Phospholipid transfer protein interacts with and stabilizes ATP-binding cassette transporter A1 and enhances cholesterol efflux from cells
124. Lipid efflux in human and mouse macrophagic cells: evidence for differential regulation of phospholipid and cholesterol efflux
125. ATP-binding cassette transporters A1 and G1, HDL metabolism, cholesterol efflux, and inflammation: important targets for the treatment of atherosclerosis
126. Expression and regulation of multiple murine ATP-binding cassette transporter G1 mRNAs/isoforms that stimulate cellular cholesterol efflux to high density …
127. Relative contributions of ABCA1 and SR-BI to cholesterol efflux to serum from fibroblasts and macrophages
128. Reconstituted high-density lipoprotein attenuates platelet function in individuals with type 2 diabetes mellitus by promoting cholesterol efflux
129. The effects of cholesterol ester transfer protein inhibition on cholesterol efflux
130. Curcumin promotes cholesterol efflux from adipocytes related to PPARgamma–LXRalpha–ABCA1 passway
131. Fatty acid saturation of the diet and plasma lipid concentrations, lipoprotein particle concentrations, and cholesterol efflux capacity
132. Anthocyanins induce cholesterol efflux from mouse peritoneal macrophages: the role of the peroxisome proliferator-activated receptor γ-liver X receptor α …
133. Myeloperoxidase impairs ABCA1-dependent cholesterol efflux through methionine oxidation and site-specific tyrosine chlorination of apolipoprotein AI
134. cholesterol efflux from bovine sperm. I. Induction of the acrosome reaction with lysophosphatidylcholine after reducing sperm cholesterol
135. Modifying apolipoprotein AI by malondialdehyde, but not by an array of other reactive carbonyls, blocks cholesterol efflux by the ABCA1 pathway
136. ATP-binding cassette transporter A7 (ABCA7) binds apolipoprotein AI and mediates cellular phospholipid but not cholesterol efflux
137. ABCA1 is essential for efficient basolateral cholesterol efflux during the absorption of dietary cholesterol in chickens
138. ABCA1-mediated cholesterol efflux is defective in free cholesterol-loaded macrophages: mechanism involves enhanced ABCA1 degradation in a process …
139. Asymmetry in the lipid affinity of bihelical amphipathic peptides: a structural determinant for the specificity of ABCA1-dependent cholesterol efflux by peptides
140. Development of a cell-based, high-throughput screening assay for cholesterol efflux using a fluorescent mimic of cholesterol
141. Role of HDL apolipoprotein E in cellular cholesterol efflux: studies in apo E knockout transgenic mice
142. Anti‐atherogenic effect of berberine on LXRα‐ABCA1‐dependent cholesterol efflux in macrophages
143. Increased cholesterol efflux from cultured fibroblasts to plasma from hypertriglyceridemic type 2 diabetic patients: Roles of pre β-HDL, phospholipid transfer protein …
144. Regulation of ABCA1 expression and cholesterol efflux during adipose differentiation of 3T3-L1 cells
145. Cyclic AMP induces apolipoprotein E binding activity and promotes cholesterol efflux from a macrophage cell line to apolipoprotein acceptors
146. In vivo modulation of HDL phospholipid has opposing effects on SR-BI-and ABCA1-mediated cholesterol efflux
147. A PEST deletion mutant of ABCA1 shows impaired internalization and defective cholesterol efflux from late endosomes
148. The effects of subfractions of high density lipoprotein on cholesterol efflux from cultured fibroblasts. Regulation of low density lipoprotein receptor activity.
149. Stearoyl-CoA desaturase inhibits ATP-binding cassette transporter A1-mediated cholesterol efflux and modulates membrane domain structure
150. SR-BI mediates cholesterol efflux via its interactions with lipid-bound ApoE. Structural mutations in SR-BI diminish cholesterol efflux
151. 24 (S)-hydroxycholesterol participates in a liver X receptor-controlled pathway in astrocytes that regulates apolipoprotein E-mediated cholesterol efflux
152. Altered lipid, apolipoprotein, and lipoprotein profiles in inflammatory bowel disease: consequences on the cholesterol efflux capacity of serum using Fu5AH cell …
153. GPS2 is required for cholesterol efflux by triggering histone demethylation, LXR recruitment, and coregulator assembly at the ABCG1 locus
154. ATP-binding cassette transporter A1: regulation of cholesterol efflux
155. Expression of sterol 27-hydroxylase (CYP27A1) enhances cholesterol efflux
156. cholesterol–sphingomyelin interaction in membrane and apolipoprotein-mediated cellular cholesterol efflux
157. Regulation of the cholesterol efflux gene, ABCA1
158. Beneficial effects of a moderate consumption of red wine on cellular cholesterol efflux in young men.
159. OSBP-related protein 8 (ORP8) suppresses ABCA1 expression and cholesterol efflux from macrophages
160. Induction of cellular cholesterol efflux to lipid-free apolipoprotein AI by cAMP
161. Phytosterols differentially influence ABC transporter expression, cholesterol efflux and inflammatory cytokine secretion in macrophage foam cells
162. Influence of caveolin-1 on cellular cholesterol efflux mediated by high-density lipoproteins
163. Downregulated CD36 and oxLDL uptake and stimulated ABCA1/G1 and cholesterol efflux as anti-atherosclerotic mechanisms of interleukin-10
164. Direct interaction of nuclear liver X receptor-β with ABCA1 modulates cholesterol efflux
165. ABCA1-mediated cholesterol efflux generates microparticles in addition to HDL through processes governed by membrane rigidity
166. Dietary ellagic acid attenuates oxidized LDL uptake and stimulates cholesterol efflux in murine macrophages
167. cholesterol efflux from cells to immunopurified subfractions of human high density lipoprotein: LP-AI and LP-AI/AII.
168. Cellular cholesterol efflux. Role of cell membrane kinetic pools and interaction with apolipoproteins AI, AII, and Cs.
169. … sites on apolipoprotein AI catalyzed by myeloperoxidase in human atheroma and associated oxidative impairment in ABCA1-dependent cholesterol efflux …
170. High-density lipoprotein: key molecule in cholesterol efflux and the prevention of atherosclerosis
171. Macrophage cholesterol efflux and the active domains of serum amyloid A 2.1
172. Paraoxonase 1 (PON1) enhances HDL-mediated macrophage cholesterol efflux via the ABCA1 transporter in association with increased HDL binding to the cells: a …
173. Pioglitazone enhances cholesterol efflux from macrophages by increasing ABCA1/ABCG1 expressions via PPARγ/LXRα pathway: findings from in vitro and ex vivo …
174. PPAR agonists protect mesangial cells from interleukin 1β-induced intracellular lipid accumulation by activating the ABCA1 cholesterol efflux pathway
175. The C-terminal lipid-binding domain of apolipoprotein E is a highly efficient mediator of ABCA1-dependent cholesterol efflux that promotes the assembly of high …
176. Human serum albumin and its structural variants mediate cholesterol efflux from cultured endothelial cells
177. Oxidative stress influences cholesterol efflux in THP-1 macrophages: role of ATP-binding cassette A1 and nuclear factors
178. TGF-β increases cholesterol efflux and ABC-1 expression in macrophage-derived foam cells: opposing the effects of IFN-γ
179. Effects of different dietary cholesterol concentrations on lipoprotein plasma concentrations and on cholesterol efflux from Fu5AH cells
180. Methyl-beta-cyclodextrin improves fertilizing ability of C57BL/6 mouse sperm after freezing and thawing by facilitating cholesterol efflux from the cells
181. cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non-insulin-dependent diabetes: importance …
182. 22R-hydroxycholesterol and 9-cis-retinoic acid induce ATP-binding cassette transporter A1 expression and cholesterol efflux in brain cells and decrease …
183. AGE-BSA decreases ABCG1 expression and reduces macrophage cholesterol efflux to HDL
184. Relationships between cholesterol efflux and high-density lipoprotein particles in patients with type 2 diabetes mellitus
185. Liver X receptor-α mediates cholesterol efflux in glomerular mesangial cells
186. Decreased cellular cholesterol efflux is a common cause of familial hypoalphalipoproteinemia: role of the ABCA1 gene mutations
187. The sterol transporting heterodimer ABCG5/ABCG8 requires bile salts to mediate cholesterol efflux
188. Metformin restores impaired HDL-mediated cholesterol efflux due to glycation
189. … A Inhibit High Density Lipoprotein-mediated cholesterol efflux from cholesterol-enriched Cells: IMPLICATIONS FOR INTRACELLULAR cholesterol …
190. SR-BI inhibits ABCG1-stimulated net cholesterol efflux from cells to plasma HDL
191. SREBP-2 positively regulates transcription of the cholesterol efflux gene, ABCA1, by generating oxysterol ligands for LXR
192. The role of apolipoprotein AI helix 10 in apolipoprotein-mediated cholesterol efflux via the ATP-binding cassette transporter ABCA1
193. CD36-mediated cholesterol efflux is associated with PPARγ activation via a MAPK-dependent COX-2 pathway in macrophages
194. Proteasomal inhibition promotes ATP-binding cassette transporter A1 (ABCA1) and ABCG1 expression and cholesterol efflux from macrophages in vitro and in vivo
195. Stable overexpression of human macrophage cholesteryl ester hydrolase results in enhanced free cholesterol efflux from human THP1 macrophages
196. Telmisartan enhances cholesterol efflux from THP-1 macrophages by activating PPARγ
197. Scavenger receptor-BI inhibits ATP-binding cassette transporter 1-mediated cholesterol efflux in macrophages
198. Plasmalogen phospholipids are involved in HDL-mediated cholesterol efflux: insights from investigations with plasmalogen-deficient cells
199. Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum …
200. Effect of niacin on LXRα and PPARγ expression and HDL-induced cholesterol efflux in adipocytes of hypercholesterolemic rabbits
201. Stimulation of lipolysis enhances the rate of cholesterol efflux to HDL in adipocytes
202. Phenolic-extract from argan oil (Argania spinosa L.) inhibits human low-density lipoprotein (LDL) oxidation and enhances cholesterol efflux from human THP-1 …
203. Insight into ABCG1-mediated cholesterol efflux
204. Adenosine monophosphate-activated protein kinase induces cholesterol efflux from macrophage-derived foam cells and alleviates atherosclerosis in …
205. ATVB In Focus: Role of ABCA1 in cellular cholesterol efflux and reverse cholesterol transport
206. TNF-α decreases ABCA1 expression and attenuates HDL cholesterol efflux in the human intestinal cell line Caco-2
207. Inhibition of ERK1/2 and activation of liver X receptor synergistically induce macrophage ABCA1 expression and cholesterol efflux
208. Serum cholesterol efflux potential is an independent predictor of coronary artery atherosclerosis
209. Dietary monounsaturated fatty acids enhance cholesterol efflux from human fibroblasts. Relation to fluidity, phospholipid fatty acid composition, overall composition …
210. Ca++ antagonists and ACAT inhibitors promote cholesterol efflux from macrophages by different mechanisms. I. Characterization of cellular lipid metabolism.
211. ATP binding cassette G1-dependent cholesterol efflux during inflammation 1
212. Effect of bariatric surgery-induced weight loss on SR-BI-, ABCG1-, and ABCA1-mediated cellular cholesterol efflux in obese women
213. ATP-binding cassette transporter A1 contains a novel C-terminal VFVNFA motif that is required for its cholesterol efflux and ApoA-I binding activities
214. Cellular cholesterol efflux to plasma from moderately hypercholesterolaemic type 1 diabetic patients is enhanced, and is unaffected by simvastatin treatment
215. … of extra virgin olive oil and its enrichment with green tea polyphenols in the atherosclerotic apolipoprotein-E-deficient mice: enhanced macrophage cholesterol efflux
216. Cyclic-AMP initiates protein tyrosine phosphorylation independent of cholesterol efflux during ram sperm capacitation
217. Voluntary exercise increases cholesterol efflux but not macrophage reverse cholesterol transport in vivo in mice
218. Overexpression of steroidogenic acute regulatory protein increases macrophage cholesterol efflux to apolipoprotein AI
219. Enhanced apoA-I-dependent cholesterol efflux by ABCA1 from sphingomyelin-deficient Chinese hamster ovary cells
220. Identification of an apolipoprotein AI structural element that mediates cellular cholesterol efflux and stabilizes ATP binding cassette transporter A1
221. Fibroblast cholesterol efflux to plasma from metabolic syndrome subjects is not defective despite low high-density lipoprotein cholesterol
222. … serum paraoxonase-1 (PON1) is essential for PON1-mediated inhibition of low density lipoprotein oxidation and stimulation of macrophage cholesterol efflux
223. Reduced cholesterol efflux to mildly oxidized high density lipoprotein
224. Interferon-γ–mediated downregulation of cholesterol efflux and ABC1 expression is by the stat1 pathway
225. Malondialdehyde modification and copper-induced autooxidation of high-density lipoprotein decrease cholesterol efflux from human cultured fibroblasts
226. Cellular SR-BI and ABCA1-mediated cholesterol efflux are gender-specific in healthy subjectss⃞
227. Inhibition of cellular cholesterol efflux by 25-hydroxycholesterol.
228. cholesterol efflux, cholesterol esterification, and cholesteryl ester transfer by LpA-I and LpA-I/A-II in native plasma
229. Niacin promotes cholesterol efflux through stimulation of the PPARγ-LXRα-ABCA1 pathway in 3T3-L1 adipocytes
230. Endogenous apolipoprotein E modulates cholesterol efflux and cholesteryl ester hydrolysis mediated by high-density lipoprotein-3 and lipid-free apolipoproteins in …
231. LPS-induced suppression of macrophage cholesterol efflux is mediated by adipocyte enhancer-binding protein 1
232. Human ApoA-IV overexpression in transgenic mice induces cAMP-stimulated cholesterol efflux from J774 macrophages to whole serum
233. Ceramide enhances cholesterol efflux to apolipoprotein AI by increasing the cell surface presence of ATP-binding cassette transporter A1
234. Cell cholesterol efflux to Reconstituted High-Density Lipoproteins Containing the Apolipoprotein AIMilano Dimer
235. … cholesterol-enriched nascent high density lipoproteins by human monocyte-derived macrophages is a mechanism that contributes to macrophage cholesterol …
236. Increased cholesterol efflux in Apolipoprotein AI (ApoAI)–Producing Macrophages as a Mechanism for Reduced Atherosclerosis in ApoAI(−/−) Mice
237. Sterol carrier protein-2 alters high density lipoprotein-mediated cholesterol efflux
238. Eicosapentaenoic acid reduces ABCA1 serine phosphorylation and impairs ABCA1-dependent cholesterol efflux through cyclic AMP/protein kinase A signaling …
239. Increased phospholipid transfer protein activity associated with the impaired cellular cholesterol efflux in type 2 diabetic subjects with coronary artery disease
240. The role of the ABCA1 transporter and cholesterol efflux in familial hypoalphalipoproteinemia
241. … high density lipoprotein particle containing the apolipoprotein A-IMilano dimer effectively promotes ATP-binding cassette A1-mediated cell cholesterol efflux
242. Purification of ATP-binding cassette transporter A1 and associated binding proteins reveals the importance of β1-syntrophin in cholesterol efflux
243. Human macrophage cholesterol efflux potential is enhanced by HDL-associated 17β-estradiol fatty acyl esters
244. The origin and metabolism of a nascent pre-β high density lipoprotein involved in cellular cholesterol efflux.
245. Role of serum amyloid a in adipocyte-macrophage cross talk and adipocyte cholesterol efflux
246. cholesterol efflux effect of high density lipoprotein is impaired by whole cigarette smoke extracts through lipid peroxidation
247. Differential role of apolipoprotein AI-containing particles in cholesterol efflux from adipose cells
248. Serum, but not monocyte macrophage foam cells derived from low HDL-C subjects, displays reduced cholesterol efflux capacity
249. An amphipathic helical region of the N-terminal barrel of phospholipid transfer protein is critical for ABCA1-dependent cholesterol efflux
250. Inhibition of cholesterol efflux by 7-ketocholesterol: comparison between cells, plasma membrane vesicles, and liposomes as cholesterol donors
251. Expression of human lecithin: cholesterol acyltransferase in transgenic mice: effects on cholesterol efflux, esterification, and transport
252. Selective down-regulation by protein kinase C inhibitors of apolipoprotein-mediated cellular cholesterol efflux in macrophages
253. Oxidation of high density lipoproteins: characterization and effects on cholesterol efflux from J774 macrophages
254. Role of apolipoproteins in cholesterol efflux from macrophages to lipid microemulsion: Proposal of a putative model for the pre-. beta.-high-density lipoprotein pathway
255. Role of free apolipoprotein AI in cholesterol efflux: formation of pre–α-migrating high-density lipoprotein particles
256. Activation of phosphatidylinositol-specific phospholipase C by HDL-associated lysosphingolipid. Involvement in mitogenesis but not in cholesterol efflux
257. Helix stabilization of amphipathic peptides by hydrocarbon stapling increases cholesterol efflux by the ABCA1 transporter
258. Pharmacological regulation of cholesterol efflux in human monocyte-derived macrophages in the absence of exogenous cholesterol acceptors
259. Marrubium vulgare extract inhibits human-LDL oxidation and enhances HDL-mediated cholesterol efflux in THP-1 macrophage
260. Reduced ABCA1-mediated cholesterol efflux and accelerated atherosclerosis in Apolipoprotein E–deficient mice lacking macrophage-derived ACAT1
261. Apolipoprotein AI-stimulated apolipoprotein E secretion from human macrophages is independent of cholesterol efflux
262. … linoleic acid increases expression of the cholesterol transporters ABCA1, ABCG1 and SR-BI and stimulates apoA-I-dependent cholesterol efflux in RAW264. 7 …
263. Atorvastatin inhibits ABCA1 expression and cholesterol efflux in THP-1 macrophages by an LXR-dependent pathway
264. Liver X receptor stimulates cholesterol efflux and inhibits expression of proinflammatory mediators in human airway smooth muscle cells
265. Regulation of cholesterol efflux by amyloid β secretion
266. Hypochlorite modification of high density lipoprotein: effects on cholesterol efflux from J774 macrophages
267. Cyclic AMP-specific phosphodiesterase 4 inhibitors promote ABCA1 expression and cholesterol efflux
268. Human immunodeficiency virus protease inhibitor ritonavir inhibits cholesterol efflux from human macrophage-derived foam cells
269. Formation of two intramolecular disulfide bonds is necessary for ApoA-I-dependent cholesterol efflux mediated by ABCA1
270. Abnormal capacity to induce cholesterol efflux and a new LpA-I pre-β particle in type 2 diabetic patients
271. Role of the plasma membrane in the mechanism of cholesterol efflux from cells
272. Aminoguanidine and metformin prevent the reduced rate of HDL-mediated cell cholesterol efflux induced by formation of advanced glycation end products
273. … accumulation of ceramide in Chinese hamster ovary cells affects detergent-resistant membrane domains and enhances cellular cholesterol efflux to methyl-β …
274. Apolipoprotein composition and particle size affect HDL degradation by chymase: effect on cellular cholesterol efflux
275. Effect of atorvastatin on SR-BI expression and HDL-induced cholesterol efflux in adipocytes of hypercholesterolemic rabbits
276. Circulating Nef induces dyslipidemia in simian immunodeficiency virus-infected macaques by suppressing cholesterol efflux
277. Effects of sphingomyelin and phosphatidylcholine degradation on cyclodextrin-mediated cholesterol efflux in cultured fibroblasts
278. … inhibits cholesterol efflux via the ABCA1/apolipoprotein AI pathway: 1-phenyl-2-decanoylamino-3-morpholino-1-propanol is a novel cholesterol efflux …
279. Lysophosphatidylcholine promotes cholesterol efflux from mouse macrophage foam cells
280. Glycation of high-density lipoprotein does not increase its susceptibility to oxidation or diminish its cholesterol efflux capacity
281. Triglyceride-rich lipoproteins inhibit cholesterol efflux to apolipoprotein (apo) A1 from human macrophage foam cells
282. Human scavenger receptor class B type II (SR-BII) and cellular cholesterol efflux
283. Selective uptake of HDL cholesteryl esters and cholesterol efflux from mouse peritoneal macrophages independent of SR-BI
284. Mast Cell Chymase Degrades ApoE and ApoA-II in ApoA-I–Knockout Mouse Plasma and Reduces Its Ability to Promote Cellular cholesterol efflux
285. SPTLC1 binds ABCA1 to negatively regulate trafficking and cholesterol efflux activity of the transporter
286. Increased prebeta-HDL levels, cholesterol efflux, and LCAT-mediated esterification in mice expressing the human cholesteryl ester transfer protein (CETP) and human …
287. cholesterol efflux from macrophage foam cells is enhanced by active phospholipid transfer protein through generation of two types of acceptor particles
288. Characteristics of the cholesterol efflux induced by novel seminal phospholipid-binding proteins
289. D-4F, an apolipoprotein AI mimetic peptide, promotes cholesterol efflux from macrophages via ATP-binding cassette transporter A1
290. Macrophage ABCA5 deficiency influences cellular cholesterol efflux and increases susceptibility to atherosclerosis in female LDLr knockout mice
291. HDL2 of Heavy Alcohol Drinkers Enhances cholesterol efflux From Raw Macrophages via Phospholipid‐Rich HDL2b Particles
292. Triglyceride-Rich HDL3 from Patients with Familial Hypercholesterolemia Are Less Able to Inhibit Cytokine Release or to Promote cholesterol efflux
293. Low-dose expression of a human apolipoprotein E transgene in macrophages restores cholesterol efflux capacity of apolipoprotein E-deficient mouse plasma
294. Tibolone lowers high density lipoprotein cholesterol by increasing hepatic lipase activity but does not impair cholesterol efflux
295. Impaired serum capacity to induce cholesterol efflux is associated with endothelial dysfunction in type 2 diabetes mellitus
296. Estrous sheep serum as a potent agent for ovine IVF: effect on cholesterol efflux from spermatozoa and the acrosome reaction
297. Isoform-dependent cholesterol efflux from macrophages by apolipoprotein E is modulated by cell surface proteoglycans
298. Ca++ antagonists and ACAT inhibitors promote cholesterol efflux from macrophages by different mechanisms. II. Characterization of intracellular morphologic changes …
299. Macrophage cholesterol efflux correlates with lipoprotein subclass distribution and risk of obstructive coronary artery disease in patients undergoing coronary …
300. Chymase in exocytosed rat mast cell granules effectively proteolyzes apolipoprotein AI-containing lipoproteins, so reducing the cholesterol efflux-inducing ability of …
301. Molecular interaction between caveolin-1 and ABCA1 on high-density lipoprotein-mediated cholesterol efflux in aortic endothelial cells
302. Glucocorticoid receptor regulates ATP-binding cassette transporter-A1 expression and apolipoprotein-mediated cholesterol efflux from macrophages
303. cholesterol efflux from adipose cells is coupled to diacylglycerol production and protein kinase C activation
304. Recycling of apolipoprotein E is not associated with cholesterol efflux in neuronal cells
305. Common ABCA1 variants, HDL levels, and cellular cholesterol efflux in subjects with familial low HDLs⃞
306. Enhanced cholesterol efflux by tyrosyl radical-oxidized high density lipoprotein is mediated by apolipoprotein AI-AII heterodimers
307. Walnut oil increases cholesterol efflux through inhibition of stearoyl CoA desaturase 1 in THP-1 macrophage-derived foam cells
308. Comparison of different cellular models measuring in vitro the whole human serum cholesterol efflux capacity
309. ApoE-mediated cholesterol efflux from macrophages: separation of autocrine and paracrine effects
310. cholesterol efflux, Lecithin− cholesterol Acyltransferase Activity, and Pre-β Particle Formation by Serum from Human Apolipoprotein AI and Apolipoprotein AI …
311. PPARγ1-induced caveolin-1 enhances cholesterol efflux and attenuates atherosclerosis in apolipoprotein E-deficient mice
312. A kinetic model to evaluate cholesterol efflux from THP-1 macrophages to apolipoprotein A-1
313. Modulation of cholesterol efflux from Fu5AH Hepatoma Cells by the Apolipoprotein Content of High Density Lipoprotein Particles.: PARTICLES CONTAINING …
314. cholesterol efflux via HDL resecretion occurs when cholesterol transport out of the lysosome is impaireds⃞
315. The role of different regions of ATP-binding cassette transporter A1 in cholesterol efflux
316. Impaired cellular cholesterol efflux by oxysterol-enriched high density lipoproteins
317. … hormone-releasing peptide that binds scavenger receptor CD36 and ghrelin receptor up-regulates sterol transporters and cholesterol efflux in macrophages through …
318. Dual use of amphiphilic macromolecules as cholesterol efflux triggers and inhibitors of macrophage athero-inflammation
319. Apolipoprotein AI-containing particles and reverse cholesterol transport: evidence for connection between cholesterol efflux and atherosclerosis risk
320. Observation of cellular cholesterol efflux at microcavity electrodes
321. Pathway of cholesterol efflux from human hepatoma cells
322. A2A adenosine receptor stimulation decreases foam cell formation by enhancing ABCA1‐dependent cholesterol efflux
323. Polyphenols and cholesterol efflux: is coffee the next red wine?
324. cholesterol efflux from arterial wall cells
325. … is defective in activation of lecithin: cholesterol acyltransferase but not in initial lipid binding, formation of reconstituted lipoproteins, or promotion of cholesterol efflux
326. CETP deficiency due to a novel mutation in the CETP gene promoter and its effect on cholesterol efflux and selective uptake into hepatocytes
327. Effects of high-density lipoprotein particles containing apo AI, with or without apo A-II, on intracellular cholesterol efflux
328. … in type IIb hyperlipoproteinemia: modulation of the atherogenic lipoprotein phenotype and stimulation of high-density lipoprotein-mediated cellular cholesterol efflux
329. Characterization of high-density lipoprotein binding and cholesterol efflux in cultured mouse adipose cells
330. Group X Secretory Phospholipase A2 Negatively Regulates ABCA1 and ABCG1 Expression and cholesterol efflux in Macrophages
331. Macrophage cholesterol efflux elicited by human total plasma and by HDL subfractions is not affected by different types of dietary fatty acids
332. ABCA1 increases extracellular ATP to mediate cholesterol efflux to ApoA-I
333. Rab8 regulates ABCA1 cell surface expression and facilitates cholesterol efflux in primary human macrophages
334. Endothelial lipase promotes apolipoprotein AI-mediated cholesterol efflux in THP-1 macrophages
335. High glucose stimulates macrophage SR-BI expression and induces a switch in its activity from cholesterol efflux to cholesterol influx
336. cholesterol efflux to apoA-I in ABCA1-expressing cells is regulated by Ca2+-dependent calcineurin signaling
337. Decreased reverse cholesterol transport from Tangier disease fibroblasts: acceptor specificity and effect of brefeldin on lipid efflux
338. cholesterol efflux Capacity In Vitro Predicts the Severity and Extent of Coronary Artery Disease in Patients with and without Type 2 Diabetes
339. cholesterol efflux potential of sera from mice expressing human cholesteryl ester transfer protein and/or human apolipoprotein AI.
340. LXRβ is the dominant LXR subtype in skeletal muscle regulating lipogenesis and cholesterol efflux
341. Contribution of D4-F to ABCA1 expression and cholesterol efflux in THP-1 macrophage-derived foam cells
342. Dietary modification of high density lipoprotein phospholipid and influence on cellular cholesterol efflux
343. … and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux
344. … of subspecies of lipoprotein containing apolipoprotein AI on cholesterol efflux from cholesterol-loaded macrophages: functional correlation with lecithin: cholesterol …
345. Detergent-mediated phospholipidation of plasma lipoproteins increases HDL cholesterophilicity and cholesterol efflux via SR-BI
346. Binding of PDZ-RhoGEF to ATP-binding cassette transporter A1 (ABCA1) induces cholesterol efflux through RhoA activation and prevention of transporter …
347. AOPPs inhibits cholesterol efflux by down-regulating ABCA1 expression in a JAK/STAT signaling pathway-dependent manner
348. Apolipoprotein CI aggravates atherosclerosis development in ApoE-knockout mice despite mediating cholesterol efflux from macrophages
349. Matrix Metalloproteinases-3,-7, and-12, but Not-9, Reduce High Density Lipoprotein-induced cholesterol efflux from Human Macrophage Foam Cells by …
350. High‐density lipoproteins from probucol‐treated patients have increased capacity to promote cholesterol efflux from mouse peritoneal macrophages loaded with …
351. Rosuvastatin blocks advanced glycation end products-elicited reduction of macrophage cholesterol efflux by suppressing NADPH oxidase activity via inhibition of …
352. Cellular phospholipid and cholesterol efflux in high-density lipoprotein deficiency
353. Opposite effects of plasma from human apolipoprotein A-II transgenic mice on cholesterol efflux from J774 macrophages and Fu5AH hepatoma cells
354. Ethanol induces cholesterol efflux and up-regulates ATP-binding cassette cholesterol transporters in fetal astrocytes
355. Limited proteolysis of high density lipoprotein abolishes its interaction with cell-surface binding sites that promote cholesterol efflux
356. Tracking diffusion of GM1 gangliosides and zona pellucida binding molecules in sperm plasma membranes following cholesterol efflux
357. Delineation of the Role of Pre-β1-HDL in cholesterol efflux Using Isolated Pre-β1-HDL
358. Synthesis and secretion of apoE in thioglycolate-elicited mouse peritoneal macrophages: effect of cholesterol efflux.
359. Localization of an apolipoprotein AI epitope critical for lipoprotein-mediated cholesterol efflux from monocytic cells.
360. Rate‐limiting factors of cholesterol efflux in reverse cholesterol transport: Acceptors and donors
361. ABCA1-dependent but apoA-I-independent cholesterol efflux mediated by fatty acid–bile acid conjugates (FABACs)
362. Secretory vesicular transport from the Golgi is altered during ATP-binding cassette protein A1 (ABCA1)-mediated cholesterol efflux
363. Role of ABC1 gene in cholesterol efflux and atheroprotection.
364. Apolipoprotein AIFIN (Leu159→Arg) Mutation Affects Lecithin: cholesterol Acyltransferase Activation and Subclass Distribution of HDL but Not cholesterol efflux …
365. Oxidative tyrosylation of high density lipoproteins impairs cholesterol efflux from mouse J774 macrophages: role of scavenger receptors, classes A and B
366. Evidence for the separation of albumin-and apo AI-dependent mechanisms of cholesterol efflux from cultured fibroblasts into human plasma.
367. Angiotensin II reduces macrophage cholesterol efflux: a role for the AT-1 receptor but not for the ABC1 transporter
368. Caveolin-1 does not affect SR-BI-mediated cholesterol efflux or selective uptake of cholesteryl ester in two cell lines
369. Influence of the fatty acid composition of high-density lipoprotein phospholipids on the cholesterol efflux from cultured fibroblasts
370. Serum cholesterol efflux potential in postmenopausal women treated with isolated isoflavones
371. Depletion of Preβ1LpA1 and LpA4 Particles by Mast Cell Chymase Reduces cholesterol efflux From Macrophage Foam Cells Induced by Plasma
372. Testing the role of apoA-I, HDL, and cholesterol efflux in the atheroprotective action of low-level apoE expression
373. Impact of android overweight or obesity and insulin resistance on basal and postprandial SR-BI and ABCA1-mediated serum cholesterol efflux capacities
374. Acidic extracellular environments strongly impair ABCA1-mediated cholesterol efflux from human macrophage foam cells
375. Targeting HDL-mediated cellular cholesterol efflux for the treatment and prevention of atherosclerosis
376. The C-terminal domain of apolipoprotein AI is involved in ABCA1-driven phospholipid and cholesterol efflux
377. Impact of heme oxygenase‐1 on cholesterol synthesis, cholesterol efflux and oxysterol formation in cultured astroglia
378. … expression of a member of the Rho GTPase family, Cdc42Hs, in cells from Tangier disease–the small G protein may play a role in cholesterol efflux
379. LDL particle subspecies are distinct in their capacity to mediate free cholesterol efflux via the SR-BI/Cla-1 receptor
380. Effect of apolipoprotein AI on ATP binding cassette transporter A1 degradation and cholesterol efflux in THP-1 macrophage-derived foam cells
381. Effect of sterol carrier protein-2 gene ablation on HDL-mediated cholesterol efflux from cultured primary mouse hepatocytes
382. Lysophosphatidylcholine promotes cholesterol efflux from mouse macrophage foam cells via PPARγ‐LXRα‐ABCA1‐dependent pathway associated with apoE
383. cholesterol metabolism and efflux in human THP-1 macrophages
384. Inhibition of acyl-coenzyme A: cholesterol acyltransferase stimulates cholesterol efflux from macrophages and stimulates farnesoid X receptor in hepatocytes
385. … obese patients with type 2 diabetes mellitus decreases plasma CETP and increases apolipoprotein AI levels without improving the cholesterol efflux properties of HDL
386. Regulation of phospholipid biosynthesis during cholesterol influx and high density lipoprotein-mediated cholesterol efflux in macrophages
387. Specific phospholipid association with apolipoprotein AI stimulates cholesterol efflux from human fibroblasts: Studies with reconstituted sonicated lipoproteins
388. Lowering of HDL cholesterol in post-menopausal women by tibolone is not associated with changes in cholesterol efflux capacity or paraoxonase activity
389. … derived from the different phases of conjugated diene formation reduces membrane fluidity and contributes to a decrease in free cholesterol efflux from human THP-1 …
390. Species difference in cholesteryl ester cycle and HDL-induced cholesterol efflux from macrophage foam cells.
391. Different effects of subclasses of HDL containing apoA-I but not apoA-II (LpA-I) on cholesterol esterification in plasma and net cholesterol efflux from foam cells
392. Disruption of the C-terminal helix by single amino acid deletion is directly responsible for impaired cholesterol efflux ability of apolipoprotein AI Nichinan
393. cholesterol efflux: mechanism and regulation
394. Epoxycholesterol impairs cholesteryl ester hydrolysis in macrophage foam cells, resulting in decreased cholesterol efflux
395. Butyrate stimulates ApoA‐IV‐containing lipoprotein secretion in differentiated Caco‐2 cells: Role in cholesterol efflux
396. Antitumoral alkylphospholipids induce cholesterol efflux from the plasma membrane in HepG2 cells
397. cholesterol efflux from bovine sperm: II. Effect of reducing sperm cholesterol on penetration of zona‐free hamster and in vitro matured bovine ova
398. … containing human apolipoprotein AI (ApoA-I) variants with murine adipocytes and macrophages. Evidence for reduced cholesterol efflux promotion by apoA-I …
399. cholesterol efflux from J774 macrophages and Fu5AH hepatoma cells to serum is preserved in CETP-deficient patients
400. Involvement of a cellular surface factor (s) in lipid-free apolipoprotein-mediated cellular cholesterol efflux
401. Identification of the bovine cholesterol efflux regulatory protein ABCA1 and its expression in various tissues
402. Wogonin promotes cholesterol efflux by increasing protein phosphatase 2B-dependent dephosphorylation at ATP-binding cassette transporter-A1 in macrophages
403. Retinoic acid isomers up-regulate ATP binding cassette A1 and G1 and cholesterol efflux in rat astrocytes: implications for their therapeutic and teratogenic effects
404. efflux of cholesterol from different cellular pools
405. Atherogenic lipids induce high-density lipoprotein uptake and cholesterol efflux in human macrophages by up-regulating transmembrane chemokine CXCL16 without …
406. Endothelial lipase-modified high-density lipoprotein exhibits diminished ability to mediate SR-BI (scavenger receptor B type I)-dependent free-cholesterol efflux
407. Effect of cyclooxygenase inhibition on cholesterol efflux proteins and atheromatous foam cell transformation in THP-1 human macrophages: a possible …
408. Effect of isolated isoflavone supplementation on ABCA1-dependent cholesterol efflux potential in postmenopausal women
409. ω-3 Fatty acids in smooth muscle cell phospholipids increase membrane cholesterol efflux
410. Diminished rate of mouse peritoneal macrophage cholesterol efflux is not related to the degree of HDL glycation in diabetes mellitus
411. Probucol enhances cholesterol efflux from cultured human skin fibroblasts.
412. Effects of dietary vitamin C and E supplementation on the copper mediated oxidation of HDL and on HDL mediated cholesterol efflux
413. Tributyltin chloride induces ABCA1 expression and apolipoprotein AI-mediated cellular cholesterol efflux by activating LXRalpha/RXR
414. SR-BI-and ABCA1-mediated cholesterol efflux to serum from patients with Alagille syndrome
415. Cellular cholesterol efflux is modulated by phospholipid-derived signaling molecules in familial HDL deficiency/Tangier disease fibroblasts
416. SR‐BI, CD36, and caveolin‐1 contribute positively to cholesterol efflux in hepatic cells
417. Acute-phase-HDL remodeling by heparan sulfate generates a novel lipoprotein with exceptional cholesterol efflux activity from macrophages
418. Twenty four hour insulin infusion impairs the ability of plasma from healthy subjects and Type 2 diabetic patients to promote cellular cholesterol efflux
419. Plasmin and kallikrein reduce HDL-induced cholesterol efflux from foam cells
420. … -sensitive and lipid-containing sites of the macrophage extracellular matrix bind apolipoprotein AI and participate in ABCA1-dependent cholesterol efflux
421. Effects of genotype and diet on cholesterol efflux into plasma and lipoproteins of normal, apolipoprotein AI-, and apolipoprotein E-deficient mice
422. Ht31, a protein kinase A anchoring inhibitor, induces robust cholesterol efflux and reverses macrophage foam cell formation through ATP-binding cassette …
423. cholesterol efflux from fibroblasts to discoidal lipoproteins with apolipoprotein AI (LpA-I) increases with particle size but cholesterol transfer from LpA-I to lipoproteins …
424. Highly active antiretroviral therapy drugs inhibit in vitro cholesterol efflux from human macrophage-derived foam cells
425. Disruption of cholesterol efflux by coxib medications and inflammatory processes: link to increased cardiovascular risk
426. The effect of glucagon, norepinephrine, and dibutyryl cyclic AMP on cholesterol efflux and on the activity of 3-hydroxy-3-methylglutaryl CoA reductase in rat …
427. Oleic acid-rich increase increase the capacity of postprandial serum to promote cholesterol efflux from Fu5AH cells
428. … phospholipases C and D in a kindred with Tangier disease. Evidence for the involvement of phosphatidylcholine breakdown in HDL-mediated cholesterol efflux …
429. Effect of phospholipid fatty acid composition of endothelial cells on cholesterol efflux rates.
430. Apolipoprotein E expression in Y1 adrenal cells is associated with increased intracellular cholesterol content and reduced free cholesterol efflux
431. Serum cholesterol efflux potential in postmenopausal monkeys treated with tibolone or conjugated estrogens
432. A low‐saturated‐fat, low‐cholesterol diet decreases plasma CETP activity and pre β‐HDL formation but does not affect cellular cholesterol efflux to plasma from type 1 …
433. Guanosine effect on cholesterol efflux and apolipoprotein E expression in astrocytes
434. Triglyceride depletion in THP-1 cells alters cholesteryl ester physical state and cholesterol efflux
435. 15-Lipoxygenase-mediated modification of high-density lipoproteins impairs SR-BI-and ABCA1-dependent cholesterol efflux from macrophages
436. … -dependent proteolytic modification of HDL particles during anaphylactic shock in the mouse reduces their ability to induce cholesterol efflux from macrophage foam …
437. The molecular structure of apolipoprotein A-II modulates the capacity of HDL to promote cell cholesterol efflux
438. A novel mutant, ApoA-I nichinan (Glu235→ 0), is associated with low HDL cholesterol levels and decreased cholesterol efflux from cells
439. Postprandial variations in the cholesteryl ester transfer protein activity, phospholipid transfer protein activity and plasma cholesterol efflux capacity in normolipidemic …
440. HDL-mediated efflux of intracellular cholesterol is impaired in fibroblasts from Tangier disease patients
441. Postprandial lipemia enhances the capacity of large HDL2 particles to mediate free cholesterol efflux via SR-BI and ABCG1 pathways in type IIB …
442. Apolipoprotein AI structural modification and the functionality of reconstituted high density lipoprotein particles in cellular cholesterol efflux
443. The effects of mutations in helices 4 and 6 of ApoA-I on scavenger receptor class B type I (SR-BI)-mediated cholesterol efflux suggest that formation of a …
444. Possibility of increasing cholesterol efflux by adiponectin and its receptors through the ATP binding cassette transporter A1 in HEK293T cells
445. … AI-and A-II-containing lipoproteins in a new case of high density lipoprotein deficiency resembling Tangier disease and their effects on intracellular cholesterol efflux.
446. … plasma to stimulate fibroblast cholesterol efflux is associated with the− 629C→ A cholesteryl ester transfer protein promoter polymorphism: Role of lecithin: cholesterol …
447. Enhanced placental cholesterol efflux by fetal HDL in Smith–Lemli–Opitz syndrome
448. Effect of the apolipoprotein AI and surface lipid composition of reconstituted discoidal HDL on cholesterol efflux from cultured fibroblasts
449. cholesterol efflux from larval Manduca sexta fat body in vitro: high-density lipophorin as the acceptor
450. Role of phospholipid transfer protein and preß-high density lipoproteins in maintaining cholesterol efflux from Fu5AH cells to plasma from insulin-resistant subjects
451. Subclasses of LpA‐I in coronary artery disease: distribution and cholesterol efflux ability
452. Role of apolipoproteins AI, A-II and CI in cholesterol efflux from endothelial and smooth muscle cells
453. cholesterol efflux is defective in macrophages from atherosclerosis-susceptible White Carneau pigeons relative to resistant show racer pigeons.
454. Effects of interactions of apolipoprotein A-II with apolipoproteins AI or A-IV on [3H] cholesterol efflux and uptake in cell culture
455. Acid sphingomyelinase-deficient macrophages have defective cholesterol trafficking and efflux
456. Placental ABCA1 and ABCG1 transporters efflux cholesterol and protect trophoblasts from oxysterol induced toxicity
457. cholesterol efflux to high-density lipoproteins and apolipoprotein AI phosphatidylcholine complexes is inhibited by ethanol: role of apolipoprotein structure and …
458. Effects of relaxin and IGF-I on capacitation, acrosome reaction, cholesterol efflux and utilization of labeled and unlabeled glucose in porcine spermatozoa
459. HDL Receptor-Mediated cholesterol efflux from Cells and its Regulattion
460. Accumulation of RhoA, RhoB, RhoG, and Rac1 in fibroblasts from Tangier disease subjects suggests a regulatory role of Rho family proteins in cholesterol efflux
461. Differential rate of cholesterol efflux from the apical and basolateral membranes of MDCK cells
462. HDL receptors and cholesterol efflux from parenchymal cells
463. Mechanisms of high density lipoprotein-mediated efflux of cholesterol from cell plasma membranes
464. cholesterol efflux from and high‐density‐lipoproteins binding to cultured bovine vascular endothelial cells are higher than with vascular smooth muscle cells
465. ABCA1 modulates the oligomerization and Golgi exit of caveolin-1 during HDL-mediated cholesterol efflux in aortic endothelial cells
466. Effect of LCAT on HDL-mediated cholesterol efflux from loaded EA. hy 926 cells.
467. LXR/RXR activation enhances basolateral efflux of cholesterol in CaCo-2 cells
468. Liver X receptor and retinoic X receptor mediated ABCA1 regulation and cholesterol efflux in macrophage cells—messenger RNA measured by branched DNA …
469. cholesterol efflux from macrophages mediated by high-density lipoprotein subfractions, which differ principally in apolipoprotein AI and apolipoprotein A-II ratios
470. Role of HDL phospholipid in efflux of cell cholesterol to whole serum: studies with human apoA-I transgenic rats.
471. Differential effects of an acyl-coenzyme A: cholesterol acyltransferase inhibitor on HDL-induced cholesterol efflux from rat macrophage foam cells
472. Insulin suppresses HDL-mediated cholesterol efflux from macrophages through inhibition of neutral cholesteryl ester hydrolase and ATP-binding cassette transporter …
473. LDL inhibits the mediation of cholesterol efflux from macrophage foam cells by apoA-I-containing lipoproteins. A putative mechanism for foam cell formation.
474. LXR-induced redistribution of ABCG1 to plasma membrane in macrophages enhances cholesterol mass efflux to HDL
475. The endothelial cholesterol efflux is promoted by the high-density lipoprotein anionic peptide factor
476. Decreased cholesterol efflux from fibroblasts of a patient without Tangier disease, but with markedly reduced high density lipoprotein cholesterol levels
477. cholesterol efflux and the effect of combined treatment with niacin and chromium on aorta of hyperlipidemic rat
478. Ceramide structural features required to stimulate ABCA1-mediated cholesterol efflux to apolipoprotein AI
479. HDL3-retroendocytosis in cultured small intestinal crypt cells: a novel mechanism of cholesterol efflux
480. High density lipoprotein 3 inhibits oxidized low density lipoprotein-induced apoptosis via promoting cholesterol efflux in RAW264. 7 cells
481. ABCA1 and placental cholesterol efflux
482. Effects of probucol on cholesterol metabolism in mouse peritoneal macrophages: inhibition of HDL-mediated cholesterol efflux
483. … -X-receptor-mediated increase in ATP-binding cassette transporter A1 expression is attenuated by fatty acids in CaCo-cells: effect on cholesterol efflux to high-density …
484. Macrophage cholesterol efflux to plasma and HDL in subjects with low and high homocysteine levels: a FIELD substudy
485. cholesterol efflux from Fu5AH cells to the serum of patients with Alagille syndrome: importance of the HDL-phospholipids/free cholesterol ratio and of the HDL …
486. Brefeldin A inhibits cholesterol efflux without affecting the rate of cellular uptake and re-secretion of apolipoprotein AI in adipocytes
487. cholesterol efflux from human monocyte-derived macrophages in the presence of LpA-I: A-II
488. Effects of niacin and Niaspan on HDL lipoprotein cellular SR-BI–mediated cholesterol efflux
489. The role of hydrophobic and negatively charged surface patches of lipid-free apolipoprotein AI in lipid binding and ABCA1-mediated cholesterol efflux
490. Effects of NTE-122, a Novel Acyl-CoA: cholesterol Acyltransferase Inhibitor, on cholesterol Esterification and High-Density LipoproteinInduced cholesterol efflux in …
491. cholesterol efflux stimulates metalloproteinase-mediated cleavage of occludin and release of extracellular membrane particles containing its C-terminal fragments
492. Modification of HDL3 by mild oxidative stress increases ATP-binding cassette transporter 1-mediated cholesterol efflux
493. Defective cholesterol efflux in Werner syndrome fibroblasts and its phenotypic correction by Cdc42, a RhoGTPase
494. Molecular species composition of membrane phosphatidylcholine influences the rate of cholesterol efflux from human erythrocytes and vesicles of erythrocyte lipid
495. … of telomerase-immortalized Tangier disease cell lines indicates the existence of an apolipoprotein AI-inducible but ABCA1-independent cholesterol efflux …
496. Effects of oleic acid and macrophage recruitment on cholesterol efflux in cell culture and in vivo
497. Sequential estrogen-progestin replacement therapy in healthy postmenopausal women: effects on cholesterol efflux capacity and key proteins regulating high-density …
498. Antiretroviral compounds and cholesterol efflux from macrophages
499. cholesterol efflux from cells enriched with cholesteryl esters by incubation with hypercholesterolemic monkey low density lipoprotein
500. Caveolin-1-mediated apolipoprotein AI membrane binding sites are not required for cholesterol efflux
501. Sterol synthesis is up-regulated in cholesterol-loaded pigeon macrophages during induction of cholesterol efflux
502. Quantitation of pre. beta.-HDL-dependent and nonspecific components of the total efflux of cellular cholesterol and phospholipid
503. Polarized cholesterol and phospholipid efflux in cultured gall-bladder epithelial cells: evidence for an ABCA1-mediated pathway
504. Stably transfected ABCA1 antisense cell line has decreased ABCA1 mRNA and cAMP-induced cholesterol efflux to apolipoprotein AI and HDL
505. Interaction abolishment between mutant caveolin-1Δ62–100 and ABCA1 reduces HDL-mediated cellular cholesterol efflux
506. Design of a new class of amphipathic helical peptides for the plasma apolipoproteins that promote cellular cholesterol efflux but do not activate LCAT
507. Effects of human follicular fluid and high-density lipoproteins on early spermatozoa hyperactivation and cholesterol efflux
508. High-density lipoprotein-induced cholesterol efflux from arterial smooth muscle cell-derived foam cells: functional relationship of the cholesteryl ester cycle and …
509. Cell surface-expressed moesin-like HDL/apoA-I binding protein promotes cholesterol efflux from human macrophages
510. Lecithin: cholesterol acyltransferase reaction on cellular lipid released by free apolipoprotein-mediated efflux
511. N-3 polyunsaturated fatty acids enhance cholesterol efflux from human fibroblasts in culture
512. Serum opacity factor enhances HDL-mediated cholesterol efflux, esterification and anti inflammatory effects
513. Absence of endogenous phospholipid transfer protein impairs ABCA1-dependent efflux of cholesterol from macrophage foam cells
514. Effects of oleate on ATP binding cassette transporter A1 expression and cholesterol efflux in THP-1 macrophage-derived foam cells
515. Basal and postprandial serum-promoted cholesterol efflux in normolipidemic subjects: importance of fat mass distribution
516. Decrease in high density lipoprotein binding sites is associated with decrease in intracellular cholesterol efflux in dedifferentiated aortic smooth muscle cells
517. efflux of cellular cholesterol and phospholipid to lipid-free apolipoproteins and class A amphipathic peptides
518. efflux of cellular cholesterol and phospholipid to apolipoprotein AI mutants
519. Effects on apoB-100 secretion and bile acid synthesis by redirecting cholesterol efflux from HepG2 cells
520. cholesterol delivered to macrophages by oxidized low density lipoprotein is sequestered in lysosomes and fails to efflux normally
521. Increased scavenger receptor class B type I-mediated cellular cholesterol efflux and antioxidant capacity in the sera of glycogen storage disease type Ia patients
522. cholesterol and plant sterol efflux from cultured intestinal epithelial cells is mediated by ATP-binding cassette transporters
523. Macrophage cholesterol efflux to free apoprotein AI in C3H and C57BL/6 mice
524. Cellular cholesterol efflux to plasma from proteinuric patients is elevated and remains unaffected by antiproteinuric treatment
525. The discovery of tertiary-amine LXR agonists with potent cholesterol efflux activity in macrophages
526. Physicochemical changes in HDL3 after bezafibrate treatment: influence on free cholesterol efflux from human fibroblasts
527. Aspirin increases apolipoprotein-AI-mediated cholesterol efflux via enhancing expression of ATP-binding cassette transporter A1
528. Lipid metabolism: recent progress in defining the contributions of cholesterol transporters to cholesterol efflux in vitro and in vivo
529. Cellular cholesterol efflux mediated by HDL isolated from subjects with low HDL levels and coronary artery disease
530. Binding of modified high density lipoproteins to endothelial cells: relation with cellular cholesterol efflux?
531. Cellular cholesterol transport and efflux in fibroblasts are abnormal in subjects with familial HDL deficiency
532. … up-regulate β-very low density lipoprotein-mediated cholesterol accumulation by enhancing β-very low density lipoprotein uptake and decreasing cholesterol efflux
533. HDL3-mediated cholesterol efflux from cultured enterocytes: the role of apoproteins AI and A-II
534. cholesterol efflux in vivo from a depot of cationized LDL injected into a thigh muscle of small rodents
535. Familial massive tendon xanthomatosis with decreased high-density lipoprotein–mediated cholesterol efflux
536. Novel potent apoA-I peptide mimetics that stimulate cholesterol efflux and pre-β particle formation in vitro
537. Seminal plasma choline phospholipid-binding proteins stimulate cellular cholesterol and phospholipid efflux
538. Induction of cholesterol efflux in the CNS
539. Study of ATP-binding cassette transporter A1 (ABCA1)-mediated cellular cholesterol efflux in diabetic golden hamsters
540. Effect of rosuvastatin treatment on cholesterol efflux from human macrophages.
541. Cell-surface binding sites for high density lipoproteins do not mediate efflux of cholesterol from human fibroblasts in tissue culture.
542. High glucose promotes intracellular lipid accumulation in vascular smooth muscle cells by impairing cholesterol influx and efflux balance
543. Oxidative Modification Reduces HDL-induced cholesterol efflux from Cultured Human Arterial Smooth Muscle Cells.
544. efflux of sphingomyelin, cholesterol, and phosphatidylcholine by ABCG1
545. efflux of intracellular versus plasma membrane cholesterol in HepG2 cells: different availability and regulation by apolipoprotein AI.
546. Wild type and tangier disease ABCA1 mutants modulate cellular amyloid-β production independent of cholesterol efflux activity
547. Avian phospholipid transfer protein causes HDL conversion without affecting cholesterol efflux from macrophages
548. LXR activation and cholesterol efflux from a lipoprotein depot in vivo
549. Overexpression of A-kinase anchoring protein 12A activates sterol regulatory element binding protein-2 and enhances cholesterol efflux in hepatic cells
550. Elevation of cyclic AMP by iloprost and prostaglandin E1 increases cholesterol efflux and the binding capacity for high-density lipoproteins in human fibroblasts
551. Studies on the rate of efflux of cholesterol from cultured human skin fibroblasts.
552. Biliary anionic peptide fraction/calcium binding protein inhibits apolipoprotein AI-mediated cholesterol efflux from cultured cells
553. Metabolism of exogenous fatty acids, fatty acid-mediated cholesterol efflux, PKA and PKC pathways in boar sperm acrosome reaction
554. Insights into cholesterol efflux in vascular endothelial cells
555. … the ability of plasma from Type 2 diabetic patients and healthy subjects to stimulate cellular cholesterol efflux: a potentially adverse effect on reverse cholesterol …
556. β-Cyclodextrin facilitates cholesterol efflux from larval Manduca sexta fat body and midgut in vitro
557. Plasma membrane caveolae mediate the efflux of cellular free cholesterol
558. Antibodies against high-density lipoprotein binding proteins enhance high-density lipoprotein uptake but do not affect cholesterol efflux from rat hepatoma cells
559. Reduced plasma capacity of cholesterol efflux, delayed postprandial lipid response, and abnormal Apo-CIII distribution in normolipemic subjects with premature …
560. Water-soluble compounds in the herbal preparation Abana inhibit lipid biosynthesis and enhance cholesterol efflux in HepG2 cells
561. Effects of starvation and plasma exchange on lecithin: cholesterol acyltransferase activity and cholesterol efflux in cholesterol-fed pigs
562. Enhanced efflux of cholesterol from ABCA1-expressing macrophages to serum from type IV hypertriglyceridemic subjects
563. ATP‐binding cassette transporters G1 and G4 mediate cholesterol and desmosterol efflux to HDL and regulate sterol accumulation in the brain
564. cholesterol efflux from cultured skin fibroblasts in 12 patients clinically heterozygous for familial hypercholesterolemia
565. High density lipoprotein loses its effect to stimulate efflux of cholesterol from foam cells after oxidative modification.
566. Serum cholesterol efflux capacity, a measure of HDL-C quality, varies according to coronary artery disease status independently of HDL-C quantity
567. Effect of high-density lipoproteins on cholesterol efflux and esterification in lipid-enriched human skin fibroblasts
568. cholesterol is poorly available for free apolipoprotein-mediated cellular lipid efflux from smooth muscle cells
569. Contribution of Cdc42 to cholesterol efflux in fibroblasts from Tangier disease and Werner syndrome
570. The type of dietary polyunsaturated fatty acids influences high density lipoprotein-mediated cholesterol efflux
571. The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from …
572. The metabolic fate of apolipoprotein AI-containing lipoproteins internalized into HepG2 cells: resecreted lipoproteins as a potent inducer for cholesterol efflux
573. In vivo tissue cholesterol efflux is impaired in carriers of mutations in APOA1 and ABCA1
574. Independent regulation of cholesterol incorporation into free apolipoprotein-mediated cellular lipid efflux in rat vascular smooth muscle cells
575. New insights into the regulation of cellular cholesterol efflux and high-density lipoprotein metabolism
576. The LXR agonist T0901317 promotes the reverse cholesterol transport from macrophages by increasing plasma efflux potential
577. cholesterol binding, efflux, and a PDZ-interacting domain of scavenger receptor–BI mediate HDL-initiated signaling
578. cholesterol–efflux capacity might be the key to the protective effects of HDL
579. Identification of a sequence of apolipoprotein AI associated with the efflux of intracellular cholesterol to human serum and apolipoprotein AI containing particles
580. Apotipoprotein E Accelerates the efflux of cholesterol from Macrophages: Mechanism of Xanthoma Formation in Apolipoprotein E Deficiency
581. Protein kinase C as a mediator of high density lipoprotein receptor-dependent efflux of intracellular cholesterol
582. Oral administration of compound RVX-208 increases serum levels of ApoA-I and improves high-density lipoprotein-mediated cholesterol efflux in African green …
583. Apolipoprotein-mediated cellular cholesterol and phospholipid efflux depend on a functional Golgi apparatus
584. HDL does not promote cholesterol efflux from macrophages of hypercholesterolemic rabbit: efflux differences between species.
585. High-density lipoprotein cholesterol levels and cholesterol efflux: a missing link?
586. Lycopene regulation of cholesterol synthesis and efflux in human macrophages
587. cholesterol efflux from normal and Tangier disease fibroblasts into normal, high-density lipoprotein-deficient, and apolipoprotein E-deficient plasmas
588. Liver X receptors mediate cholesterol efflux in mouse glomerular mesangial cells
589. Activated human phagocytes modify high density lipoprotein to a form that enhances cellular cholesterol efflux
590. Apolipoprotein AI efficiently binds to and mediates cholesterol and phospholipid efflux from human but not rat aortic smooth muscle cells
591. The cholesterol efflux Capacity of Serum Predicts Carotid Intimal-Medial Thickness Independently of HDL-C and Apo AI Levels
592. Growth hormone-releasing peptides, CD36, and stimulation of cholesterol efflux: cyclooxygenase-2 is the link
593. Interleukin-10 facilitates both cholesterol uptake and efflux in macrophages
594. efflux of lipid from fibroblasts to apolipoproteins: dependence on elevated levels of cellular unesterified cholesterol.
595. Binding of apolipoproteins A to adipose cells: role of receptor sites in cholesterol efflux and purification of binding protein (s)
596. Effects of oxidized low-density lipoprotein on cholesterol efflux in 3T3-L1 cells
597. Effects of apolipoprotein A-Ⅰon ATP binding cassette transporter A1 degradation and cholesterol efflux in THP-1 macrophage-derived foam cells
598. Action of ATP binding cassette transporter A 1 on cholesterol efflux in THP-1 macrophage-derived foam cells
599. Direct evidence of abca1-mediated efflux of cholesterol at the mouse blood–brain barrier
600. Human ABCA1 BAC transgenic mice show increased high density lipoprotein cholesterol and ApoAI-dependent efflux stimulated by an internal promoter …
601. Paraoxon Down Regulates ATP-binding Cassette Transporter A1 Expression and Decreases cholesterol efflux Through Cyclic AMP Signaling Pathway in RAW 264.7 …
602. FAMP, A Powerful Producer of Pre-Beta HDL via an ABCA1-Mediated cholesterol efflux Pathway
603. HDL and cellular cholesterol efflux
604. Effects of enrichment of fibroblasts with unesterified cholesterol on the efflux of cellular lipids to apolipoprotein AI
605. Hypercholesterolemia in rats with hepatomas: increased oxysterols accelerate efflux but do not inhibit biosynthesis of cholesterol
606. ABCA1 mediates concurrent cholesterol and phospholipid efflux to apolipoprotein AI
607. Role of the protein kinase C signaling pathway in high-density lipoprotein receptor-mediated efflux of intracellular cholesterol.
608. Apolipoprotein-mediated plasma membrane microsolubilization: role of lipid affinity and membrane penetration in the efflux of cellular cholesterol and …
609. Apo AI/ABCA1‐Dependent and HDL3‐Mediated Lipid efflux from Compositionally Distinct cholesterol‐Based Microdomains
610. SR-BI mediated HDL endocytosis leads to HDL resecretion facilitating cholesterol efflux
611. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers
612. Genetics and molecular biology: the ABC of cholesterol efflux and high-density lipoprotein formation
613. Increased cellular cholesterol efflux in glycogen storage disease type Ia mice: A potential mechanism that protects against premature atherosclerosis
614. Apolipoprotein AI-mediated cell cholesterol efflux
615. Effect of apolipoprotein AI mimetic peptides on cholesterol efflux in RAW264. 7 cells
616. Effect of lysophosphatidylcholine on cholesterol efflux from macrophage foam cells
617. Exchange and mass efflux of cholesterol in macrophages. Evidence for a common mechanism and a role for plasma membrane proteins.
618. Exosomes act as molecular vehicles contributing to cellular cholesterol efflux
619. Brief communication Voluntary exercise increases cholesterol efflux but not macrophage reverse cholesterol transport in vivo in mice
620. Effects of Acceptor Particle Size on the efflux of Cellular Free cholesterol (∗)
621. Effects of sphingomyelin degradation on cholesterol mobilization and efflux to high-density lipoproteins in cultured fibroblasts
622. Effect of weight loss on macrophage cholesterol efflux to plasma of obese individuals with metabolic syndrome
623. Effect of astragalus polysaccharides on cholesterol efflux in THP-1 macrophage-derived foam cells
624. The effect of anthocyanins on cholesterol efflux from mouse peritoneal macrophage-derived foam cells and its possible molecular mechanism
625. P-glycoprotein downregulation using RNAi decreases cholesterol efflux from human renal cancer cells
626. … -I (L141R) Pisa, interferes with the formation of alpha-high density lipoproteins (HDL) but not with the formation of pre beta 1-HDL and influences efflux of cholesterol …
627. Is the decreased high-density lipoprotein cholesterol in the metabolic syndrome due to cellular lipid efflux defect?
628. Arterial-wall thickness and impairment in ABCA1-driven cholesterol efflux
629. enhancing cholesterol efflux pathways suppresses hematopoietic stem cell proliferation and monocytosis in apoE−/− mice
630. Cyclodextrin-mediated efflux of cellular cholesterol
631. The action of liver X receptor# alpha# on cholesterol efflux in THP-1 macrophage-derived foam cells
632. Effects of oxidized low density lipoprotein and lysophosphatidylcholine on cholesterol efflux from mouse peritoneal macrophage foam cells
633. Lipid metabolism: reviews of HDL and cholesterol efflux, ethanol and hepatic lipid metabolism and lipid disorders during childhood
634. cholesterol and phospholipid efflux from cultured cells
635. High levels of human apolipoprotein AI and high density lipoproteins in transgenic mice do not enhance efflux of cholesterol from a depot of injected lipoproteins …
636. Functional Properties of Discoidal Apoprotein/Phospholipid Complexes: cholesterol efflux from Macrophages and Conversion by Lecithin-cholesterol Acyl …
637. Complexation of an apoA-I mimetic peptide with phospholipid increases ABCA1-specific cholesterol efflux
638. ABC Transporters and Apolipoprotein E: Critical Players in Macrophage cholesterol efflux and Atherosclerosis
639. Very-low dose endotoxemia induces high density lipoprotein remodeling and reduces cholesterol efflux in the absence of a clinical inflammatory response
640. The efflux of lysosomal cholesterol from cells.
641. Effects of hypoxia on sterol synthesis, acyl-CoA: cholesterol acyltransferase activity, and efflux of cholesterol in cultured rabbit skin fibroblasts.
642. Pioglitazone Enhances cholesterol efflux From Macrophages by Increasing ABCA1/ABCG1 Expressions via LXRα/PPARγ Pathway: Findings From in vitro and ex vivo …
643. Trimerized apolipoprotein AI (TripA) forms lipoproteins, activates lecithin: cholesterol acyltransferase, elicits lipid efflux, and is transported through aortic endothelial …
644. Inhibiting NF-κ B increases cholesterol efflux from THP-1 derived-foam cells treated with AngII via up-regulating the expression of ATP-binding cassette transporter A1
645. Human Apolipoproteins AI and A-II in Cell cholesterol efflux
646. RESVERATROL COUNTERS ATHEROGENIC EFFECTS OF INTERFERON-GAMMA ON cholesterol efflux IN THP-1 HUMAN MONOCYTES/MACROPHAGES
647. Lysosomal cholesterol derived from mildly oxidized low density lipoprotein is resistant to efflux
648. Cyclic AMP stimulates efflux of intracellular sterol from cholesterol-loaded cells.
649. Relative importance of apoE in cholesterol efflux
650. The role of cholesterol efflux in macrophage cholesterol homeostasis
651. Connection between cholesterol efflux and atherosclerosis
652. The guanine exchange factor 11 PDZ protein binds ABCA1 positively regulating transporter expression and cholesterol efflux via Rho activation
653. Atherogenic Lipids Induce HDL Uptake and cholesterol efflux in Human Macrophages by Upregulating Transmembrane Chemokine CXCL16, without …
654. cholesterol efflux in adipose tissue
655. lipid-lowering therapy: effect on cholesterol efflux from the cells
656. Role of human apolipoproteins in cell cholesterol efflux: Studies with transgenic mice
657. The Role of Plasma Membrane cholesterol Pools in the Regulation of Cellular cholesterol efflux
658. The influence of apolipoprotein structure on the efflux of cellular free cholesterol to high density lipoprotein.
659. cholesterol efflux Capcity in Genetic Forms of HDL Deficiency
660. The mechanism of apolipoprotein mediated cholesterol efflux
661. The Effect of High Density Lipoprotein Phospholipid Acyl Chain Composition on the efflux of Cellular Free cholesterol (∗)
662. Effects of high-density lipoprotein on the cholesterol efflux from endothelial cells
663. The fate of the chromaffin granule during catecholamine release from the adrenal medulla—I.: Unchanged efflux of phospholipid and cholesterol
664. Apolipoprotein-mediated cellular cholesterol/phospholipid efflux and plasma high density lipoprotein level in mice
665. Fractional efflux and net change in cellular cholesterol content mediated by sera from mice expressing both human apolipoprotein AI and human lecithin: cholesterol …
666. Pharmacologically-induced changes in the concentration of high density lipoprotein cholesterol and the relationship with cholesterol efflux
667. STUDIES ON cholesterol efflux FROM HUMAN SKIN FIBROBLASTS.
668. Phospholipids: Key parameters in modulating cholesterol efflux
669. Anti-HIV activity of drugs that stimulate cholesterol efflux
670. Cellular physiology of cholesterol efflux in endothelial cells
671. Preferential efflux of phytosterols over cholesterol from macrophages
672. Enhanced hepatic apoA-I secretion and peripheral efflux of cholesterol and phospholipid in CD36 null mice
673. cholesterol efflux from Fu5AH hepatoma cells induced by sera of subjects with metabolic Reaven’s syndrome
674. Effect of LpAI subpopulations on cholesterol efflux from mouse macrophages
675. Effect of Phospholipid on the Ability of HDL3 Mediated cholesterol efflux from Rat Skin Fibroblasts
676. Serum Amyloid A (SAA) and cholesterol efflux–a mechanistic study
677. Molecular Basis of Cellular cholesterol efflux and Regulation of Plasma HDL Level
678. cholesterol efflux into plasma and lipoproteins of normal, ApoA-I-, and ApoE-deficient mice
679. cholesterol efflux from macrophages mediated by HDL-subfractions, which differ in ratios of apoA-I to apoA-II
680. Regulation of cholesterol efflux from mouse peritoneal macrophages by endogenous ApoE
681. Apolipoprotein AI structure modifications differently affect LCAT activation and cholesterol efflux
682. The Role ABCG1 in Cellular cholesterol efflux: Relevance to Atherosclerosis and Endothelial Function
683. The effects of soluble epoxide hydrolase inhibitors on cholesterol efflux in adipocytes
684. Mechanisms of high-density lipoprotein-mediated cellular cholesterol efflux
685. Abnormal apoC-III distribution and reduced cholesterol efflux capacity of plasma in normolipidemic subjects with premature coronary artery disease
686. Decreased fluidity of oxidized high density lipoprotein: Its relation to cholesterol efflux
687. Effect of ATP-binding cassette transporter A1 on cholesterol efflux from cells
688. Pparδ activation leads to increased transintestinal cholesterol efflux
689. Establishment of a mouse model of atherosclerosis regression and the molecular analysis of macrophage pathways of cholesterol efflux and inflammation
690. 097 IFFERENTIAL EXPRESSION OF GENES IMPLICATED IN cholesterol efflux IN HUMAN OSTEOARTHRITIC CHONDROCYTES
691. Importance of the HDL free cholesterol to phospholipids ratio for cholesterol efflux from Fu5AH hepatoma cells to the serum of cholestatic children
692. ATP-binding cassette A1-roles in cellular cholesterol efflux and atherosclerosis
693. Role of Membrane Tubulation in NPC1-Mediated cholesterol efflux
694. Effect of promoting cellular cholesterol efflux on the apoptosis of foam cells derived from monocytes
695. Regulation of macrophage cholesterol efflux and activation of liver X receptor by atorvastatin
696. Increased capacity of cellular cholesterol efflux of serum after moderate intake of red wine in young men
697. Impaired cholesterol efflux in macrophages of patients with type 2 diabetes mellitus is associated with the decreased expression of ABCG1
698. Effects of Polyunsaturated Phospholipid on cholesterol efflux in Vitro and in Experimental Animals and Human Subjects
699. Role of Plasmalemmal Vesicles on the HDL-Mediated cholesterol efflux in Aortic Endothelial Cells
700. Regulation of cholesterol efflux from cultured human skin fibroblasts by lipoprotein lipase and phospholipids
701. Inhibition of Cholesteryl Ester Transfer Protein by Torcetrapib Modestly Increases Macrophage cholesterol efflux…
702. Influence of in vitro HDL glycodesialylation and glycoxidation on the cellular cholesterol efflux from macrophage foam cells
703. … protein (PLTP) and PLTP-generated pre-β-high density lipoprotein by mast cell chymase impairs high affinity efflux of cholesterol from macrophage foam cells
704. cholesterol efflux from J774 rat macrophages mediated by the serum of mice expressing human apo AIV
705. Effects of berberine on cholesterol efflux in THP-1 macrophage derived foam cells
706. Effects of anthocyanin on cholesterol efflux from mouse peritoneal macrophage foam cells
707. P‐glycoprotein overexpression in MDCKII kidney cells is associated with increased cholesterol efflux to high density lipoprotein
708. Regulation of human macrophage cholesterol efflux by Nicotine
709. Role of Apolipoprotein a IV in Promotion of Cellular cholesterol efflux from Adipose Cells
710. Oxysterol-enriched high density lipoproteins inhibit cellular cholesterol efflux
711. cholesterol efflux from cultured human fibroblasts under the influence of serum lipoproteins
712. Adiponectin prevents atherosclerosis by increasing cholesterol efflux from macrophages
713. cholesterol absorption and transintestinal cholesterol efflux (TICE) rates are unaltered in mice overexpressing intestinal SR-BI
714. Effect of niacin on HDL-induced cholesterol efflux and LXRalpha expression in adipocytes of hypercholesterolemic rabbits
715. … of a calcium antagonist and a β-blocker on cell-and copper-mediated oxidation of LDL and on the accumulation and efflux of cholesterol in human macrophages and …
716. ROCK2 in Macrophages Inhibits cholesterol efflux and Increases Atherosclerosis
717. Metformin Improves HDL-Mediated cholesterol efflux Through the Inhibition of HDL Glycation.
718. Effect of ATP-binding cassette transporter A1 on cholesterol efflux from cells
719. Alpha linolenic acid increases cholesterol efflux via regulation of stearoyl CoA desaturase in foam cells
720. INTERACTION OF PARAOXONASE 1 WITH LIPID RAFT MICRO-DOMAINS FOR THE ENHANCEMENT OF cholesterol efflux
721. Caveolin-dependent free cholesterol efflux-major regulatory pathway in peripheral cells
722. The Role of HDL Apolipoproteins in Mediating HDL Receptor Binding and Intracellular cholesterol efflux
723. Desialylation of plasma high density lipoprotein alters its capacity to mediate the cellular cholesterol efflux from macrophage foam cells
724. O-16: Metabolism of Exogenous Fatty Acids, Fatty Acid-Mediated cholesterol efflux, PKA and PKC Pathways in Boar Sperm Acrosome Reaction
725. Impaired ABCA-1 Mediated cholesterol efflux In Hypoxic Macrophages
726. The function of albumin and lipoproteins containing apoA-I in promoting cellular cholesterol efflux from human skin fibroblasts.
727. Unique Epitope of Apolipoprotein AI Expressed in Pre-. beta.-1 High-Density Lipoprotein and Its Role in the Catalyzed efflux of Cellular cholesterol
728. cholesterol efflux from Cells in Culture: Studies with Lipid-Free Acceptors, Reconstituted Particles and Whole Serum
729. The role of free apolipoprotein AI in reverse cholesterol transport: Characterization of high-density lipoprotein particles formed in cholesterol efflux
730. Cellular Physiology of cholesterol efflux Defects in Low HDL-c Individuals with a Normal ABCA1 Gene
731. Impact of dietary Ellagic acid on cholesterol efflux in lipid‐laden murine macrophages
732. In vivo tissue cholesterol efflux is reduced in carriers of mutations in APOA1 and ABCA1
733. Interaction abolishment between mutant caveolin-1Δ₆₂–₁₀₀ and ABCA1 reduces HDL-mediated cellular cholesterol efflux
734. Arterial-wall thickness and impairment in ABCA1-driven cholesterol efflux
735. The Mechanism of cholesterol efflux by ATP Binding Cassette Transporter in Human Gallbladder Epithelial Cells
736. efflux of cholesterol from cholesterol loaded macrophages by incubation with synthetic HDL-particles
737. Lipid-free apolipoprotein AI can act as a shuttle to promote cholesterol efflux to apolipoprotein AI-containing lipoproteins
738. Effects of fatty acids on albumin-mediated cholesterol efflux from endothelial cells and on the growth of hamster pancreatic β-cells
739. cholesterol Trapping in the Endosomal Pathway Does not Impair cholesterol efflux in Niemann-Pick Disease Type B Fibroblasts
740. P140: Serum amyloid a inhibits cholesterol efflux from human macrophage-derived foam cells
741. Effect of cigarette smoking on macrophage cholesterol efflux mediated by mice serum and the potential mechanisms.
742. Whole egg consumption compared to yolk free egg increases the cholesterol efflux
743. Effects of high-density lipoprotein and lipoprotein-deficient serum on intracellular cholesterol efflux in patients with type 2 diabetes mellitus
744. Effect of Serum Amyloid A (SAA) in Vivo on Splenic cholesterol efflux During Acute Inflammation, 1996-1999
745. Abnormal DHL 3 and Apo-Al-Mediated Cellular cholesterol efflux in Subjects With Familial HDL Deficiency
746. … that Hyperinsulinemia, known to Accelerate Diabetes Progression, may also Contribute to Dyslipidemia via Impairing ApoA1/ABCA1-Mediated cholesterol efflux
747. Effect of intracellular cholesterol trafficking on its efflux to APOA-I
748. cholesterol efflux transporter gene expression predicts clinical outcome in serous ovarian cancer
749. Transintestinal cholesterol efflux contributes significantly to total fecal neutral sterol excretion in mice
750. Regulation of Lipid Droplet cholesterol efflux from Macrophage Foam Cells: a Role for Oxysterols and Autophagy
751. Aminoguanidine and metformin prevent reduction of cellular cholesterol efflux, induced by glication advanced products; Aminoguanidina e metformina previnem …
752. The up-regulation of cholesterol transporters and cholesterol acceptor-mediated cholesterol efflux in brain cells as a novel mechanism of developmental …
753. ABCA1-dependent but ApoA-I-independent cholesterol efflux mediated by fatty acid-bile acid conjugates (FABACs)
754. Identifying and overcoming the HIV-induced inhibition of ABCA1-mediated cholesterol efflux: Implications for HIV treatment
755. Genetic deletion of LDL receptor impairs mouse macrophage ABCA1 expression and cholesterol efflux: A new SREBP‐1 dependent mechanism
756. Assessment of cholesterol efflux Potential of High-Density Lipoprotein after Treatment with Niacin Extended-Release or Fenofibrate
757. Increase in Sterol Synthesis and Decrease in cholesterol efflux in Niemann-Pick Disease Type C Fibroblasts
758. Purification of ABCA1 and associated binding proteins reveals the importance of β1‐syntrophin in cholesterol efflux
759. The role of sphingolipids in cholesterol efflux mediated by ATP-binding cassette transporter AI (ABCAI)
760. Effect of methylglyoxal-mediated apolipoprotein AI modification on ABCA1-dependent cholesterol efflux from cells
761. Proteolytic Modification of High Density Lipoproteins Decreases Their Ability to Induce cholesterol efflux from Macrophage Foam Cells
762. cholesterol efflux from bovine sperm: Role of oviductal fluid secretions and potential importance in sperm capacitation and fertilization.
763. Quercetin but not myricetin increases cholesterol efflux in PMA-differenciated human THP-1 macrophages
764. EMBRYOLOGY: METABOLISM OF EXOGENOUS FATTY ACIDS, FATTY ACID-MEDIATED cholesterol efflux, PKA AND PKC PATHWAYS IN BOAR SPERM …
765. HIV protease inhibitor ritonavir inhibits cholesterol efflux from human macrophage derived foam cells
766. RAPAMYCIN DECREASES cholesterol efflux AND ABCA1 PROTEIN EXPRESSION WITHIN THP-1 MACROPHAGES: 1931
767. Controlled cholesterol efflux from the aortic smooth muscle cells triggers microheterogeneity of plasma membrane lipids and induces modification of the mitochondrial …
768. In cultured intestinal CaCo-2 cells HDL-mediated cholesterol efflux is calcium independent
769. Differential effects of 24 (S)‐hydroxycholesterol in astrocytes and on the expression of apolipoprotein E and apolipoprotein E‐mediated cholesterol efflux.
770. Regulation of ABCA1 Protein Turnover and cholesterol efflux by Oxysterol Binding Protein (OSBP).
771. Role of High Density Lipoprotein in Plasma Lipid Transport: is cholesterol efflux from Cells Coupled to Lipolysis of Triglyceride-Rich Lipoproteins?
772. Adiponectin Enhanced ApoA-1-and HDL-mediated Cellular cholesterol efflux from Human Monocyte-Derived Macrophages
773. Wild type and Tangier disease ABCA1 mutants modulate cellular amyloid-beta production independent of cholesterol efflux activity
774. … Atherosclerosis in Hypercholesterolemic Mouse Models by ATI-5261: a Novel α-helix Peptide that Stimulates ABCA1 cholesterol efflux with High Efficiency
775. Binding of apolipoproteins to HDL receptors sites. Role in the efflux of cholesterol
776. 24 (S)-Hydroxycholesterol Participates in a Liver X Receptor-controlled Pathway in Astrocytes That Regulates Apolipoprotein E-mediated cholesterol efflux
777. … MIMETIC PEPTIDE D4-F ON EXPRESSION OF ATP-BINDING CASSETTE TRANSPORTER A1 THROUGH PKA SIGNALING AND cholesterol efflux IN THP-1 …
778. WITHDRAWN: Liver X receptor and retinoic X receptor mediated ABCA1 regulation and cholesterol efflux in macrophage cells—messenger RNA measured by …
779. Insulin suppresses HDL-mediated cholesterol efflux from macrophages through inhibition of neutral cholesteryl ester hydrolase and ATP-binding cassette transporter …
780. Cigarette smoke-modification of HDL causes loss of its effect to stimulate efflux of cholesterol from foam cells
781. cAMP selectively promotes the efflux of cholesterol derived from cholesteryl ester hydrolysis in J774 foam cells
782. … Reticulum Stress Enhances Steroidogenic Acute Regulatory (StAR)‐Related Lipid Transfer Domain Protein 5 (STARD5) Expression and cholesterol efflux in HKC‐8 …
783. cholesterol metabolism and efflux in human THP-1 macrophages
784. Impaired efflux of cholesterol from aged cells and its molecular mechanism: A basis for age‐related enhancement of atherosclerosis
785. 12/15-Lipoxygenase Activity Inhibits cholesterol efflux from Macrophages by Enhancing Degradation of ATP-Binding Cassette Transporter G1
786. 1047-181 High-density lipoprotein-mediated cholesterol efflux from cells is a strong independent predictor of cardiovascular risk
787. … of foam cell formation: A2A adenosine receptor activation decreases foam cell formation by enhancing ABCA1 and 27-hydroxylase dependent cholesterol efflux
788. Proteolytic degradation of preβ-1-LpAI by rat mast cell chymase reduces high-affinity efflux of cholesterol from macrophage foam cells in vitro
789. 137: Chlamydia heat shock protein 60 inhibits cholesterol efflux from human macrophage-derived foam cells
790. High glucose levels do not directly impair cellular binding of HDL3 or HDL-mediated efflux of cholesterol from human skin fibroblasts
791. Interaction of the P-glycoprotein multidrug efflux pump with cholesterol: effects on ATPase activity, drug binding and transport
792. … RECEPTOR-BI AND ESTROGEN RECEPTOR-DEPENDENT 17-BETA ESTRADIOL UPTAKE AND cholesterol efflux MEDIATED BY ESTRADIOL FATTY …
793. A two-step mechanism for free cholesterol and phospholipid efflux from human vascular cells to apolipoprotein A-1
794. cholesterol absorption is mainly regulated by the jejunal and ileal ATP-binding cassette sterol efflux transporters Abcg5 and Abcg8 in mice1
795. Changes in the biosynthesis, esterification and efflux of cholesterol in fibroblasts in culture from patients with Niemann-Pick disease type C
796. Contribution of cholesterol and phospholipids to inhibitory effect of dimethyl-β-cyclodextrin on efflux function of P-glycoprotein and multidrug resistance-associated …
797. A surgical model to study in vivo efflux of cholesterol from porcine aorta Evidence for cholesteryl ester transfer through the aortic wall
798. Effect of atorvastatin on intracellular cholesterol content and efflux of macrophages separated from diabetic hamster
799. Oxidized low density lipoprotein causes impaired efflux of cholesterol from macrophages: implications for atherogenesis
800. Sterol 27-Hydroxylase–and ApoAI/Phospholipid–Mediated efflux of cholesterol From cholesterol-Laden Macrophages: Evidence for an Inverse Relation Between the …
801. Regulation of HDL-mediated cellular cholesterol uptake and efflux
802. Sphingomyelin biosynthesis and efflux correlates with cholesterol metabolism and is higher in vascular endothelial cells than in smooth muscle cells
803. Identification of a Novel Lipid efflux Defect Causing Low HDL cholesterol that is not due to Mutations in the ABCA1 Gene but to Regulation of ABCA1 Protein
804. Transcytotic efflux from early endosomes is dependent on cholesterol and glycosphingolipids in polarized hepatic cells
805. Effects of CSF-1 on cholesterol accumulation and efflux by macrophages
806. … of newly synthesized cholesterol and biosynthetic sterol intermediates from cells: dependence on acceptor type and on enrichment of cells with cholesterol
807. … in human lymphocytes by sterols efflux or phytohemagglutinin stimulation: Cellular division as the requirement for efficient cholesterol biosynthesis in lymphocytes
808. Enhanced Hepatic apoA-I Secretion and Peripheral efflux of cholesterol and Phospholipid
809. Effects of apolipoprotein AI on ATP-binding cassette transporter A1-mediated efflux of macrophage phospholipid and cholesterol: formation of nascent high …
810. An Investigation Into the Role of ABCA1 in the efflux of cholesterol from the Intestine and the Liver
811. Scavenger receptor class B type I-mediated cholesteryl ester-selective uptake and efflux of unesterified cholesterol: Influence of high density lipoprotein size …
812. Role of the HefC efflux Pump in Helicobacter pylori cholesterol-Dependent Resistance to Ceragenins and Bile Salts
813. … GULP mediates trafficking of the LRP ligand prosaposin, leading to sphingolipid and free cholesterol accumulation in late endosomes and impaired efflux
814. In nonhepatic cells, cholesterol 7α-hydroxylase induces the expression of genes regulating cholesterol biosynthesis, efflux, and homeostasis
815. Comparison of the hepatic clearances of campesterol, sitosterol, and cholesterol in healthy subjects suggests that efflux transporters controlling intestinal sterol …
816. Introduction of a Model for Study of Polarized cholesterol and Phospholipid efflux in Gallbladder Epithelial Cell
817. Promotion of sterol efflux and net transport by apolipoprotein E in lecithin: cholesterol acyltransferase deficiency
818. The Defect in HDL3 Mediated efflux of Newly Synthesized cholesterol is Associated with Impaired Activation of Protein Kinase C in Tangier Fibroblasts
819. The relation between membrane cholesterol and phospholipid and sodium efflux in erythrocytes from healthy subjects and patients with chronic cholestasis.
820. Lipid efflux Factors Are Required For The Regression Of Atherosclerosis Independent Of Non-HDL cholesterol Levels
821. Influx, efflux, and accumulation of LDL in normal arterial areas and atherosclerotic lesions of white Carneau pigeons with naturally occurring and cholesterol …
822. Effects of cholesterol Diet and Exercise on Plasma and Liver Lipids, Platelet Aggregation and Erythrocyte Na efflux in Rats
823. Effects of cholesterol diet and excercise on lipid level, liver function, platelet aggregation and erythrocyte Na+ efflux in rats
824. Influx, efflux, and hydrolysis of cholesteryl ester in atheromatous lesions of cholesterol-fed rabbits.
825. cholesterol regulates volume-sensitive osmolyte efflux from human SH-SY5Y neuroblastoma cells following receptor activation
826. Hypercholesterolemia in rats with hepatomas: increased oxysterols accelerate efflux but do not inhibit biosynthesis of cholesterol
827. Uptake and efflux by everted intestinal sacs of micellar cholesterol in bile salts and in non-ionic detergent
828. Phytosterols induce changes in hepatic protein expression patterns and increase cholesterol biosynthesis and sterol efflux in a hypercholesterolemic animal model
829. Detoxification Of 7-ketocholesterol Seems To Be Dependent On HDL-mediated efflux And Esterification By Acyl-Coenzyme A: cholesterol Acyltransferases
830. … APOA-II in reconstituted HDL particles and reduces the ability of plasma derived from APOA-I-KO mouse to promote efflux of cellular cholesterol by degrading APOE …
831. Effect of purified pre-beta 1 HDL on efflux of 3H-cholesterol loaded in human smooth muscle cells
832. … -3-methylglutaryl coenzyme A reductase and [14C]-acetate incorporation into cholesterol in human lymphocytes stimulated by phytohemagglutinin or sterol efflux.
833. cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport
834. Molecular mechanisms of cellular cholesterol efflux
835. cholesterol efflux and reverse cholesterol transport
836. HDL cholesterol efflux capacity and incident cardiovascular events
837. cholesterol efflux assay
838. Determinants of cholesterol efflux capacity in humans
839. Control of angiogenesis by AIBP-mediated cholesterol efflux
840. Paradoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks
841. cholesterol efflux capacity: An introduction for clinicians
842. Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study
843. Modulating cholesterol efflux capacity to improve cardiovascular disease
844. cholesterol efflux pathways suppress inflammasome activation, NETosis, and atherogenesis
845. Psoriasis alters hdl composition and cholesterol efflux capacity [s]
846. cholesterol efflux and reverse cholesterol transport: experimental approaches
847. Impaired serum cholesterol efflux capacity in rheumatoid arthritis and systemic lupus erythematosus
848. cholesterol efflux capacity and pre-beta-1 HDL concentrations are increased in dyslipidemic patients treated with evacetrapib
849. cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthritis
850. Serum albumin acts as a shuttle to enhance cholesterol efflux from cells [S]
851. Abnormal lipoprotein particles and cholesterol efflux capacity in patients with psoriasis
852. Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity [S]
853. New insights into the regulation of cholesterol efflux from the sperm membrane
854. HDL cholesterol efflux capacity: cardiovascular risk factor and potential therapeutic target
855. High-density lipoprotein function measurement in human studies: focus on cholesterol efflux capacity
856. Regulation of hematopoietic stem and progenitor cell mobilization by cholesterol efflux pathways
857. Transcriptional regulation of macrophage cholesterol efflux and atherogenesis by a long noncoding RNA
858. cholesterol efflux is differentially regulated in neurons and astrocytes: implications for brain cholesterol homeostasis
859. Regulation of lipid droplet cholesterol efflux from macrophage foam cells
860. ABCA8 regulates cholesterol efflux and high-density lipoprotein cholesterol levels
861. AIBP-mediated cholesterol efflux instructs hematopoietic stem and progenitor cell fate
862. Membrane cholesterol efflux drives tumor-associated macrophage reprogramming and tumor progression
863. cholesterol efflux capacity, macrophage reverse cholesterol transport, and cardioprotective HDL
864. cholesterol efflux: a novel regulator of myelopoiesis and atherogenesis
865. From evolution to revolution: miRNAs as pharmacological targets for modulating cholesterol efflux and reverse cholesterol transport
866. Association between cholesterol efflux capacity and atherosclerotic cardiovascular disease in patients with familial hypercholesterolemia
867. Association of serum cholesterol efflux capacity with mortality in patients with ST-segment elevation myocardial infarction
868. The role of cholesterol efflux in mechanisms of endothelial protection by HDL
869. The association between reduction in inflammation and changes in lipoprotein levels and HDL cholesterol efflux capacity in rheumatoid arthritis
870. Genotype-dependent effects of dalcetrapib on cholesterol efflux and inflammation: concordance with clinical outcomes
871. MiR-106b impairs cholesterol efflux and increases Aβ levels by repressing ABCA1 expression
872. Prognostic usefulness of serum cholesterol efflux capacity in patients with coronary artery disease
873. High density lipoprotein biogenesis, cholesterol efflux, and immune cell function
874. Macrophage mitochondrial energy status regulates cholesterol efflux and is enhanced by anti-miR33 in atherosclerosis
875. High-density lipoprotein mediated cellular cholesterol efflux in acute coronary syndromes
876. Association of cholesterol efflux capacity with clinical features of metabolic syndrome: relevance to atherosclerosis
877. Role of liver X receptors in cholesterol efflux and inflammatory signaling
878. HDL cholesterol efflux predicts graft failure in renal transplant recipients
879. HDL cholesterol efflux does not predict cardiovascular risk in hemodialysis patients
880. cholesterol efflux is LXRα isoform-dependent in human macrophages
881. cholesterol efflux capacity is an independent predictor of all-cause and cardiovascular mortality in patients with coronary artery disease: A prospective cohort study
882. MicroRNA-33a regulates cholesterol synthesis and cholesterol efflux-related genes in osteoarthritic chondrocytes
883. Trans-intestinal cholesterol efflux is not mediated through high density lipoprotein
884. Olive oil polyphenols enhance the expression of cholesterol efflux related genes in vivo in humans. A randomized controlled trial
885. Mechanism of cholesterol efflux in humans after infusion of reconstituted high-density lipoprotein
886. Genetic determination of plasma cholesterol efflux capacity is gender-specific and independent of HDL-cholesterol levels
887. Quercetin regulates hepatic cholesterol metabolism by promoting cholesterol-to-bile acid conversion and cholesterol efflux in rats
888. ApoCIII enrichment in HDL impairs HDL-mediated cholesterol efflux capacity
889. Impaired cholesterol efflux in senescent macrophages promotes age-related macular degeneration
890. Inflammation, remodeling and other factors affecting HDL cholesterol efflux
891. Measurement of reverse cholesterol transport pathways in humans: in vivo rates of free cholesterol efflux, esterification, and excretion
892. HDL cholesterol efflux capacity and cardiovascular events in patients with chronic kidney disease
893. High-density lipoprotein cholesterol efflux capacity is inversely associated with cardiovascular risk: a systematic review and meta-analysis
894. Inhibitory effect of PCSK9 on Abca1 protein expression and cholesterol efflux in macrophages
895. Increased cholesterol efflux capacity in metabolic syndrome: Relation with qualitative alterations in HDL and LCAT
896. Humans with atherosclerosis have impaired ABCA1 cholesterol efflux and enhanced high-density lipoprotein oxidation by myeloperoxidase
897. Delivery of MicroRNAs by Chitosan Nanoparticles to Functionally Alter Macrophage cholesterol efflux in Vitro and in Vivo
898. … , dense high-density lipoprotein-3 particles are enriched in negatively charged phospholipids: relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti …
899. BODIPY-cholesterol can be reliably used to monitor cholesterol efflux from capacitating mammalian spermatozoa
900. Patients with coronary endothelial dysfunction have impaired cholesterol efflux capacity and reduced HDL particle concentration
901. The role of adiponectin in cholesterol efflux and HDL biogenesis and metabolism
902. CSL112 (apolipoprotein AI [human]) enhances cholesterol efflux similarly in healthy individuals and stable atherosclerotic disease patients
903. Impaired HDL cholesterol efflux in metabolic syndrome is unrelated to glucose tolerance status: the CODAM study
904. Structural characterisation and cholesterol efflux improving capacity of the novel polysaccharides from Cordyceps militaris
905. cholesterol efflux capacity: full steam ahead or a bump in the road?
906. Effect of Drug Therapy on Net cholesterol efflux Capacity of High‐Density Lipoprotein–Enriched Serum in Rheumatoid Arthritis
907. cholesterol efflux capacity in humans with psoriasis is inversely related to non-calcified burden of coronary atherosclerosis
908. PMP22 regulates cholesterol trafficking and ABCA1-mediated cholesterol efflux
909. Vitamin D protects against atherosclerosis via regulation of cholesterol efflux and macrophage polarization in hypercholesterolemic swine
910. Cellular cholesterol efflux and cholesterol loading capacity of serum: effects of LDL-apheresis
911. Beyond coronary calcification, family history, and C-reactive protein: cholesterol efflux capacity and cardiovascular risk prediction
912. Impairment of macrophage cholesterol efflux by cholesterol hydroperoxide trafficking: implications for atherogenesis under oxidative stress
913. Apigenin retards atherogenesis by promoting ABCA1-mediated cholesterol efflux and suppressing inflammation
914. Anti‐oxidative and cholesterol efflux capacities of high‐density lipoprotein are reduced in ischaemic cardiomyopathy
915. Involvement of cholesterol efflux pathway in the control of cardiomyocytes cholesterol homeostasis
916. HDL-apolipoprotein AI exchange is independently associated with cholesterol efflux capacity
917. MiR-26 controls LXR-dependent cholesterol efflux by targeting ABCA1 and ARL7
918. Cellular cholesterol efflux pathways: impact on intracellular lipid trafficking and methodological considerations
919. Changes in high-density lipoprotein cholesterol efflux capacity after bariatric surgery are procedure dependent
920. Large-scale analysis of determinants, stability, and heritability of high-density lipoprotein cholesterol efflux capacity
921. Anthocyanin supplementation improves HDL-associated paraoxonase 1 activity and enhances cholesterol efflux capacity in subjects with hypercholesterolemia
922. cholesterol efflux capacity, high-density lipoprotein particle number, and incident cardiovascular events: an analysis from the JUPITER Trial (Justification for the Use …
923. Genetics of cholesterol efflux
924. Intestinal SR-BI does not impact cholesterol absorption or transintestinal cholesterol efflux in mice
925. HDL cholesterol efflux capacity in rheumatoid arthritis patients: contributing factors and relationship with subclinical atherosclerosis
926. ABCA12 regulates ABCA1-dependent cholesterol efflux from macrophages and the development of atherosclerosis
927. Effects of the SGLT2 inhibitor dapagliflozin on HDL cholesterol, particle size, and cholesterol efflux capacity in patients with type 2 diabetes: a randomized …
928. Chlorogenic Acid Protects against Atherosclerosis in ApoE−/− Mice and Promotes cholesterol efflux from RAW264.7 Macrophages
929. LXR suppresses inflammatory gene expression and neutrophil migration through cis-repression and cholesterol efflux
930. Plasma metabolite profiles, cellular cholesterol efflux, and non-traditional cardiovascular risk in patients with CKD
931. Extra virgin olive oil polyphenols promote cholesterol efflux and improve HDL functionality
932. α-synuclein regulates neuronal cholesterol efflux
933. Intracoronary imaging, cholesterol efflux, and transcriptomes after intensive statin treatment: the YELLOW II study
934. Histone deacetylase 9 represses cholesterol efflux and alternatively activated macrophages in atherosclerosis development
935. Akt inhibition promotes ABCA1-mediated cholesterol efflux to ApoA-I through suppressing mTORC1
936. ABCA1-and ABCG1-mediated cholesterol efflux capacity of cerebrospinal fluid is impaired in Alzheimer’s disease
937. … of almonds in a cholesterol-lowering diet improves plasma HDL subspecies and cholesterol efflux to serum in normal-weight individuals with elevated LDL cholesterol
938. Impaired HDL cholesterol efflux capacity in patients with non-alcoholic fatty liver disease is associated with subclinical atherosclerosis
939. ABCA1 Overexpression in Endothelial Cells In Vitro Enhances ApoAI-Mediated cholesterol efflux and Decreases Inflammation
940. cholesterol efflux capacity, HDL cholesterol, and risk of coronary heart disease: a nested case-control study in men
941. The negative effect of ANGPTL8 on HDL-mediated cholesterol efflux capacity
942. Plasminogen promotes cholesterol efflux by the ABCA1 pathway
943. cholesterol efflux capacity and subclasses of HDL particles in healthy women transitioning through menopause
944. Both STAT3 activation and cholesterol efflux contribute to the anti-inflammatory effect of apoA-I/ABCA1 interaction in macrophages
945. Statin-induced decrease in ATP-binding cassette transporter A1 expression via microRNA33 induction may counteract cholesterol efflux to high-density lipoprotein
946. Simvastatin and bezafibrate increase cholesterol efflux in men with type 2 diabetes
947. Liraglutide improves lipid metabolism by enhancing cholesterol efflux associated with ABCA1 and ERK1/2 pathway
948. ABCA1‐mediated cholesterol efflux capacity to cerebrospinal fluid is reduced in patients with mild cognitive impairment and alzheimer’s disease
949. cholesterol efflux alterations in adolescent obesity: role of adipose-derived extracellular vesical microRNAs
950. A loss-of-function variant in OSBPL1A predisposes to low plasma HDL cholesterol levels and impaired cholesterol efflux capacity
951. Quercetin enhances ABCA1 expression and cholesterol efflux through a p38-dependent pathway in macrophages
952. … consumption of walnuts and walnut components differentially affect postprandial lipemia, endothelial function, oxidative stress, and cholesterol efflux in humans with …
953. Direct estimation of HDL-mediated cholesterol efflux capacity from serum
954. The transcription factor MafB promotes anti-inflammatory M2 polarization and cholesterol efflux in macrophages
955. MiR-486 regulates cholesterol efflux by targeting HAT1
956. Impaired cholesterol efflux capacity of high-density lipoprotein isolated from interstitial fluid in type 2 diabetes mellitus—brief report
957. Mangiferin promotes macrophage cholesterol efflux and protects against atherosclerosis by augmenting the expression of ABCA1 and ABCG1
958. Low cholesterol efflux capacity and abnormal lipoprotein particles in youth with type 1 diabetes: a case control study
959. Prdx1 (peroxiredoxin 1) deficiency reduces cholesterol efflux via impaired macrophage lipophagic flux
960. Infliximab reverses suppression of cholesterol efflux proteins by TNF-α: a possible mechanism for modulation of atherogenesis
961. Effect of chronic kidney disease on macrophage cholesterol efflux
962. Familial hypercholesterolaemia: cholesterol efflux and coronary disease
963. Increased maternal and fetal cholesterol efflux capacity and placental CYP27A1 expression in preeclampsia [S]
964. Pitavastatin increases HDL particles functionally preserved with cholesterol efflux capacity and antioxidative actions in dyslipidemic patients
965. Regulation of ABCA1-mediated cholesterol efflux by sphingosine-1-phosphate signaling in macrophages
966. The macrophage and its related cholesterol efflux as a HDL function index in atherosclerosis
967. Mitochondrial (dys) function and regulation of macrophage cholesterol efflux
968. Effects of seasons on enzymatic changes and cholesterol efflux in relation to freezability in Tharparkar bull semen
969. Adiponectin increases macrophages cholesterol efflux and suppresses foam cell formation in patients with type 2 diabetes mellitus
970. In vivo tissue cholesterol efflux is reduced in carriers of a mutation in APOA1 [S]
971. Adiponectin predicts high-density lipoprotein cholesterol efflux capacity in adults irrespective of body mass index and fat distribution
972. SIRT 6 reduces macrophage foam cell formation by inducing autophagy and cholesterol efflux under ox‐LDL condition
973. Activation of the TLR4 signaling pathway and abnormal cholesterol efflux lead to emphysema in ApoE-deficient mice
974. Potent peroxisome proliferator-activated receptor-α agonist treatment increases cholesterol efflux capacity in humans with the metabolic syndrome
975. Dihydromyricetin ameliorates foam cell formation via LXRα-ABCA1/ABCG1-dependent cholesterol efflux in macrophages
976. Ezetimibe promotes brush border membrane-to-lumen cholesterol efflux in the small intestine
977. Anti-atherosclerotic potential of baicalin mediated by promoting cholesterol efflux from macrophages via the PPARγ-LXRα-ABCA1/ABCG1 pathway
978. Retinal pigment epithelium cholesterol efflux mediated by the 18 kDa translocator protein, TSPO, a potential target for treating age-related macular degeneration
979. Puerarin promotes ABCA1-mediated cholesterol efflux and decreases cellular lipid accumulation in THP-1 macrophages
980. Knock-down of the oxysterol receptor LXRα impairs cholesterol efflux in human primary macrophages: lack of compensation by LXRβ activation
981. Long non-coding RNA CDKN2B-AS1 reduces inflammatory response and promotes cholesterol efflux in atherosclerosis by inhibiting ADAM10 expression
982. Curcumin enhanced cholesterol efflux by upregulating ABCA1 expression through AMPK-SIRT1-LXRα signaling in THP-1 macrophage-derived foam cells
983. … therapy-induced foam cells apoptosis activates the phagocytic PPARγ-LXRα-ABCA1/ABCG1 pathway and promotes cholesterol efflux in advanced plaque
984. Effects of pemafibrate (K-877) on cholesterol efflux capacity and postprandial hyperlipidemia in patients with atherogenic dyslipidemia
985. Pomegranate peel polyphenols inhibit lipid accumulation and enhance cholesterol efflux in raw264. 7 macrophages
986. Quercetin increases macrophage cholesterol efflux to inhibit foam cell formation through activating PPARγ-ABCA1 pathway
987. Arctigenin promotes cholesterol efflux from THP-1 macrophages through PPAR-γ/LXR-α signaling pathway
988. Monocytes from HIV+ individuals show impaired cholesterol efflux and increased foam cell formation after transendothelial migration
989. ABCA1-dependent serum cholesterol efflux capacity inversely correlates with pulse wave velocity in healthy subjects [S]
990. Spiromastixones inhibit foam cell formation via regulation of cholesterol efflux and uptake in RAW264. 7 macrophages
991. The implication of cigarette smoking and cessation on macrophage cholesterol efflux in coronary artery disease patients [S]
992. Effect of apoA-I mutations in the capacity of reconstituted HDL to promote ABCG1-mediated cholesterol efflux
993. Antagonism of betulinic acid on LPS-mediated inhibition of ABCA1 and cholesterol efflux through inhibiting nuclear factor-kappaB signaling pathway and miR …
994. Specific disruption of Abca1 targeting largely mimics the effects of miR-33 knockout on macrophage cholesterol efflux and atherosclerotic plaque development
995. Impaired renal function on cholesterol efflux capacity, HDL particle number, and cardiovascular events
996. MicroRNA-20a/b regulates cholesterol efflux through post-transcriptional repression of ATP-binding cassette transporter A1
997. HDL-mediated cellular cholesterol efflux assay method
998. Sesamin enhances cholesterol efflux in RAW264. 7 macrophages
999. EEPD1 is a novel LXR target gene in macrophages which regulates ABCA1 abundance and cholesterol efflux
1000. Upconversion nanoparticle-mediated photodynamic therapy induces autophagy and cholesterol efflux of macrophage-derived foam cells via ROS generation
1001. Tweaking the cholesterol efflux capacity of reconstituted HDL
1002. Synthetic farnesoid X receptor agonists induce high-density lipoprotein-mediated transhepatic cholesterol efflux in mice and monkeys and prevent atherosclerosis in …
1003. cholesterol efflux: Does it contribute to aortic stiffening?
1004. Variants at the APOE/C1/C2/C4 Locus Modulate cholesterol efflux Capacity Independently of High‐Density Lipoprotein cholesterol
1005. Diminished cholesterol efflux mediated by HDL and coronary artery disease in young male anabolic androgenic steroid users
1006. Proteomic analysis of HDL from inbred mouse strains implicates APOE associated with HDL in reduced cholesterol efflux capacity via the ABCA1 pathway [S]
1007. HIV-1 Nef mobilizes lipid rafts in macrophages through a pathway that competes with ABCA1-dependent cholesterol efflux
1008. HDL cholesterol efflux capacity and cardiovascular events.
1009. Increased proinflammatory cytokine production and decreased cholesterol efflux due to downregulation of ABCG1 in macrophages exposed to indoxyl sulfate
1010. Saikosaponin-a attenuates oxidized LDL uptake and prompts cholesterol efflux in THP-1 cells
1011. Brain pericytes ABCA1 expression mediates cholesterol efflux but not cellular amyloid-β peptide accumulation
1012. Quantification of in vitro macrophage cholesterol efflux and in vivo macrophage-specific reverse cholesterol transport
1013. Elevated CETP activity improves plasma cholesterol efflux capacity from human macrophages in women
1014. TRAK2, a novel regulator of ABCA1 expression, cholesterol efflux and HDL biogenesis
1015. High-density lipoprotein subfractions and cholesterol efflux capacities after infusion of MDCO-216 (apolipoprotein A-IMilano/palmitoyl-oleoyl-phosphatidylcholine) in …
1016. Effects of miR-33a-5P on ABCA1/G1-mediated cholesterol efflux under inflammatory stress in THP-1 macrophages
1017. Transintestinal transport of the anti-inflammatory drug 4F and the modulation of transintestinal cholesterol efflux [S]
1018. LXR agonist treatment of blastic plasmacytoid dendritic cell neoplasm restores cholesterol efflux and triggers apoptosis
1019. HDL cholesterol efflux is impaired in older patients with early sepsis: a subanalysis of a prospective pilot study
1020. Association of cholesterol efflux capacity with plasmalogen levels of high-density lipoprotein: a cross-sectional study in chronic kidney disease patients
1021. Novel effect of paeonol on the formation of foam cells: Promotion of LXRα-ABCA1–dependent cholesterol efflux in macrophages
1022. Testosterone replacement in hypogonadal men alters the HDL proteome but not HDL cholesterol efflux capacity
1023. 9-cis β-carotene increased cholesterol efflux to HDL in macrophages
1024. Tangshen formula attenuates diabetic nephropathy by promoting ABCA1-mediated renal cholesterol efflux in db/db mice
1025. Decreased cholesterol efflux capacity in patients with low cholesteryl ester transfer protein plasma levels
1026. miR-613 regulates cholesterol efflux by targeting LXRα and ABCA1 in PPARγ activated THP-1 macrophages
1027. Human paraoxonase 1 overexpression in mice stimulates HDL cholesterol efflux and reverse cholesterol transport
1028. Enhanced cellular cholesterol efflux by naringenin is mediated through inhibiting endoplasmic reticulum stress-ATF6 activity in macrophages
1029. Differential effects of fenofibrate and extended-release niacin on high-density lipoprotein particle size distribution and cholesterol efflux capacity in dyslipidemic …
1030. Ethanolic extracts of Brazilian red propolis increase ABCA1 expression and promote cholesterol efflux from THP-1 macrophages
1031. Targeted cholesterol efflux
1032. Piperine inhibits ABCA1 degradation and promotes cholesterol efflux from THP‐1‐derived macrophages
1033. cholesterol efflux analyses using stable isotopes and mass spectrometry
1034. Resveratrol counters systemic lupus erythematosus-associated atherogenicity by normalizing cholesterol efflux
1035. LncRNA ENST00000602558. 1 regulates ABCG1 expression and cholesterol efflux from vascular smooth muscle cells through a p65-dependent pathway
1036. cholesterol efflux from macrophages is influenced differentially by plasmas from overweight insulin-sensitive and-resistant subjects
1037. Impairment of the ABCA1 and SR-BI-mediated cholesterol efflux pathways and HDL anti-inflammatory activity in Alzheimer’s disease
1038. Novel interactomics approach identifies ABCA1 as direct target of evodiamine, which increases macrophage cholesterol efflux
1039. Targeting mitochondrial 18 kDa translocator protein (TSPO) regulates macrophage cholesterol efflux and lipid phenotype
1040. Characterization of fluorescent NBD‑cholesterol efflux in THP‑1‑derived macrophages
1041. Dietary interesterified fat enriched with palmitic acid induces atherosclerosis by impairing macrophage cholesterol efflux and eliciting inflammation
1042. The detrimental effect of asymmetric dimethylarginine on cholesterol efflux of macrophage foam cells: Role of the NOX/ROS signaling
1043. Small HDL promotes cholesterol efflux by the ABCA1 pathway in macrophages: implications for therapies targeted to HDL
1044. miR-206 controls LXRα expression and promotes LXR-mediated cholesterol efflux in macrophages
1045. … HDL2-mediated cholesterol efflux is associated with metabolic syndrome in families with early onset coronary heart disease and low HDL-cholesterol level
1046. Hesperetin upregulates ABCA1 expression and promotes cholesterol efflux from THP-1 macrophages
1047. Impact of a one-year lifestyle modification program on cholesterol efflux capacities in men with abdominal obesity and dyslipidemia
1048. cholesterol efflux and metabolic abnormalities associated with low high-density-lipoprotein-cholesterol and high triglycerides in statin-treated coronary men with low …
1049. Modest diet-induced weight loss reduces macrophage cholesterol efflux to plasma of patients with metabolic syndrome
1050. Enhanced cholesterol efflux to HDL through the ABCA1 transporter in hypertriglyceridemia of type 2 diabetes
1051. 6‐Dihydroparadol, a Ginger Constituent, Enhances cholesterol efflux from THP‐1‐Derived Macrophages
1052. 17β-estradiol promotes cholesterol efflux from vascular smooth muscle cells through a liver X receptor α-dependent pathway
1053. FGF21 increases cholesterol efflux by upregulating ABCA1 through the ERK1/2–PPARγ–LXRα pathway in THP1 macrophage-derived foam cells
1054. Effects of the cholesteryl ester transfer protein inhibitor, TA-8995, on cholesterol efflux capacity and high-density lipoprotein particle subclasses
1055. Apolipoprotein A-1 binding protein promotes macrophage cholesterol efflux by facilitating apolipoprotein A-1 binding to ABCA1 and preventing ABCA1 degradation
1056. Bilirubin decreases macrophage cholesterol efflux and ATP‐binding cassette transporter A1 protein expression
1057. AIBP and APOA-I synergistically inhibit intestinal tumor growth and metastasis by promoting cholesterol efflux
1058. Effects of garlic on brachial endothelial function and capacity of plasma to mediate cholesterol efflux in patients with coronary artery disease
1059. HMG-CoA reductase inhibitors, simvastatin and atorvastatin, downregulate ABCG1-mediated cholesterol efflux in human macrophages
1060. Impact of endothelial lipase on cholesterol efflux capacity of serum and high-density lipoprotein
1061. Deleterious impact of elaidic fatty acid on ABCA1-mediated cholesterol efflux from mouse and human macrophages
1062. Liver X receptor reduces proliferation of human oral cancer cells by promoting cholesterol efflux via up-regulation of ABCA1 expression
1063. … acid in combination with EPHA2 inhibition shows efficacy in preclinical models of triple-negative breast cancer by disrupting cellular cholesterol efflux
1064. IL-22 is induced by S100/calgranulin and impairs cholesterol efflux in macrophages by downregulating ABCG1
1065. … peroxisome proliferator-activated receptor γ, liver X receptor α, and ATP binding cassette transporter A1 genes and increases cholesterol efflux in human macrophage …
1066. Soluble dietary fiber from Qing Ke (highland barley) brewers spent grain could alter the intestinal cholesterol efflux in Caco-2 cells
1067. Apolipoprotein B-100 and ApoA-II kinetics as determinants of cellular cholesterol efflux
1068. Interleukin-32 promotes lipid accumulation through inhibition of cholesterol efflux
1069. cholesterol efflux capacity does not associate with coronary calcium, plaque vulnerability, and telomere length in healthy octogenarians
1070. Effect of repeated apoA-IMilano/POPC infusion on lipids,(apo) lipoproteins, and serum cholesterol efflux capacity in cynomolgus monkeys
1071. Homocysteine-mediated cholesterol efflux via ABCA1 and ACAT1 DNA methylation in THP-1 monocyte-derived foam cells
1072. HDL cholesterol efflux predicts incident new-onset diabetes after transplantation (NODAT) in renal transplant recipients independent of HDL cholesterol levels
1073. LincRNA DYN‐LRB2‐2 upregulates cholesterol efflux by decreasing TLR2 expression in macrophages
1074. Hepatic forkhead box protein A3 regulates ApoA-I (apolipoprotein AI) expression, cholesterol efflux, and atherogenesis
1075. Regulation of the cholesterol efflux transporters ABCA1 and ABCG1 in retina in hemochromatosis and by the endogenous siderophore 2, 5-dihydroxybenzoic …
1076. HDL activates expression of genes stimulating cholesterol efflux in human monocyte-derived macrophages
1077. Alpha-linolenic acid increases cholesterol efflux in macrophage-derived foam cells by decreasing stearoyl CoA desaturase 1 expression: evidence for a farnesoid-X …
1078. cholesterol efflux capacity is impaired in subjects with an elevated Fatty Liver Index, a proxy of non-alcoholic fatty liver disease
1079. Therapeutic FGF19 promotes HDL biogenesis and transhepatic cholesterol efflux to prevent atherosclerosis [S]
1080. Spontaneous remodeling of HDL particles at acidic pH enhances their capacity to induce cholesterol efflux from human macrophage foam cells
1081. Beneficial effects of exercise-based cardiac rehabilitation on high-density lipoprotein-mediated cholesterol efflux capacity in patients with acute coronary syndrome
1082. Caveolin-1 interacts with ATP binding cassette transporter G1 (ABCG1) and regulates ABCG1-mediated cholesterol efflux
1083. Retinoic acid induces macrophage cholesterol efflux and inhibits atherosclerotic plaque formation in apoE-deficient mice
1084. Matrix metalloproteinase 8 degrades apolipoprotein A‐I and reduces its cholesterol efflux capacity
1085. … of GPR55 receptors exacerbates oxLDL-induced lipid accumulation and inflammatory responses, while reducing cholesterol efflux from human macrophages
1086. Relationship between HDL cholesterol efflux capacity, calcium coronary artery content, and antibodies against apolipoproteinA-1 in obese and healthy subjects
1087. Hsp27 promotes ABCA1 expression and cholesterol efflux through the PI3K/PKCζ/Sp1 pathway in THP-1 macrophages
1088. Regulation of retinoid mediated cholesterol efflux involves liver X receptor activation in mouse macrophages
1089. Phospholipid transfer protein is differentially expressed in human arterial and venous placental endothelial cells and enhances cholesterol efflux to fetal HDL
1090. Methyl protodioscin increases ABCA1 expression and cholesterol efflux while inhibiting gene expressions for synthesis of cholesterol and triglycerides by suppressing …
1091. Curcumin inhibits monocyte chemoattractant protein-1 expression and enhances cholesterol efflux by suppressing the c-Jun N-terminal kinase pathway in …
1092. Quantifying cellular cholesterol efflux
1093. Bexarotene promotes cholesterol efflux and restricts apical-to-basolateral transport of amyloid-β peptides in an in vitro model of the human blood-brain barrier
1094. Danshensu promotes cholesterol efflux in RAW264. 7 macrophages
1095. Whole egg consumption compared with yolk-free egg increases the cholesterol efflux capacity of high-density lipoproteins in overweight, postmenopausal women
1096. Leoligin, the Major Lignan from Edelweiss (Leontopodium nivale subsp. alpinum), Promotes cholesterol efflux from THP-1 Macrophages
1097. Sphingomyelin depletion impairs anionic phospholipid inward translocation and induces cholesterol efflux
1098. Apolipoprotein mimetic peptides for stimulating cholesterol efflux
1099. Retinoic acid and liver X receptor agonist synergistically inhibit HIV infection in CD4+ T cells by up-regulating ABCA1-mediated cholesterol efflux
1100. Poly (ADP-ribose) polymerase 1 represses liver X receptor-mediated ABCA1 expression and cholesterol efflux in macrophages
1101. Role of cholesterol homeostasis and its efflux pathways in cancer progression
1102. Robust passive and active efflux of cellular cholesterol to a designer functional mimic of high density lipoprotein
1103. Coenzyme Q10 increases cholesterol efflux and inhibits atherosclerosis through microRNAs
1104. Erythrodiol, an olive oil constituent, increases the half-life of ABCA1 and enhances cholesterol efflux from THP-1-derived macrophages
1105. PEG-lipid micelles enable cholesterol efflux in Niemann-Pick Type C1 disease-based lysosomal storage disorder
1106. Mitochondrial function is involved in regulation of cholesterol efflux to apolipoprotein (apo) AI from murine RAW 264.7 macrophages
1107. Saturated fats from butter but not from cheese increase HDL-mediated cholesterol efflux capacity from J774 macrophages in men and women with abdominal obesity
1108. Validation and application of a novel cholesterol efflux assay using immobilized liposomes as a substitute for cultured cells
1109. Modulation of microRNA expression in subjects with metabolic syndrome and decrease of cholesterol efflux from macrophages via microRNA-33-mediated …
1110. In type 2 diabetes mellitus glycated albumin alters macrophage gene expression impairing ABCA1‐mediated cholesterol efflux
1111. Cystathionine γ-lyase (CSE)/hydrogen sulfide system is regulated by miR-216a and influences cholesterol efflux in macrophages via the PI3K/AKT/ABCA1 pathway
1112. Decreased APOE-containing HDL subfractions and cholesterol efflux capacity of serum in mice lacking Pcsk9
1113. Impact of lifestyle intervention on HDL-induced eNOS activation and cholesterol efflux capacity in obese adolescent
1114. Development and validation of apolipoprotein AI-associated lipoprotein proteome panel for the prediction of cholesterol efflux capacity and coronary artery disease
1115. Serum FABP5 concentration is a potential biomarker for residual risk of atherosclerosis in relation to cholesterol efflux from macrophages
1116. High-density lipoprotein cholesterol efflux, nitration of apolipoprotein AI, and endothelial function in obese women
1117. cholesterol efflux capacity of large, small and total HDL particles is unaltered by atorvastatin in patients with type 2 diabetes
1118. High-density lipoprotein subfractions and cholesterol efflux capacity are not affected by supervised exercise but are associated with baseline interleukin-6 in …
1119. Incubation of MDCO-216 (ApoA-IMilano/POPC) with human serum potentiates ABCA1-mediated cholesterol efflux capacity, generates new prebeta-1 HDL …
1120. SAA: a link between cholesterol efflux capacity and inflammation? 1
1121. cholesterol efflux capacity of apolipoprotein AI varies with the extent of differentiation and foam cell formation of THP-1 cells
1122. Inhibition of the NLRP3 inflammasome attenuates foam cell formation of THP-1 macrophages by suppressing ox-LDL uptake and promoting cholesterol efflux
1123. Deficiency of TDAG51 protects against atherosclerosis by modulating apoptosis, cholesterol efflux, and peroxiredoxin‐1 expression
1124. … and epigallocatechin gallate aggravate autophagy of foam cells through the activation of Class III PI3K/Beclin1‐complex mediated cholesterol efflux
1125. The anti-atherogenic properties of sesamin are mediated via improved macrophage cholesterol efflux through PPARγ1-LXRα and MAPK signaling
1126. Determinants of HDL cholesterol efflux Capacity after Virgin Olive Oil Ingestion: Interrelationships with Fluidity of HDL Monolayer
1127. MicroRNA-101 overexpression by IL-6 and TNF-α inhibits cholesterol efflux by suppressing ATP-binding cassette transporter A1 expression
1128. Effects of cell culture techniques on gene expression and cholesterol efflux in primary bovine mammary epithelial cells derived from milk and tissue
1129. Exendin-4 ameliorates lipotoxicity-induced glomerular endothelial cell injury by improving ABC transporter A1-mediated cholesterol efflux in diabetic apoE …
1130. USF1 deficiency alleviates inflammation, enhances cholesterol efflux and prevents cholesterol accumulation in macrophages
1131. Salvianolic acid B accelerated ABCA1-dependent cholesterol efflux by targeting PPAR-γ and LXRα
1132. … proteins from stroke patients with and without endovascular closure of PFO are significantly different and suggest a novel mechanism for cholesterol efflux
1133. Directional ABCA1-mediated cholesterol efflux and apoB-lipoprotein secretion in the retinal pigment epithelium
1134. Protease-activated receptor 1 inhibits cholesterol efflux and promotes atherogenesis via cullin 3–mediated degradation of the ABCA1 transporter
1135. Excess Nitric Oxide Impairs LXR (α)‐ABCA1‐Dependent cholesterol efflux in Macrophage Foam Cells
1136. IL-8 negatively regulates ABCA1 expression and cholesterol efflux via upregulating miR-183 in THP-1 macrophage-derived foam cells
1137. Helical domains that mediate lipid solubilization and ABCA1-specific cholesterol efflux in apolipoproteins CI and A-II [S]
1138. Sex steroids mediate discrete effects on HDL cholesterol efflux capacity and particle concentration in healthy men
1139. Plasma cholesterol efflux capacity from human THP-1 macrophages is reduced in HIV-infected patients: impact of HAART [S]
1140. Theobromine does not affect fasting and postprandial HDL cholesterol efflux capacity, while it decreases fasting miR‐92a levels in humans
1141. Emodin enhances cholesterol efflux by activating peroxisome proliferator‐activated receptor‐γ in oxidized low density lipoprotein‐loaded THP 1 macrophages
1142. Sage weed (Salvia plebeia) extract antagonizes foam cell formation and promotes cholesterol efflux in murine macrophages
1143. Carvedilol ameliorates experimental atherosclerosis by regulating cholesterol efflux and exosome functions
1144. High-density lipoprotein-mediated cholesterol efflux capacity is improved by treatment with antiretroviral therapy in acute human immunodeficiency virus infection
1145. p62/mTOR/LXRα pathway inhibits cholesterol efflux mediated by ABCA1 and ABCG1 during autophagy blockage
1146. Metformin promotes cholesterol efflux in macrophages by up-regulating FGF21 expression: a novel anti-atherosclerotic mechanism
1147. Paraoxonase 1‐treated ox LDL promotes cholesterol efflux from macrophages by stimulating the PPAR γ–LXR α–ABCA 1 pathway
1148. Diets low in saturated fat with different unsaturated fatty acid profiles similarly increase serum-mediated cholesterol efflux from THP-1 macrophages in a population …
1149. cholesterol efflux capacity, HDL particle number, and incident cardiovascular events: an analysis from the JUPITER trial (Justification for the Use of Statins in …
1150. Lipoprotein concentration, particle number, size and cholesterol efflux capacity are associated with mitochondrial oxidative stress and function in an HIV positive …
1151. HDL acceptor capacities for cholesterol efflux from macrophages and lipid transfer are both acutely reduced after myocardial infarction
1152. Fibroblast growth factor 21 enhances cholesterol efflux in THP‑1 macrophage‑derived foam cells
1153. … Charge Heterogeneity, cholesterol efflux Capacity, and the Expression of High‐Density Lipoprotein‐Related Genes in Mononuclear Cells to the HDL‐cholesterol …
1154. microRNA-212 promotes lipid accumulation and attenuates cholesterol efflux in THP-1 human macrophages by targeting SIRT1
1155. HDL cholesterol efflux normalised to apoA-I is associated with future development of type 2 diabetes: from the CORDIOPREV trial
1156. … cell model to compare the lipid-lowering effects of pomegranate peel polyphenols with several other plant polyphenols as well as its related cholesterol efflux …
1157. Evidence of deregulated cholesterol efflux in abdominal aortic aneurysm
1158. Antibodies against the C-terminus of ApoA-1 are inversely associated with cholesterol efflux capacity and HDL metabolism in subjects with and without type 2 diabetes …
1159. Net cholesterol efflux capacity of HDL enriched serum and coronary atherosclerosis in rheumatoid arthritis
1160. Identification of an amino acid residue in ATP-binding cassette transport G1 critical for mediating cholesterol efflux
1161. Acyl-CoA synthetase 1 is required for oleate and linoleate mediated inhibition of cholesterol efflux through ATP-binding cassette transporter A1 in macrophages
1162. Codetermination of sphingomyelin and cholesterol in cellular plasma membrane in sphingomyelin-depletion-induced cholesterol efflux
1163. Elevated lipoprotein (a) levels lower ABCA1 cholesterol efflux capacity
1164. Lonicera caerulea Berry Polyphenols Activate SIRT1, Enhancing Inhibition of Raw264.7 Macrophage Foam Cell Formation and Promoting cholesterol efflux
1165. An LXR–NCOA 5 gene regulatory complex directs inflammatory crosstalk‐dependent repression of macrophage cholesterol efflux
1166. DNA topoisomerase II inhibitors induce macrophage ABCA1 expression and cholesterol efflux—An LXR-dependent mechanism
1167. Mono-(2-Ethylhexyl)phthalate Regulates cholesterol efflux via MicroRNAs Regulated m6A RNA Methylation
1168. ApoE promotes hepatic selective uptake but not RCT due to increased ABCA1-mediated cholesterol efflux to plasma
1169. Evidence for a role of CETP in HDL remodeling and cholesterol efflux: role of cysteine 13 of CETP
1170. Eicosapentaenoic acid membrane incorporation impairs ABCA1-dependent cholesterol efflux via a protein kinase A signaling pathway in primary human …
1171. Active cholesterol efflux in the retina and retinal pigment epithelium
1172. Relationship between serum cholesterol efflux capacity and glucose intolerance in Japanese-Americans
1173. Role of HDL in cholesterol efflux and reverse cholesterol transport
1174. Purple perilla extracts with α-asarone enhance cholesterol efflux from oxidized LDL-exposed macrophages
1175. Curcumin increases cholesterol efflux via heme oxygenase‑1‑mediated ABCA1 and SR‑BI expression in macrophages
1176. HNF4α increases liver-specific human ATP-binding cassette transporter A1 expression and cholesterol efflux to apolipoprotein AI in response to cholesterol depletion
1177. Overexpression and deletion of phospholipid transfer protein reduce HDL mass and cholesterol efflux capacity but not macrophage reverse cholesterol …
1178. Down-regulation of lipoprotein lipase increases ABCA1-mediated cholesterol efflux in THP-1 macrophages
1179. The phosphatase activity of soluble epoxide hydrolase regulates ATP‐binding cassette transporter‐A1‐dependent cholesterol efflux
1180. Arsenic inhibited cholesterol efflux of THP-1 macrophages via ROS-mediated ABCA1 hypermethylation
1181. … cholesterol redistribution, attenuates liver-X receptor/ATP-Binding cassette transporter A1/ATP-binding cassette transporter G1 pathway, and impairs cholesterol efflux
1182. Association between cholesterol efflux capacity and coronary restenosis after successful stent implantation
1183. V-ATPase (Vacuolar ATPase) activity required for ABCA1 (ATP-Binding cassette protein A1)-mediated cholesterol efflux
1184. Tanshinone IIA promotes macrophage cholesterol efflux and attenuates atherosclerosis of apoE-/-mice by omentin-1/ABCA1 pathway
1185. Characterization of the cholesterol efflux of apolipoprotein E-containing high-density lipoprotein in THP-1 cells
1186. Acute sex steroid withdrawal increases cholesterol efflux capacity and HDL-associated clusterin in men
1187. Apolipoprotein AI configuration and cell cholesterol efflux activity of discoidal lipoproteins depend on the reconstitution process
1188. Hyperlipidemia Determines Dysfunctional HDL Production and Impedes cholesterol efflux in the Small Intestine: Alleviation by Ginger Extract
1189. cholesterol efflux mediators in homozygous familial hypercholesterolemia patients on low-density lipoprotein apheresis
1190. Treatment of HIV infection with a raltegravir-based regimen increases LDL levels, but improves HDL cholesterol efflux capacity
1191. Impaired cholesterol efflux capacity and vasculoprotective function of high-density lipoprotein in heart transplant recipients
1192. 6-Gingerol regulates hepatic cholesterol metabolism by up-regulation of LDLR and cholesterol efflux-related genes in HepG2 cells
1193. A new method for measuring cholesterol efflux capacity uses stable isotope-labeled, not radioactive-labeled, cholesterol
1194. Sesamol and sesame (Sesamum indicum) oil enhance macrophage cholesterol efflux via up-regulation of PPARγ1 and LXRα transcriptional activity in a MAPK …
1195. HDL cholesterol efflux capacity and cholesteryl ester transfer are associated with body mass, but are not changed by diet-induced weight loss: A randomized trial in …
1196. Interferon-stimulated gene 15 promotes cholesterol efflux by activating autophagy via the miR-17-5p/Beclin-1 pathway in THP-1 macrophage-derived foam cells
1197. Red blood cells participate in reverse cholesterol transport by mediating cholesterol efflux of high-density lipoprotein and apolipoprotein AI from THP-1 macrophages
1198. Impaired HDL (High-Density lipoprotein)-mediated macrophage cholesterol efflux in patients with abdominal aortic aneurysm—brief report
1199. Glycated human serum albumin isolated from poorly controlled diabetic patients impairs cholesterol efflux from macrophages: an investigation by mass spectrometry
1200. Effect of rosuvastatin on cholesterol efflux capacity and endothelial function in type 2 diabetes mellitus and dyslipidemia
1201. ApoE isoforms and carboxyl-terminal-truncated apoE4 forms affect neuronal BACE1 levels and Aβ production independently of their cholesterol efflux capacity
1202. Intracoronary imaging, cholesterol efflux, and transcriptomics after intensive statin treatment in diabetes
1203. Eicosapentaenoic acid membrane incorporation impairs cholesterol efflux from cholesterol-loaded human macrophages by reducing the cholesteryl ester mobilization …
1204. Decreased OxLDL uptake and cholesterol efflux in THP1 cells elicited by cortisol and by cortisone through 11β-hydroxysteroid dehydrogenase type 1
1205. The formation of giant plasma membrane vesicles enable new insights into the regulation of cholesterol efflux
1206. Molecular complex composed of β-cyclodextrin-grafted Chitosan and pH-sensitive amphipathic peptide for enhancing cellular cholesterol efflux under acidic pH
1207. Rho-Associated Coiled-Coil-Containing Kinase 2 Deficiency in Bone Marrow–Derived Cells Leads to Increased cholesterol efflux and Decreased Atherosclerosis
1208. Endothelial-cell inflammation and damage by reactive oxygen species are prevented by propofol via ABCA1-mediated cholesterol efflux
1209. The target of regulating the ATP-binding cassette A1 protein (ABCA1): promoting ABCA1-mediated cholesterol efflux in different cells
1210. In vivo evidence for transintestinal cholesterol efflux in patients with complete common bile duct obstruction
1211. Caveolin-1 and ATP binding cassette transporter A1 and G1-mediated cholesterol efflux
1212. Chemoenzymatic synthesis of cholesteryl-6-O-tetradecanoyl-α-d-glucopyranoside: a product of host cholesterol efflux promoted by Helicobacter pylori
1213. cholesterol efflux from THP-1 macrophages is impaired by the fatty acid component from lipoprotein hydrolysis by lipoprotein lipase
1214. Mitochondrial hydrogen peroxide and defective cholesterol efflux prevent in vitro fertilization by cryopreserved inbred mouse sperm
1215. Hydrophobic amino acids in the hinge region of the 5A apolipoprotein mimetic peptide are essential for promoting cholesterol efflux by the ABCA1 transporter
1216. Effects of cardiac rehabilitation on high-density lipoprotein-mediated cholesterol efflux capacity and Paraoxonase-1 activity in patients with acute coronary syndrome
1217. … acidophilus K301 inhibits atherogenesis via induction of 24 (S), 25-epoxycholesterol-mediated ABCA1 and ABCG1 production and cholesterol efflux in …
1218. A novel gene regulator, pyrrole–imidazole polyamide targeting ABCA1 gene increases cholesterol efflux from macrophages and plasma HDL concentration
1219. Pentraxin 3 promotes oxLDL uptake and inhibits cholesterol efflux from macrophage-derived foam cells
1220. Impact of hormonal contraception and weight loss on high‐density lipoprotein cholesterol efflux and lipoprotein particles in women with polycystic ovary syndrome
1221. Visceral adipose tissue-derived serine protease inhibitor accelerates cholesterol efflux by up-regulating ABCA1 expression via the NF-κB/miR-33a pathway in THP-1 …
1222. trans-Chalcone prevents insulin resistance and hepatic inflammation and also promotes hepatic cholesterol efflux in high-fat diet-fed rats: modulation of miR-34a-, miR …
1223. Structure-function relationships in reconstituted HDL: Focus on antioxidative activity and cholesterol efflux capacity
1224. Subantimicrobial-dose doxycycline treatment increases serum cholesterol efflux capacity from macrophages
1225. Activation of PPARγ does not contribute to macrophage ABCA1 expression and ABCA1-mediated cholesterol efflux to apoAI
1226. Associations of ABCG1-mediated cholesterol efflux capacity with coronary artery lipid content assessed by near-infrared spectroscopy
1227. Decreased cholesterol uptake and increased liver X receptor-mediated cholesterol efflux pathways during prostaglandin F2 alpha-induced and spontaneous …
1228. Apolipoprotein AI and cholesterol efflux: the good, the bad, and the modified
1229. Citrulline increases cholesterol efflux from macrophages in vitro and ex vivo via ATP-binding cassette transporters
1230. A single infusion of MDCO-216 (ApoA-1 Milano/POPC) increases ABCA1-mediated cholesterol efflux and pre-beta 1 HDL in healthy volunteers and patients with …
1231. … AI missense mutation apoA-I (Arg149Ser) Boston associated with decreased lecithin-cholesterol acyltransferase activation and cellular cholesterol efflux
1232. Improved plasma cholesterol efflux capacity from human macrophages in patients with hyperalphalipoproteinemia
1233. Modulation of cholesterol efflux capacity in patients with myocardial infarction
1234. Differential regulation of ABCA1 and macrophage cholesterol efflux by elaidic and oleic acids
1235. Baicalin promotes cholesterol efflux by regulating the expression of SR‑BI in macrophages
1236. The combination of L-4F and simvastatin stimulate cholesterol efflux and related proteins expressions to reduce atherosclerotic lesions in apoE knockout mice
1237. Impaired cholesterol efflux capacity is related to increased carotid intima media thickness in patients with end-stage renal disease
1238. Communication—Microelectrode Detection of cholesterol efflux from the Human Buccel Mucosa
1239. HDL and apolipoprotein A1 concentrations as markers of cholesterol efflux in middle-aged women: interaction with smoking
1240. Extracellular lipid-free apolipoprotein E inhibits HCV replication and induces ABCG1-dependent cholesterol efflux
1241. Correlation between the decrease of cholesterol efflux from macrophages in patients with type II diabetes mellitus and down-regulated CYP7A1 expression
1242. High-density lipoprotein benefits beyond the cardiovascular system: A potential key role for modulating acquired immunity through cholesterol efflux
1243. The E693Δ (Osaka) mutation in amyloid precursor protein potentiates cholesterol‐mediated intracellular amyloid β toxicity via its impaired cholesterol efflux
1244. A functional virgin olive oil enriched with olive oil and thyme phenolic compounds improves the expression of cholesterol efflux-related genes: a randomized …
1245. Amphipathic polyproline peptides stimulate cholesterol efflux by the ABCA1 transporter
1246. Effect of IL-6 receptor blockade on proprotein convertase subtilisin/kexin type-9 and cholesterol efflux capacity in rheumatoid arthritis patients
1247. Coenzyme Q10 consumption promotes ABCG1‐mediated macrophage cholesterol efflux: A randomized, double‐blind, placebo‐controlled, cross‐over study in …
1248. cholesterol efflux from sperm: approaches and applications
1249. Atherosclerosis regulation via media lipid-driven VSMC cholesterol efflux switch
1250. Longitudinal changes in cholesterol efflux capacities in patients with coronary artery disease undergoing lifestyle modification therapy
1251. Involvement of cdc42/Rho kinase in ApoA‐I‐mediated cholesterol efflux through interaction between cytosolic lipid‐protein particles and microtubules in rat astrocytes
1252. Toll-like receptor 2 downregulates the cholesterol efflux by activating the nuclear factor‑κB pathway in macrophages and may be a potential therapeutic target …
1253. cholesterol efflux capacity of high-density lipoprotein correlates with survival and allograft vasculopathy in cardiac transplant recipients
1254. Reduced glutathione increases quercetin stimulatory effects on HDL-or apoA1-mediated cholesterol efflux from J774A. 1 macrophages
1255. Fertility of cold-stored mouse sperm is recovered by promoting acrosome reaction and hyperactivation after cholesterol efflux by methyl-beta-cyclodextrin
1256. Is defective cholesterol efflux an integral inflammatory component in myelopoiesis-driven cardiovascular diseases?
1257. CC-chemokine ligand 2 (CCL2) suppresses high density lipoprotein (HDL) internalization and cholesterol efflux via CC-chemokine receptor 2 (CCR2) …
1258. … cholesterol efflux predicts incident new onset diabetes after transplantation (NODAT) in renal transplant recipients independent of high density lipoprotein cholesterol …
1259. Fibrate treatment induced quantitative and qualitative HDL changes associated with an increase of SR-BI cholesterol efflux capacities in rabbits
1260. Liver X receptor agonist modulation of cholesterol efflux in mice with intestine-specific deletion of microsomal triglyceride transfer protein
1261. Effect of seminal plasma proteins on membrane cholesterol efflux of ram epididymal spermatozoa
1262. … lipid-derived electrophile 4-hydroxynonenal on macrophage cholesterol efflux: silencing carboxylesterase 1 has paradoxical effects on cholesterol uptake and efflux
1263. RIP140 triggers foam-cell formation by repressing ABCA1/G1 expression and cholesterol efflux via liver X receptor
1264. The dietary constituent falcarindiol promotes cholesterol efflux from THP-1 macrophages by increasing ABCA1 gene transcription and protein stability
1265. Regulation of ATP-binding cassette transporters and cholesterol efflux by glucose in primary human monocytes and murine bone marrow-derived macrophages
1266. CSL112 restores cholesterol efflux in patients immediately after acute myocardial infarction
1267. Moderate renal impairment does not impact the ability of CSL112 (apolipoprotein A‐I [human]) to enhance cholesterol efflux capacity
1268. Prostaglandin A1 Inhibits the Cognitive Decline of APP/PS1 Transgenic Mice via PPARγ/ABCA1-dependent cholesterol efflux Mechanisms
1269. cholesterol efflux responds to viral load and CD4 counts in HIV+ patients and is dampened in HIV exposed
1270. Effects of nutraceuticals and botanicals on macrophage cholesterol efflux: implications for atherosclerosis
1271. G protein pathway suppressor 2 (GPS2) links inflammation and cholesterol efflux by controlling lipopolysaccharide‐induced ATP‐binding cassette transporter A1 …
1272. Nifedipine enhances cholesterol efflux in RAW264. 7 macrophages
1273. Synthesis of the anionic hydroxypropyl-β-cyclodextrin: poly (decamethylenephosphate) polyrotaxane and evaluation of its cholesterol efflux potential in Niemann–Pick …
1274. In vivo inflammation does not impair ABCA1-mediated cholesterol efflux capacity of HDL
1275. cholesterol efflux capacity: choke point of reverse cholesterol traffic?
1276. Alpinetin enhances cholesterol efflux and inhibits lipid accumulation in oxidized low‐density lipoprotein‐loaded human macrophages
1277. Luminal plant sterol promotes brush border membrane-to-lumen cholesterol efflux in the small intestine
1278. Effect of ferulic acid on cholesterol efflux in macrophage foam cell formation and potential mechanism
1279. Atorvastatin blocks advanced glycation end products induced reduction in macrophage cholesterol efflux mediated with ATP-binding cassette transporters G 1
1280. Ethyl 2, 4, 6-trihydroxybenzoate is an agonistic ligand for liver X receptor that induces cholesterol efflux from macrophages without affecting lipid accumulation in …
1281. Usefulness of apolipoprotein B-depleted serum in cholesterol efflux capacity assays using immobilized liposome-bound gel beads
1282. E3317 promotes cholesterol efflux in macrophage cells via enhancing ABCA1 expression
1283. Reduced cellular cholesterol efflux and low plasma high-density lipoprotein cholesterol in a patient with type B Niemann-Pick disease because of a novel SMPD-1 …
1284. Effect of vildagliptin and pravastatin combination on cholesterol efflux in adipocytes
1285. Linoleic acid suppresses cholesterol efflux and ATP-binding cassette transporters in murine bone marrow-derived macrophages
1286. HDL cholesterol efflux capacity in newly diagnosed HIV and effects of antiretroviral therapy
1287. Gly [14]-humanin inhibits ox-LDL uptake and stimulates cholesterol efflux in macrophage-derived foam cells
1288. Lipoxin A4 promotes ABCA1 expression and cholesterol efflux through the LXRα signaling pathway in THP-1 macrophage-derived foam cells
1289. Effect of 1-deoxynojirimycin on cholesterol efflux through ABCA1-LXRα pathway in 3T3-L1 adipocytes
1290. Inhibition of ABCA1 protein expression and cholesterol efflux by TNF α in MLO-Y4 osteocytes
1291. Intermedin ameliorates atherosclerosis by increasing cholesterol efflux through the cAMP-PKA pathway in macrophage RAW264. 7 cell line
1292. A novel inducible cholesterol efflux peptide, FAMP, protects against myocardial ischemia reperfusion injury through a nitric oxide pathway
1293. Increased 27-hydroxycholesterol plasma level in men with low high density lipoprotein-cholesterol may circumvent their reduced cell cholesterol efflux rate
1294. Association Between the ABCA1-565C/T Gene Promoter Polymorphism and Coronary Heart Disease Severity and cholesterol efflux in the Chinese Han Population
1295. Nuclear receptors and microRNA-144 coordinately regulate cholesterol efflux
1296. Double potential pulse chronocoulometry for detection of plasma membrane cholesterol efflux at disk platinum microelectrodes
1297. … of GPR55 receptors exacerbates oxLDL-induced lipid accumulation and inflammatory responses, while reducing cholesterol efflux from human macrophages
1298. Lack of correlation of plasma HDL with fecal cholesterol and plasma cholesterol efflux capacity suggests importance of HDL functionality in attenuation of …
1299. ATR‐101 inhibits cholesterol efflux and cortisol secretion by ATP‐binding cassette transporters, causing cytotoxic cholesterol accumulation in adrenocortical …
1300. The measurement of high-density lipoprotein mediated cholesterol efflux from macrophage cells by liquid chromatography tandem mass spectrometry
1301. SR-BI associates with ABCG1 and inhibits ABCG1-mediated cholesterol efflux from cells to high-density lipoprotein 3
1302. Importance of evaluating cell cholesterol influx with efflux in determining the impact of human serum on cholesterol metabolism and atherosclerosis
1303. Tribbles homolog 1 enhances cholesterol efflux from oxidized low-density lipoprotein-loaded THP-1 macrophages
1304. Metformin ameliorates Ox-LDL-induced foam cell formation in raw264. 7 cells by promoting ABCG-1 mediated cholesterol efflux
1305. Zerumbone, a natural cyclic sesquiterpene, promotes ABCA1-dependent cholesterol efflux from human THP-1 macrophages
1306. Total HDL cholesterol efflux capacity in healthy children–associations with adiposity and dietary intakes of mother and child
1307. cholesterol efflux capacity—a new biomarker for cardiovascular risk?
1308. Angiotensin‑(1‑7) stimulates cholesterol efflux from angiotensin II‑treated cholesterol‑loaded THP‑1 macrophages through the suppression of p38 and c‑Jun N …
1309. Nutritionally derived metabolic cues typical of the obese microenvironment increase cholesterol efflux capacity of adipose tissue macrophages
1310. N-homocysteinylation of apolipoprotein AI impairs the protein’s antioxidant ability but not its cholesterol efflux capacity
1311. Apolipoprotein A-1 (apoA-1) deposition in, and release from, the enterocyte brush border: A possible role in transintestinal cholesterol efflux (TICE)?
1312. Attenuated macrophage cholesterol efflux function in patients with obstructive sleep apnea–hypopnea syndrome
1313. cholesterol efflux capacity as a novel biomarker for incident cardiovascular events: has high-density lipoprotein been resuscitated?
1314. Lower than average HDL cholesterol efflux capacity in Lithuanian population
1315. Effect of peroxisome proliferator-activated receptor γ on the cholesterol efflux of peritoneal macrophages in inflammation
1316. Interleukin 8 Inhibition Enhanced cholesterol efflux in Acetylated Low-Density Lipoprotein–Stimulated THP-1 Macrophages
1317. CSL112, a novel formulation of human apolipoprotein AI, dramatically increases cholesterol efflux capacity in healthy subjects: a, placebo-controlled, double-blinded …
1318. Analysis of low molecular weight substances and related processes influencing cellular cholesterol efflux
1319. cholesterol efflux capacity assay using immobilized liposomes and apolipoprotein B-depleted serum
1320. cholesterol efflux in the transplant patient
1321. Expressions of lipoprotein receptors and cholesterol efflux regulatory proteins during luteolysis in bovine corpus luteum
1322. … structure by HDL mimetic peptide ATI-5261 upon extensive dilution represents an important determinant for stimulating ABCA1 cholesterol efflux with high efficiency
1323. Novel association between CDKAL1 and cholesterol efflux capacity: Replication after GWAS-based discovery
1324. … of the cholesteryl ester transfer protein inhibitor, evacetrapib, administered as monotherapy or in combination with statins on cholesterol efflux and HDL particles in …
1325. … ‐Epoxycholesterol Attenuates Human Smooth Muscle–Derived Foam Cell Formation Via Reduced Low‐Density Lipoprotein Uptake and Enhanced cholesterol efflux
1326. Caveolin-1 reduces HIV-1 infectivity by restoration of HIV Nef mediated impairment of cholesterol efflux by apoA-I
1327. Genetic obesity increases pancreatic expression of mitochondrial proteins which regulate cholesterol efflux in BRIN-BD11 insulinoma cells
1328. The effects of Phellinus linteus polysaccharide extracts on cholesterol efflux in oxidized low-density lipoprotein–loaded THP-1 macrophages
1329. Regulation of macrophage cholesterol efflux and liver X receptor α activation by nicotine
1330. Analysis of ABCA1 and cholesterol efflux in HIV-infected cells
1331. A newly integrated model for intestinal cholesterol absorption and efflux reappraises how plant sterol intake reduces circulating cholesterol levels
1332. Lysophosphatidylcholine promotes SREBP-2 activation via rapid cholesterol efflux and SREBP-2-independent cytokine release in human endothelial cells
1333. Protection effect of curcumin for macrophage-involved polyethylene wear particle-induced inflammatory osteolysis by increasing the cholesterol efflux
1334. Curcumin promotes cholesterol efflux from brain through LXR/RXR-ABCA1-apoA1 pathway in chronic cerebral hypoperfusion aging-rats
1335. Improved survival rate after myocardial infarction using an inducible cholesterol efflux (iCE) peptide: FAMP
1336. cholesterol mass efflux capacity, incident cardiovascular disease, and progression of carotid plaque: the multi-ethnic study of atherosclerosis
1337. Interferon-β promotes macrophage foam cell formation by altering both cholesterol influx and efflux mechanisms
1338. The non-synonymous polymorphism at position 114 of the WRN protein affects cholesterol efflux in vitro and correlates with cholesterol levels in vivo
1339. CSL112, a novel formulation of human apolipoprotein AI, dramatically increases cholesterol efflux capacity in patients with stable atherothrombotic disease: a …
1340. cholesterol efflux capacity: A weak player in the complex plot of cardiac allograft vasculopathy
1341. Is Coffee the Next Red Wine? Coffee Polyphenol and cholesterol efflux
1342. cholesterol efflux capacity
1343. Combined treatment with 9-cis β-carotene and 22R-hydroxycholesterol augments cholesterol efflux in macrophages
1344. Elastic aortic wrap reduced aortic stiffness by partially alleviating the impairment of cholesterol efflux capacity in pigs
1345. IMB2026791, a xanthone, stimulates cholesterol efflux by increasing the binding of apolipoprotein AI to ATP-binding cassette transporter A1
1346. Simvastatin promotes NPC 1‐mediated free cholesterol efflux from lysosomes through CYP 7A1/LXR α signalling pathway in ox LDL‐loaded macrophages
1347. β3-Adrenoceptor activation upregulates apolipoprotein AI expression in HepG2 cells, which might further promote cholesterol efflux from macrophage foam …
1348. Regulated efflux of photoreceptor outer segment-derived cholesterol by human RPE cells
1349. Ac‑hE‑18A‑NH2, a novel dual‑domain apolipoprotein mimetic peptide, inhibits apoptosis in macrophages by promoting cholesterol efflux
1350. adiponectin stimulates cholesterol efflux efficiently in human THP-1 macrophages and modulates HDL-apoA-I biogenesis
1351. Retinoid regulated macrophage cholesterol efflux involves the steroidogenic acute regulatory protein
1352. Adenylyl cyclase 1 as a major isoform to generate cAMP signaling for apoA-1-mediated cholesterol efflux pathway
1353. Tailoring of biomimetic high-density lipoprotein nanostructures changes cholesterol binding and efflux
1354. Effect of Anacetrapib on ABCA1-specific cholesterol efflux Capacity: a Substudy of the DEFINE Trial
1355. HDL cholesterol efflux capacity is inversely associated with incident CHD events independent of HDL-C and ApoA-I concentrations
1356. Analysis of serum cholesterol efflux capacity in a Minipig model of nonischemic heart failure
1357. Sex-dependent difference in the relationship between adipose-tissue cholesterol efflux and estradiol concentrations in young healthy humans
1358. Histone deacetylase inhibition decreases cholesterol levels in neuronal cells by modulating key genes in cholesterol synthesis, uptake and efflux
1359. A reliable and reproducible assay for determining the effect of natural product on macrophages lipid uptake and cholesterol efflux: A case study of maslinic acid
1360. cholesterol efflux monitoring in macrophage form cells by using fluorescence lifetime imaging
1361. Impaired cholesterol efflux into hdl2 in metabolic syndrome
1362. The Saturated Fatty Acids Palmitic Acid And Stearic Acid Do Not Differently Affect cholesterol efflux Capacity: Results Of A Human Dietary Intervention Trial
1363. Excess nitric oxide impairs liver X receptor a-ATP-binding cassette transporter A1-dependent cholesterol efflux in macrophage foam cells
1364. … in macrophages through upregulation of receptor of advanced glycation end products: increasing uptake, esterification and decreasing efflux of cholesterol
1365. Persimmon Tannin Regulates Gene Expressions Important for Lipogenesis And cholesterol efflux in HepG2 Cells
1366. IRAK regulates macrophage foam cell formation by modulating genes involved in cholesterol uptake and efflux
1367. CETP Inhibitor Increases HDL-C and cholesterol efflux Capacity, but Reduces Subsequent cholesterol Esterification and Hepatic Cell Uptake
1368. Macrophage cholesterol efflux and Atherosclerosis in Psoriasis: A role for microRNA‐33
1369. HDL-C, ABCA1-mediated cholesterol efflux, and lipoprotein (a): insights into a potential novel physiologic role of lipoprotein (a) 1
1370. Diosgenin decrease proliferation of human lung cancer cells by promoting cholesterol efflux via up-regulation of LXR-and its target ABCA1 expression α
1371. IN VIVO GLYCATED HUMAN SERUM ALBUMIN IMPAIRS cholesterol efflux FROM MACROPHAGES (MO9)
1372. Rosuvastatin Activates ATP-Binding Cassette Transporter A1–Dependent efflux Ex Vivo and Promotes Reverse cholesterol Transport in Macrophage Cells in Mice …
1373. Tanshinone IIA affects the HDL subfractions distribution not serum lipid levels: involving in intake and efflux of cholesterol
1374. STATIN–INDUCED DECREASE IN ABCA1 EXPRESSION VIA MIR33 INDUCTION MAY COUNTERACT cholesterol efflux BY HIGH–DENSITY …
1375. Mutations in ABCA8 result in HDL deficiency and cholesterol efflux defects
1376. SR-B1: a unique multifunctional receptor for cholesterol influx and efflux
1377. Impaired cholesterol efflux Capacity in Aboriginal Australians-Implications for Elevated Cardiovascular Risk in Indigenous Populations
1378. … cholesterol efflux Capacity of Plasma HDL With J774 Mouse Macrophages Reveals Superiority of the Radioactive cholesterol Method over the BODIPY-cholesterol …
1379. The lipid-droplet associated protein perilipin 2 (PLIN2) plays a central role in lipid accumulation and cholesterol efflux via effects on LXR signaling in human …
1380. HDL Particles, Cell-cholesterol efflux, and CHD Risk: The Preβ-1 Paradox
1381. Serum from patients with aortic valvular stenosis shows decreased cholesterol efflux capacities despite similar high-density lipoprotein cholesterol levels
1382. Role of Hyaluronic Acid on Apolipoprotein A1 and HDL-Mediated cholesterol efflux in Macrophages
1383. Quality Control Of The cholesterol efflux Capacity Assay In A High Throughput Setting
1384. The Role Of Effector Proteins In Cellular cholesterol efflux
1385. cholesterol efflux drives stem cell expansion in hypercholesterolaemia
1386. TCTAP A-019 Paradoxical Elevation of cholesterol efflux Capacity During Acute Coronary Syndrome in Young Heterogenous Asians
1387. Differential impairment of serum cholesterol efflux capacity in patients with rheumatoid arthritis and systemic lupus erythematosus
1388. Effects Of Palm Oil Tocotrienols Rich Fraction On cholesterol efflux
1389. Autophagy is not required for abca1-mediated cholesterol efflux in cholesterol loaded human monocyte-derived macrophages
1390. Ezetimibe Enhances Macrophage Reverse cholesterol Transport in Hamsters Independent of Transintestinal cholesterol efflux Pathway
1391. cholesterol and ergosterol affect the activity of Staphylococcus aureus antibiotic efflux pumps
1392. Effect of high glucose on cholesterol efflux in renal tubular cell and intervention of anthocyanins
1393. Differential Relationships Between Serum cholesterol efflux Capacities Measured From Three Cell Models and Coronary Artery Disease Status in the Montreal Heart …
1394. Synthetic fxr agonists induce HDL-mediated transhepatic cholesterol efflux in mice and monkeys and prevent atherosclerosis in cetp transgenic Ldlr/mice
1395. … steroid pro-atherogenic action: Up regulation of macrophage LDL receptors, down regulation of cholesterol efflux transporters and increase in intracellular cholesterol …
1396. Beneficial Effects of Exercise-based Cardiac Rehabilitation on HDL-mediated cholesterol efflux Capacity in Patients with Acute Coronary Syndrome
1397. Serum cholesterol efflux capacity and mortality in patients with acute myocardial infarction
1398. High-throughput Nitrobenzoxadiazole-labeled cholesterol efflux Assay
1399. Apolipoprotein AI configuration and cell cholesterol efflux activity of discoidal lipoproteins depend on the reconstitution process
1400. The study of hydrogen sulfide up-regulates the expression of ABCA1 and promotes the cholesterol efflux in foam cells
1401. Lipidomic study of the impact of eicosapentaenoic acid (EPA) on abca1-mediated cholesterol efflux from human macrophages
1402. cholesterol efflux Capacity, Hdl-Particle Number, and Incident Cardiovascular Events: Results from the Jupiter Trial
1403. … targeted theranostic photoactivation attenuates plaque inflammation and regresses the atheroma via autophagy-induced cholesterol efflux assessed by serial in vivo …
1404. Stimulation of cholesterol efflux from Human Macrophage by Liver X Receptor Agonists is a 2-Step Mechanism Requiring ARL7 and ABCA1
1405. ROCK2 Deficiency in Bone Marrow-Derived Cells Leads to Increased cholesterol efflux and Decreased Atherosclerosis
1406. Inflammation potently suppresses abca1-mediated cholesterol efflux from macrophages, and not adipocytes, via activation of JAK/STAT pathway
1407. Roles of cholesterol efflux capacity in the occurrence and prognosis coronary artery disease
1408. NGM282 Promotes HDL Biogenesis and Transhepatic cholesterol efflux to Prevent Atherosclerosis in Mice
1409. Beyond cholesterol efflux: Defining HDL Function in Atherosclerosis and the Requirement for Procollagen C-Endopeptidase Enhancer Protein 2
1410. cholesterol efflux capacity in young acute coronary syndrome in Malaysia
1411. ATP-binding cassette transporter A subfamily 8 is a sinusoidal efflux transporter for cholesterol and taurocholate in mouse and human liver
1412. cholesterol efflux Assay
1413. Covalent Modifications of Apolipoproteins in High Density Lipoprotein by Oxidized Phospholipids Impair the cholesterol efflux Function of High Density Lipoprotein …
1414. The cholesterol efflux Capacity (Cec) Correlates With Oxidative Stress In Type 2 Diabetes Mellitus
1415. Inhibition of CETP by Dalcetrapib Results in a Modest Increase in cholesterol efflux Capacity Associated With an Increase in Large HDL Particles, but Does Not …
1416. Testosterone stimulates cholesterol metabolism and efflux from human macrophages via liver X receptor
1417. FP032 INDOXYL SULFATE INDUCES PROINFLAMMATORY CYTOKINE PRODUCTION AND INHIBITS cholesterol efflux DUE TO DOWNREGULATION OF …
1418. the dual effect of cigarette smoke on macrophage Abca1-dependent cholesterol efflux and protease production leads to decreased collagen and increased necrosis in …
1419. CSL112, a Novel Formulation of Human ApoA-I, Enhances the Capacity of Serum to efflux cholesterol from Macrophages
1420. A functional virgin olive oil enriched with olive and thyme phenolic compounds improves the expression of cholesterol efflux-related genes: a randomized, cross-over …
1421. The human ABCG1 transporter mobilizes plasma membrane and late endosomal non-sphingomyelin-associated-cholesterol for efflux and esterification
1422. Asymmetric Dimethylarginine Exacerbates Lipid Accumulation in Macrophage Foam Cells by Impairing LXRα/ABCA1-Dependent cholesterol efflux
1423. Enhanced Roles of cholesterol efflux Capacity in Coronary Atheroma Regression in Patients Achieving Targets for Cardiovascular Risk
1424. EAS19-0434. QUALITY CONTROL OF THE cholesterol efflux CAPACITY ASSAY IN A HIGH THROUGHPUT SETTING
1425. Association Of cholesterol efflux Capacity With Regression Of Coronary Atherosclerosis
1426. Amphipols: Peptide-like Synthetic Amphipathic Polymers That Promote Cellular cholesterol efflux
1427. High-density lipoprotein proteomic composition, and not efflux capacity, reflects differential modulation of reverse cholesterol transport by saturated and …
1428. Sphingomyelin regulation of plasma membrane asymmetry, efflux and reverse cholesterol transport
1429. The impact of S1P receptors on the high-density lipoprotein-mediated cholesterol efflux in Chinese hamster ovary cells
1430. IL-19 halts progression of atherosclerotic plaque, polarizes, and increases cholesterol uptake and efflux in macrophages
1431. P3767 Progressive left atrial remodeling associates with cholesterol efflux capacity of HDL in atrial fibrillation patients
1432. A High-throughput, Fluorescence-based cholesterol efflux Assay
1433. Transcriptome analysis of human macrophages reveals genes regulating cellular cholesterol efflux
1434. Association of Exercise-Induced Changes in cholesterol efflux Capacity with Changes in the HDL Proteome
1435. Peptide mediators of cholesterol efflux
1436. GW29-e1819 Association of cholesterol efflux capacity of high-density lipoprotein with coronary collateralization in patients with stable angina and chronic total …
1437. Eicosapentaenoic Acid (Epa) Differentially Affects Abca1-Mediated cholesterol efflux From Primary Human Macrophages Or Thp-1 Cell Line
1438. The Capacity Of Cerebrospinal Fluid To Promote cholesterol efflux Through Abca1 And Abcg1 Is Specifically Impaired In Alzheimer’S Disease Patients
1439. Assessing the Molecular Basis for Variation in Extremes of ABCA-1 Specific cholesterol efflux
1440. AIBP suppresses choroidal neovascularization (CNV) by enhancing cholesterol efflux
1441. Robust and High-Throughput cholesterol efflux Assay
1442. cholesterol efflux capacity modulation by the nutraceutical compound “Oleactive®”
1443. Mechanisms Of Functional Hdl Production And cholesterol efflux In The Small Intestine Of Hyperlipidemic Hamster; Stimulation By Ginger Administration
1444. cholesterol efflux capacity—inverse association with incident cardiovascular disease
1445. Androgen Abuse is Associated With Reversible, HDL-dependent Suppression of cholesterol efflux Capacity
1446. HDL cholesterol efflux capacity and cardiovascular mortality
1447. The role of cholesterol efflux pathways in T-cell activation and proliferation
1448. cholesterol efflux CAPACITY AND ITS ASSOCIATION WITH METABOLIC SYNDROME IN A MULTI-ETHNIC POPULATION (DALLAS HEART STUDY): A …
1449. Evaluation of serum cholesterol efflux capacity in diabetic compared to healthy subjects
1450. Elevated Lipoprotein (a) Levels Impair Abca1 cholesterol efflux Capacity
1451. Prognostic Usefulness of Serum cholesterol efflux Capacity in Patients with Coronary Artery
1452. CHARACTERISATION OF FLUORESCENT NBD-cholesterol efflux IN THP-1 DERIVED
1453. Farnesoid X Receptor Activation Lowers Hdl-C But Increases Abca1-Specific Serum Hdl cholesterol efflux Capacity
1454. Research on the determination of cholesterol efflux from foam cells mediated by apoA-1 using HPLC analysis
1455. Polyunsaturated fatty acids (PUFAs) differentially affected abca1-mediated cholesterol efflux from cholesterol-loaded mouse or human macrophages
1456. Regulators of cholesterol efflux from Macrophages to High-Density Lipoprotein
1457. cholesterol efflux Capacity & Collateral Circulation in Patients With Chronic Total Coronary Occlusion
1458. Identifying the regulatory mechanisms underlying cholesterol efflux from the sperm plasma membrane during capacitation
1459. Impaired HDL2-mediated cholesterol efflux is associated with metabolic syndrome in families with early onset coronary heart disease and low HDL-cholesterol level
1460. P1690 Diminished macrophage cholesterol efflux mediated by HDL and coronary artery disease in young male anabolic androgenic steroid users
1461. cholesterol efflux Capacity: Biological and Clinical Determinants in a Large Multi-ethnic Population Study (Dallas Heart Study)
1462. Impact of Haptoglobin Genotype and Diabetes Status on Anacetrapib-Mediated Increase in cholesterol efflux Capacity
1463. (Retraction Request) Effect of Rosuvastatin on cholesterol efflux Capacity and Endothelial Function in Type 2 Diabetes Mellitus and Dyslipidemia
1464. Associations of Cardiovascular Risk Factors With cholesterol efflux Capacity in Indigenous Australians
1465. CSL112, A NOVEL FORMULATION OF HUMAN APOA-I, RAPIDLY ENHANCES cholesterol efflux CAPACITY OF PLASMA FOLLOWING INFUSION
1466. CORONARY PLAQUE BURDEN IS ASSOCIATED WITH cholesterol efflux CAPACITY PARTIALLY MEDIATED BY THE HEMATOPOIETIC SYSTEM IN …
1467. Integration of Macrophage cholesterol efflux and Hepatic cholesterol Uptake by Direct and Indirect Pathways in a Co-culture System for Reverse cholesterol …
1468. Association between alpha-tocopherol concentration in HDL fraction and cholesterol efflux capacity in patients with familial hypercholesterolemia
1469. cholesterol efflux as a measure of HDL functionality in humans: impact of genetics, diet and weight loss
1470. Optimization of Microelectrode cholesterol efflux Measurements By Platinum Crystallites on Carbon
1471. Apolipoprotein AI structure and stability dictate cholesterol efflux efficiency
1472. In vivo acute systemic inflammation affects hdl cholesterol efflux capacity
1473. Improving of HDL capacity for macrophages cholesterol efflux after plasma incubation with phospholipid nanoparticles
1474. Disentangling The Shared Genetic Etiology Between Serum cholesterol And Suicide Risk: A Potential Moderating Role For cholesterol efflux
1475. Increased cholesterol efflux Capacity is Associated with Improved Survival in Heart Transplant Recipients
1476. Adequate glycemic control prevents cholesterol efflux impairment and lipid accumulation in macrophages induced by advanced glycated albumin
1477. Defective HDL remodeling and macrophage cholesterol efflux in adult and adolescent familial hypercholesterolemic patients
1478. Structure-function relationships in reconstituted HDL: Focus on antioxidative activity and cholesterol efflux capacity
1479. Miltefosine increases macrophage cholesterol efflux and inhibits NLRP3-inflammasome assembly and IL-1β release
1480. The effect of glucose on cholesterol efflux in obesity related type 2 diabetes
1481. Treatment With 2-Hydroxypropyl-Β-Cyclodextrin Induces Macrophage cholesterol efflux In Vitro But Does Not Induce Lesion Regression In Apoe Knockout Mice In …
1482. CSL112 Enhances cholesterol efflux Equally in Patients with High and Low High Density Lipoprotein Functionality
1483. A loss-of-function variant in OSBPL1A predisposes to low plasma HDL cholesterol levels and impaired cholesterol efflux capacity
1484. High-throughput NBD-cholesterol efflux assay as a biomarker for subclinical atherosclerosis in HIV-1 infected individuals
1485. cholesterol efflux capacity of healthy octogenarians does not associate with coronary calcium, plaque vulnerability and telomere length
1486. cholesterol efflux Capacity of HDL is Impaired in Patients With Persistent Atrial Fibrillation
1487. The Incorporation of Oxidation Resistant ApoA1-4WF in Adeno-Associated Viral and Lentiviral Gene Vectors With Robust cholesterol efflux in vitro
1488. Liver X Receptor cis-Repression and cholesterol efflux Restrain Innate Immunity and Coronary Artery Disease
1489. miRNA targeting of oxysterol-binding protein-like 6 regulates cholesterol trafficking and efflux
1490. 802. cholesterol efflux Mediates the Relationship between Suicide Risk and Unesterified cholesterol
1491. CSL112, A NOVEL FORMULATION OF HUMAN APOA-I, ROBUSTLY ENHANCES THE ABILITY OF SERUM TO efflux cholesterol
1492. Control of Macrophage cholesterol efflux and Atherogenesis by the Noncoding RNA MeXis
1493. cholesterol efflux capacity inversely correlates with HDL cholesterol fractional catabolic rate
1494. Mast Cells and HDL: Studies on cholesterol efflux and Reverse cholesterol Transport
1495. P1106Direct augmentation of cholesterol efflux capacity in AMI patients: a PKPD substudy of AEGIS-I
1496. Effects of Palm Oil Tocotrienols Rich Fraction on cholesterol efflux
1497. P3773 Homocysteine accelerates lipid accumulation in macrophages and atherosclerotic lesions via PCSK9-mediated ABCA1/ABCG1-dependent cholesterol efflux
1498. Increased Accumulation of Malondialdehyde-Acetaldehyde Modified HDL in Macrophage without Decreased cholesterol efflux
1499. Serum Amyloid A Isoforms and the Capacity to Mediate cholesterol efflux
1500. Uremia alters HDL composition and cholesterol efflux capacity
1501. Pre-transplant Macrophage cholesterol efflux Capacity is Associated With Angiographic Cardiac Allograft Vasculopathy in a Multi-center Observational Study
1502. Relationship of Hdl-associated cholesterol efflux Capacity to Coronary Collateralization In Diabetic and Non-diabetic Patients With Stable Angina and Chronic Total …
1503. cholesterol Uptake Capacity, a Novel Indicator for HDL Functionality, vs. cholesterol efflux Capacity in Association With Coronary Plaque Lipid Burden
1504. HDL cholesterol efflux is not predictive of cardiovascular risk in diabetic patients on hemodialysis
1505. Reduction in plasma cholesterol efflux capacity from human macrophages is associated with the appearance of clinical features of metabolic syndrome
1506. Inverse Correlation of cholesterol efflux Capacity of High Density Lipoprotein With Survival After Cardiac Transplantation.: Abstract# B1252
1507. AMELIORATION OF cholesterol efflux CAPACITY BY CARDIAC REHABILITATION IN PATIENTS WITH ACUTE CORONARY SYNDROME
1508. Effect of clinically used selective estrogen receptor modulators on macrophage cholesterol efflux and reverse cholesterol transport
1509. HDL-Mediated Cellular cholesterol efflux in Patients with Severe Carotid Atherosclerosis
1510. A Novel Proteomic Predictor of cholesterol efflux Capacity Demonstrates Inverse Association With Cardiovascular Disease
1511. Impaired cholesterol efflux capacity may help explain development of early coronary artery disease in subjects with very high HDL-C
1512. miRNA Nanoparticles Targeting cholesterol efflux: a Promising Tool for the Treatment of Atherosclerosis
1513. cholesterol efflux Pathways Suppress Inflammasome Activation in Mice and Humans
1514. P2334Association between cholesterol efflux capacity and coronary plaque lipid composition on near infrared spectroscopy
1515. Effects of PPARγ on the cholesterol efflux of C57 mice peritoneal macrophage in inflammatory conditions
1516. cholesterol efflux Pathways in Dendritic Cells Suppress Autoimmune Responses
1517. A link exists between hdl cholesterol efflux capacity and plasma gut microbiota metabolite levels in subjects with calcific aortic valve stenosis
1518. High-density Lipoprotein cholesterol efflux Does Not Predict Cardiovascular Risk in Hemodialysis Patients
1519. A beneficial role of ATP-binding cassette transporter G1-mediated cholesterol efflux capacity in regression of coronary lipid content assessed by near-infrared …
1520. ABCA7 downregulation modifies cellular cholesterol homeostasis and decreases amyloid-β peptide efflux in an in vitro model of the blood-brain barrier
1521. Serum cholesterol efflux Capacity is an Independent Predictor of All-cause and Cardiovascular Mortality in Patients With Coronary Artery Disease
1522. Bilirubin Decreases Macrophage cholesterol efflux and ABCA1 Protein Expression
1523. THU0143 cholesterol efflux capacity of hdl is otherwise improved by different biologic-dmards in rheumatoid arthritis
1524. A Novel Assay that Incorporates Measurement of Ex Vivo LCAT Activity with Measurement of cholesterol efflux Capacity-Assessment of Two Biomarkers of Serum …
1525. GW25-e1621 cholesterol efflux regulating gene expression in peripheral blood leukocytes and associated factors for subjects with low plasma HDL cholesterol …
1526. Metabolically activated and classically activated pro-inflammatory M1 macrophages exhibit divergent effects on ABCA1 cholesterol efflux capacity
1527. Relationship of cholesterol efflux Capacity with Coronary Plaque Lipid Composition on Near Infrared Spectroscopy
1528. Perimenopausal Transdermal Estrogen Replacement Therapy Reduces Serum High-density Lipoprotein cholesterol efflux Capacity but Improves Cardiovascular …
1529. High-density Lipoprotein cholesterol efflux Capacity is not associated with Atherosclerosis and Cardiovascular Events: the CODAM Study
1530. Effects of dihydromyricetin on the cholesterol efflux in macrophage derived foam cells
1531. Association of Apolipoprotein C-III Distribution With cholesterol efflux Capacity and Coronary Plaque Burden
1532. HDL cholesterol efflux Capacity in HIV is Inversely Related to Classical Monocyte Number
1533. Targeting cholesterol efflux, Autophagy, and Inflammation to Prevent Atherosclerosis
1534. IMPROVEMENT IN cholesterol efflux CAPACITY IS ASSOCIATED WITH A REDUCTION IN AORTIC WALL THICKNESS BY MRI INDEPENDENT OF …
1535. E3317 Promotes cholesterol efflux in Macrophage Cells via Enhancing ABCA1 Expression
1536. Olive oil polyphenols enhance cholesterol efflux capacity of HDL
1537. Plasminogen Promotes cholesterol efflux by the ABCA1
1538. Flavin Monoxygenase 3 (FMO3) is a Novel Regulator of Hepatic cholesterol Metabolism and Transintestinal cholesterol efflux (TICE).
1539. IMPROVEMENT IN cholesterol efflux CAPACITY IS ASSOCIATED WITH IMPROVEMENT IN VASCULAR INFLAMMATION BY 18-FDG PET CT IN PSORIASIS
1540. Hereditary ApoA-I-related amyloidosis: aggregation propensity in the presence of ECM components and modulation of cholesterol efflux
1541. cholesterol Hydroperoxide Trafficking: Impairment of Macrophage cholesterol efflux with Implications for Atherogenesis under Oxidative Stress
1542. Correction: Effect of apoA-I Mutations in the Capacity of Reconstituted HDL to Promote ABCG1-Mediated cholesterol efflux
1543. Polyrotaxane Variants and Their Effects on the cholesterol efflux in Patients Suffering from Niemann Pick type C
1544. High-amount and High-intensity Exercise Training Improves HDL cholesterol efflux Capacity
1545. Juvenile Idiopathic Arthritis Does Not Impair ABCA-1 and SR-B1-Mediated cholesterol efflux Capacity
1546. 17β-ESTRODIAL INCREASES ABCA1 EXPRESSION AND cholesterol efflux TO APOA I IN VIVO AND IN VITRO
1547. Deficiency of TDAG51 Protects Against Atherosclerosis by Modulating Apoptosis, cholesterol efflux, and…
1548. An inducible cholesterol efflux (iCeE) peptide-famp is taken up by the intracellular atherosclerotic plaque burden
1549. Expression of Anti-mir-33a-5p in Cultured Endothelial Cells Increases Macrophage and Smooth Muscle Cell cholesterol efflux by Exosome-mediated Transfer of Anti …
1550. … RELEVANCE OF HIGH DENSITY LIPOPROTEIN STRUCTURE AND COMPOSITION IN THE IMPROVEMENT OF cholesterol efflux CAPACITY AFTER ROUX …
1551. SAT0088 Hdl cholesterol efflux capacity in rheumatoid arthritis patients: contributing factors and relationship with subclinical atherosclerosis
1552. OSBPL6 is a Novel miR-33 Target Gene Involved in Cellular cholesterol efflux
1553. Effect of epigallocatechin-3 gallate on cholesterol efflux in foam cells and its mechanism
1554. β3-adrenoceptor activation promotes cholesterol efflux from foam cells by upregulating apoA-Ⅰ expression
1555. HDL anti-oxidative and cholesterol efflux function is impaired in ischaemic HF
1556. Interleukin 22 Downregulates ABCG1 and Impairs cholesterol efflux in Macrophages
1557. Tumor-Induced cholesterol efflux from Macrophages Drives IL-4 Mediated Reprogramming and Tumor Progression
1558. O10. Increased maternal and fetal HDL cholesterol efflux capacity and placental CYP27A1 expression in pre-eclampsia
1559. A short synthetic peptide mimetic of apolipoprotein A1 mediates cholesterol and globotriaosylceramide efflux from Fabry fibroblasts
1560. Matrix metalloproteinase 8 cleaves apolipoprotein ai and reduces its cholesterol efflux capacity
1561. Testosterone stimulates cholesterol efflux and metabolism in human macrophages via liver X receptor
1562. Both STAT3 Activation and cholesterol efflux Contribute to the Anti-inflammatory Effect of ABCA1/apoa-interaction
1563. Niacin therapy increases HDL particles and total cholesterol efflux capacity but not ABCA1-specific cholesterol efflux in statin-treated subjects
1564. Abstract P216: The Association Between Reduction in Inflammation and Changes in Lipoprotein Levels and HDL cholesterol efflux Capacity in Rheumatoid Arthritis
1565. Antioxidant property of HDL as well as cholesterol efflux capacity are independent risk markers for atherosclerotic cardiovascular disease in patients with familial …
1566. 70 Reduced maternal cholesterol efflux capacity in women 6–8 Weeks postpartum who had pre-eclampsia: Cardiovascular risks and metabolic diseases
1567. … exercise training does not systematically affect macrophage gene expression involved in reverse cholesterol transport and cholesterol efflux in CETP transgenic mice
1568. Incorporation of Almonds in a cholesterol‐lowering Diet Improves non‐ABCA1‐mediated cholesterol efflux in Normal Weight Adults
1569. Effect of vitamin D deficiency and replacement on serum HDL cholesterol efflux capacity in premenopausal women
1570. Improved HDL cholesterol efflux capacity in morbidly obese individuals after bariatric surgery
1571. Activation of Liver X Receptor Reverses Decrease in cholesterol efflux in Diabetic Retinal Endothelial Cells.
1572. Effects of garlic on brachial endothelial function and capacity of plasma to mediate cholesterol efflux in patients with coronary artery disease.
1573. THE IMPLICATION OF CIGARETTE SMOKING AND SMOKING CESSATION ON MACROPHAGE cholesterol efflux IN CORONARY ARTERY DISEASE …
1574. Biochemical Characterization of ATP-Binding Cassette Transporter G1 Mediated cholesterol efflux
1575. Acute Inflammation Following Dental Treatment Alters Endothelial Effects, but not cholesterol efflux Capacity of HDL
1576. Impact of the Cholesteryl Ester Transfer Protein Inhibitor Evacetrapib on cholesterol efflux Capacity in High Risk Patients Within the ACCELERATE Trial
1577. DBZ exert anti-atherosclerotic role via regulating macrophage inflammation and cholesterol efflux
1578. cholesterol efflux Capacity is Inversely Associated with Severity of Carotid Atherosclerosis and Increases with Time Since Cerebrovascular Event
1579. Apolipoprotein AI configuration and cell cholesterol efflux activity of discoidal lipoproteins depend on the reconstitution process
1580. Correlation of Improved cholesterol efflux Capacity of High Density Lipoprotein With Survival and Allograft Vasculopathy in Cardiac Transplant Recipients
1581. Decreased High-Density Lipoprotein cholesterol Levels and Macrophage cholesterol efflux Capacity in Mice Lacking Proprotein Convertase Subtilisin/Kexin Type 9
1582. Prolonged fasting increases the cholesterol efflux capacity and anti‐inflammatory functionality of HDL particles in human subjects.
1583. Olive oil polyphenols enhance the expression of cholesterol efflux related genes in vivo in humans. A randomized controlled trial
1584. cholesterol efflux pathways suppress inflammasome activation, neutrophil extracellular trap formation, and atherosclerosis
1585. Paraoxonase 1 (PON1) maintains cellular cholesterol homeostasis via the regulation of cholesterol efflux
1586. The Remodeling of HDL-SAA by Macrophage Surface Heparan Sulfate is Necessary for Efficient cholesterol efflux
1587. Characterization of Glycated Albumin Isolated From Poorly Controlled Diabetic Patients and Its Role in Macrophage cholesterol efflux
1588. High-density lipoprotein phospholipid content and apolipoprotein AI level are determinants of cholesterol efflux capacity in patients with familial hypercholesterolemia
1589. Macrophage-Specific cholesterol efflux Capacity as a Biomarker for High-Density Lipoprotein Function: Comparison of Isotopic Versus Fluorometric Methods for High …
1590. Deleterious impact of elaidic [i] trans [/i] fatty acid on ABCA1-mediated cholesterol efflux from mouse and human and human macrophages
1591. Effect of heart failure induced by pacing on HDL levels and cellular cholesterol efflux in a model of minipig
1592. HDL cholesterol efflux predicts graft failure but not cardiovascular and overall mortality in renal transplant recipients
1593. Punicalagin, ellagic acid and gallic acid promotes cholesterol efflux from raw264. 7 Macrophages
1594. PDE Inhibitor Rolipram Increases cholesterol efflux and ABCA1 Expression: Rolipram Increases ABCA1 Expression
1595. Impact of endothelial lipase overexpression on cholesterol efflux capacity of serum, apolipoprotein B-depleted serum and HDL
1596. Intracellular cholesterol efflux and Drug Delivery in Macrophage by Discoid Reconstituted High Density Lipoprotein strengthened by Cyclodextrins
1597. Eicosapentaenoic acid (EPA) membrane incorporation reduces abca1-dependent cholesterol efflux in unloaded as well as in cholesterol-loaded primary human …
1598. Resveratrol Enhances cholesterol efflux Through PPAR-γ–Dependent Signaling Pathways in Human Macrophages
1599. Decreased HDL cholesterol efflux capacity in morbidly obese individuals as a surrogate marker for increased cardiovascular risk
1600. Lipid Composition of Gold Nanoparticle-Templated High-Density Lipoprotein Analogs Dictates cholesterol efflux Function
1601. The Receptor for Advanced Glycation Endproducts (RAGE) Regulates Macrophage cholesterol efflux
1602. Evaluation of hdl cholesterol efflux capacity (CEC) after consumption of an innovative pasta enriched with bioactive components and functional probiotics
1603. TMAO an L‐carnitine metabolite does not affect foam cell formation or cholesterol efflux in J774 mouse macrophage (249.6)
1604. Lipid Composition of Gold Nanoparticle-Templated High-Density Lipoprotein Analogs Dictates cholesterol efflux Function
1605. apolipoprotein ai expression in hepg2 cells, which might further promote cholesterol efflux from macrophage foam cells
1606. Structure-Function Studies of ApoA-I Mimetic Peptides for ABCA1-Dependent cholesterol efflux and HDL Formation
1607. GW25-e3426 Homocysteine impairs macrophage cholesterol efflux via LXR alpha hypermethylation
1608. … -Mediated Modulation of Cholesteryl Ester Transfer Protein Activity Increases HDL-cholesterol, Apolipoprotein AI Levels and cholesterol efflux Capacity in Chow-Fed …
1609. microRNA-212 promotes lipid accumulation and attenuates cholesterol efflux in
1610. Consumption of vegetable oils with different unsaturated fatty acid profiles increases cholesterol efflux from THP‐1 macrophages (269.4)
1611. Characterization of a synthetic leoligin derivative, with agonistic FXR and enhancing macrophage cholesterol efflux activity
1612. Nlrp3 Inflammasome Inhibits cholesterol efflux in Macrophages by Downregulating Gpr109a Expression. A Novel Proatherogenic Mechanism
1613. Reply to” Osteopontin inhibits macrophage cholesterol efflux via NF-κB/ABCA1 pathway”
1614. Osteopontin inhibits macrophage cholesterol efflux via NF-κB/ABCA1 pathway
1615. Atorvastatin Has No Impact on the Effects of CETP Inhibitors on HDL Structure and cholesterol efflux Capacity in Chow-Fed Rabbits
1616. GW25-e3395 microRNA-27a represses cholesterol efflux through targeting ABCA1 in oxLDL-stimulated THP-1 Macrophages
1617. Impaired hdl cholesterol efflux capacity during development of pacing-induced heart failure in minipig
1618. HDL-Induced cholesterol efflux Capacity From Niacin Therapy in Diabetes is Haptoglobin Genotype-Dependent
1619. 1569-P: cholesterol efflux Capacity (CEC) and HDL Subspecies Associate with Estimated Insulin Sensitivity (eIS) in Type 1 Diabetes (T1D)
1620. C34 INSIGHTS INTO COPD PATHOGENESIS FROM PRE-CLINICAL STUDIES: Modulation Of cholesterol efflux Through Treatment With An Lxr Agonist In Cigarette …
1621. Linoleic acid suppresses cholesterol efflux and ATP‐binding cassette transporters in murine bone marrow‐derived macrophages
1622. Incubation of MDCO216 with human serum potentiates ABCA1 mediated cholesterol efflux capacity and generates new prebeta-1 Hdl
1623. PKA Signaling in ABCA1 Function: A Role in Modulation of cholesterol efflux and Macrophage Inflammation
1624. Very Low Serum cholesterol efflux Capacity is a Positive Predictor of Cardiovascular Risk, Independent of HDL-cholesterol, Apolipoprotein AI and HDL Particle …
1625. Abstract P353: Acute Consumption of Walnuts Increases Ex Vivo cholesterol efflux and Postprandial Lipid Response in Overweight and Obese Adults
1626. Hypomorphic sialidase expression increases LDL uptake and cholesterol efflux in macrophages
1627. … phosphate accumulation in macrophages induces intracellular cholesterol redistribution, attenuates LXR/ABCA1/ABCG1 pathway and impairs cholesterol efflux
1628. Abstract MP046: Visceral Adipose Tissue but Not Subcutaneous Adipose Tissue Associates With cholesterol efflux Capacity in Psoriasis
1629. Abstract P119: Changes in cholesterol efflux Capacity are Associated With Greater Progression of Aortic Calcification in Women at Midlife. Effects of Estradiol …
1630. cholesterol efflux is higher in cortical neonatal astrocytes than in non-cortical neonatal astrocytes
1631. Lymphatic derived HDL Is an Effective Donor for the Trans-Intestinal cholesterol efflux Pathway That Is Impaired During Insulin Resistance
1632. Serum FABP5 Concentration, a Novel Determinant of cholesterol efflux From Macrophages, is a Potential Biomarker for Residual Risk of Atherosclerosis
1633. … of Dietary Carbohydrate Type on Serum Lipid Profile, Adipose Tissue Macrophage Infiltration and Inflammatory Status, and Peripheral Macrophage cholesterol efflux
1634. HDL phospholipid and ABCA1-mediated cholesterol efflux are reduced in patients with very high HDL-C who develop early coronary artery disease
1635. Cigarette Smoke Regulation of cholesterol efflux and Protease Production in Atherosclerosis Decreases Plaque Collagen Content and Increases Plaque Necrosis
1636. Regulation of macrophage cholesterol efflux and hepatic lipogenesis by trans fatty acids: Implications for the effects of trans fatty acids on hdl and ldl cholesterol
1637. Overexpression of ABCA1 in Cultured Endothelial Cells Using Helper-Dependent Adenovirus Enhances ApoAI-Mediated cholesterol efflux and has Anti-Inflammatory …
1638. Abstract P039: Lipid Rich Plaque by Coronary CT Angiography Associates With cholesterol efflux Capacity Independent of Traditional Cardiovascular Risk Factors in …
1639. NLRP3 Inflammasome Inhibits cholesterol efflux in Macrophages by Down-Regulating Gpr109a Expression: A Novel Pro-Atherogenic Mechanism
1640. LCAT Activation in Combination with the CETP Inhibitor Anacetrapib Results in Enhanced cholesterol efflux and a Favorable Lipid Profile in Dyslipidemic Hamsters
1641. MicroRNA-33 regulates sterol and lipoprotein metabolism: Impact on cholesterol efflux, hepatobiliary homeostasis and lipoprotein secretion
1642. Fatty acids liberated from lipoproteins by lipoprotein lipase negatively influences cholesterol efflux from THP-1 macrophages
1643. Effects of Saturated Fatty Acids from Butter and Cheese on High‐density Lipoprotein (HDL)‐Mediated cholesterol efflux Capacity
1644. SNPs located in ABCA1, CETP and apoA5/A4/C3/A1 are associated with plasma cholesterol efflux
1645. Regulation of the cholesterol efflux transporters ABCA1/ABCG1 in retina in hemochromatosis and by the endogenous iron chelator 2, 5-dihydroxybenzoic acid
1646. ApoE promotes hepatic selective uptake but not RCT due to increased ABCA1-mediated cholesterol efflux to plasma
1647. Adipocyte-derived exosomes from visceral adipose tissue explants and urine contain microRNAs related to macrophage cholesterol efflux capacity
1648. Niacin Improves Atherogenic Postprandial Lipemia in Patients at High Cardiovascular Risk Despite Reduced cholesterol efflux From Human Macrophages
1649. Human Aortic Valve Interstitial Cells Exhibit Decreased cholesterol efflux Associated with Hypo-α1-nascent HDL Particles
1650. Eicosapentaenoic acid (EPA) membrane incorporation impaired ABCA1-dependent cholesterol efflux through a PKA pathway in primary human macrophages
1651. … “Two-pronged” Approach to Attenuate/regress Atherosclerosis by Simultaneous Knock Down OfSR-A and LXR-mediated Stimulation of Macrophage cholesterol efflux
1652. Purple Perilla frutescens extracts enhanced cholesterol efflux and inhibited ER stress in macrophages exposed to oxidized LDL (831.8)
1653. GW25-e4306 Angiotensin-(1-7) stimulates cholesterol efflux from angiotensin II-treated cholesterol-loaded THP-1 macrophages through suppression of p38 and JNK …
1654. GW26-e1038 MicroRNA-20a/b Regulates cholesterol efflux through Posttranscriptional Repression of ATP-Binding Cassette Transporter A1 in THP-1 macrophage …
1655. HIGH DENSITY LIPOPROTEIN cholesterol efflux CAPACITY AS A NOVEL RISK MARKER FOR INCIDENT ATHEROSCLEROTIC CARDIOVASCULAR …
1656. … ATP-Binding Cassette Transporter A1 mRNA Expression in Human Leukocytes and Murine Bone Marrow-Derived Macrophages and Decreases cholesterol efflux
1657. ABCA1 Ligand Peptides That Stimulate Cellular cholesterol efflux With High Potency Increase Insulin Sensitivity in Metabolic and Genetic Mouse Models of Obesity …
1658. A single infusion of trimeric apoA-I in hypercholesterolemic rabbits stabilizes atherosclerotic plaques and increases plasma cholesterol efflux capacity
1659. Proteomic Analysis of HDL from Inbred Strains of Mice Implicates APOE in Reduced cholesterol efflux Capacity via the ABCA1 Pathway
1660. CAVEOLIN-1/ABC-A1 COMPLEX-MEDIATED cholesterol efflux OF LIPID-LADEN CELLS AND DRUG DEVELOPMENT FROM CHINESE HERBAL MEDICINE
1661. GW25-e5399 Effects of AngII and Ang-(1-7) on the cholesterol efflux in THP-1 Derived Foam Cells
1662. Increased lipoprotein binding to arterial proteoglycans and normal macrophage cholesterol efflux capacity define the pro-atherogenic feature of CKD dyslipidemia
1663. P02. 97. Lipoic acid supplementation induces a transient stress response and improves episodic memory and cholesterol efflux in humans
1664. Transcriptional profiling of the human M-CSF-1-driven monocyte-macrophage transition identifies genes regulating cholesterol efflux and synthesis
1665. Incubation of MDCO216 With Human Serum or Plasma Potentiates ABCA1-Mediated cholesterol efflux Capacity, Increases Prebeta-1 HDL and Causes a Shift From …
1666. Excess nitric oxide impairs liver X receptor α‐ATP‐binding cassette transporter A1‐dependent cholesterol efflux in macrophage foam cells (671.1)
1667. HIV-1 protein Nef impairs cellular cholesterol efflux by disrupting the interaction between abca1 and calnexin
1668. Insulin Reverses Mcp-1 Suppressed cholesterol efflux to Hdl3/apoa1 Through Up-regulation of Abca1, Abcg1 and Sr-bi in Differentiated 3t3-l1 Adipocytes
1669. Regulation of monocyte/macrophage ATP-binding cassette transporters and cholesterol efflux by elevated glucose and free fatty acid concentrations
1670. Deficiency of TDAG51 protects against atherosclerosis by modulating apoptosis, cholesterol efflux, and peroxiredoxin-1 expression
1671. … application title: EFFECT OF PHOSPHOLIPID COMPOSITION OF RECONSTITUTED HDL ON ITS cholesterol efflux AND ANTI-INFLAMMATORY …
1672. GW28-e0907 Insulin reverses MCP-1 suppressed cholesterol efflux to HDL3/ApoA1 through up-regulation of ABCA1, ABCG1 and SR-BI in differentiated 3T3-L1 …
1673. 3: INHIBITION OF THE RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS RESTORES cholesterol efflux IN THP-1 HUMAN MACROPHAGES …
1674. Effects of Na+-H+ exchanger 1 knockdown on protein expression levels of ATP binding cassette transporter A1 and cholesterol efflux in hypoxic RAW264. 7 cells
1675. Corrigendum to” Dietary interesterified fat enriched with palmitic acid induces atherosclerosis by impairing macrophage cholesterol efflux and eliciting inflammation”[J …
1676. Effect of puerarin on cholesterol influx and efflux in RAW264. 7-treated foam cells
1677. Niacin‐induced enhancement of lysosomal cholesterol efflux in macrophages through CD38‐NAADP signaling pathway: implication in reduced foam cell formation …
1678. Regulation of the cholesterol efflux transporter ABCA1 by the niacin receptor GPR109A: potential relevance to drusen biogenesis and inflammation in age-related …
1679. The Association of 5A Peptide With Sphingomyelin Increases Its Ability to efflux cholesterol Both in vitro and in vivo
1680. Chronic cerebral hypoperfusion induces ABCA1 and apolipoprotein AI mediated cellular cholesterol efflux by activating LXR/RXR in aging rat brain
1681. … ESTER TRANSFER PROTEIN (CETP) INCREASES CIRCULATING INSULIN, INSULIN SECRETION AND cholesterol efflux FROM PANCREATIC β-CELLS
1682. GW24-e0042 Effects of AngII and Ang-(1-7) on the expression of SR-BI, ABCA1 and cholesterol efflux in THP-1 derived foam cells
1683. Digoxin and ouabain induce the efflux of cholesterol via liver X receptor signalling and the synthesis of ATP in cardiomyocytes
1684. Regulation effect of quercetin on cholesterol influx and efflux from RAW264. 7 macrophage
1685. The mycobacterial P55 efflux pump is required for optimal growth on cholesterol
1686. … hyperactivation. Components in oviductal fluid such as high weight molecular proteins and high density lipoproteins promote cholesterol efflux resulting in an …
1687. Pre‐and Post‐weaning diets with low omega‐6 to omega‐3 fatty acid ratio reduced plasma lipid levels and increased cholesterol efflux capacity in the offspring of …
1688. HDL Mimetic Peptides ATI-5261 and CS-6253 Induce ABCA1 Oligomerization, Cellular cholesterol efflux and Generate Nascent HDL-Like Lipoproteins
1689. … (Hp) Genotype Predicts Coronary Artery Disease (CAD) During 25 Years of Follow-up in Type 1 Diabetes: Potential Pole of Impaired HDL cholesterol efflux Capacity
1690. … to Phosphatidylinositol 4, 5 Bisphosphate (PIP2), Which is Exposed on the Cell Surface by Novel PIP2 Floppase Activity of ABCA1, and Promotes cholesterol efflux
1691. The Intermediate-conductance Ca2+ -activated K+ Channel KCa3.1 Regulates Monocyte Adhesiveness to VCAM-1 and Macrophage cholesterol efflux
1692. A Newly Integrated Model for Intestinal cholesterol Absorption and efflux Infers How Plant Sterol Intake Reduces Circulating cholesterol Levels
1693. Lipoprotein Lipase regulates the expression of genes responsible for cellular cholesterol uptake and efflux in human and mouse macrophages.
1694. Effects of electroacupuncture at” Fenglong”(ST 40) on formation of macrophage-derived foam cell and efflux of cholesterol in hyperlipidemia rats
1695. Recombinant Lecithin cholesterol Acyltransferase Generates Mature High Density Lipoprotein with Increased Capacity to efflux cholesterol via ABCG1 in …
1696. CSL112 ENHANCES THE ABILITY OF SERUM TO efflux cholesterol IN PATIENTS WITH MODERATE RENAL IMPAIRMENT
1697. Polysaccharides from chayote enhance lipid efflux and regulate NLRP3 inflammasome priming in macrophage-like THP-1 cells exposed to cholesterol …
1698. Intracellular trafficking mechanism, from intracellular uptake to extracellular efflux, for phospholipid/cholesterol liposomes
1699. Localization of the placental BCRP/ABCG2 transporter to lipid rafts: role for cholesterol in mediating efflux activity
1700. Regulation of genes responsible for cholesterol uptake and efflux by fatty acids in THP‐1 macrophages
1701. Effect of Testosterone on cholesterol Synthesis and efflux in the Liver of the Testicular Feminised (Tfm) Mouse
1702. Apolipoprotein A5 ‐ enriched HDL is Poor Acceptor for cholesterol in in vitro efflux Study
1703. HDL proteomic quality, and not efflux capacity, reflects differential modulation of reverse cholesterol transport by saturated and monounsaturated fat diets
1704. The Niemann-Pick C1 and caveolin-1 proteins interact to modulate efflux of low density lipoprotein-derived cholesterol from late endocytic compartments
1705. Effects of electroacupuncture at “Fenglong”(ST 40) on formation of macrophage-derived foam cell and efflux of cholesterol in hyperlipidemia rats
1706. cholesterol efflux pathways, inflammation, and atherosclerosis
1707. Molecular basis of cholesterol efflux via ABCG subfamily transporters
1708. ABC transporters, cholesterol efflux, and implications for cardiovascular diseases
1709. cholesterol efflux capacity and cardiovascular disease: the Ludwigshafen Risk and Cardiovascular Health (LURIC) study
1710. Brothers in arms: ABCA1-and ABCG1-mediated cholesterol efflux as promising targets in cardiovascular disease treatment
1711. High density lipoprotein cholesterol efflux capacity and atherosclerosis in cardiovascular disease: pathophysiological aspects and pharmacological perspectives
1712. Atherosclerosis regression and cholesterol efflux in hypertriglyceridemic mice
1713. Macrophage miR-34a is a key regulator of cholesterol efflux and atherosclerosis
1714. MicroRNA-320b modulates cholesterol efflux and atherosclerosis
1715. Effects of phytochemicals on macrophage cholesterol efflux capacity: Impact on atherosclerosis
1716. A new pathway of macrophage cholesterol efflux
1717. Association between cholesterol efflux capacity and peripheral artery disease in coronary heart disease patients with and without type 2 diabetes: from the …
1718. Compounds targeting OSBPL7 increase ABCA1-dependent cholesterol efflux preserving kidney function in two models of kidney disease
1719. Anthocyanin supplementation at different doses improves cholesterol efflux capacity in subjects with dyslipidemia—A randomized controlled trial
1720. Identification of novel lipid droplet factors that regulate lipophagy and cholesterol efflux in macrophage foam cells
1721. C-terminal of ABCA1 separately regulates cholesterol floppase activity and cholesterol efflux activity
1722. Adiponectin’s mechanisms in high-density lipoprotein biogenesis and cholesterol efflux
1723. HDL cholesterol efflux capacity is impaired in severe short-term hypothyroidism despite increased HDL cholesterol
1724. Effect of anacetrapib on cholesterol efflux capacity: a substudy of the DEFINE trial
1725. Diabetes impairs cellular cholesterol efflux from ABCA1 to small HDL particles
1726. Molecular patterns of extreme and persistent cholesterol efflux capacity
1727. cholesterol efflux efficiency of reconstituted HDL is affected by nanoparticle lipid composition
1728. HDL cholesterol efflux capacity is inversely associated with subclinical cardiovascular risk markers in young adults: The cardiovascular risk in Young Finns …
1729. Bariatric surgery improves HDL function examined by ApoA1 exchange rate and cholesterol efflux capacity in patients with obesity and type 2 diabetes
1730. Two putative probiotic strains improve diet‐induced hypercholesterolemia through modulating intestinal cholesterol uptake and hepatic cholesterol efflux
1731. CTRP12 ameliorates atherosclerosis by promoting cholesterol efflux and inhibiting inflammatory response via the miR-155-5p/LXRα pathway
1732. Site‐specific microRNA‐33 antagonism by pH‐responsive nanotherapies for treatment of atherosclerosis via regulating cholesterol efflux and adaptive immunity
1733. A New Small Molecule Increases cholesterol efflux
1734. Nitro-oleic acid, a ligand of CD36, reduces cholesterol accumulation by modulating oxidized-LDL uptake and cholesterol efflux in RAW264. 7 macrophages
1735. HDL particle size is increased and HDL-cholesterol efflux is enhanced in type 1 diabetes: A cross-sectional study
1736. Soraphen A enhances macrophage cholesterol efflux via indirect LXR activation and ABCA1 upregulation
1737. The impact of biologic drugs on high-density lipoprotein cholesterol efflux capacity in rheumatoid arthritis patients
1738. LncRNA ZFAS1 confers inflammatory responses and reduces cholesterol efflux in atherosclerosis through regulating miR-654-3p-ADAM10/RAB22A axis
1739. The Yin and Yang of high-density lipoprotein and atherosclerotic cardiovascular disease: focusing on functionality and cholesterol efflux to reframe the HDL …
1740. Angiopoietin-1 aggravates atherosclerosis by inhibiting cholesterol efflux and promoting inflammatory response
1741. A chalcone derivative, 1m‐6, exhibits atheroprotective effects by increasing cholesterol efflux and reducing inflammation‐induced endothelial dysfunction
1742. High-density lipoprotein cholesterol efflux capacity as a novel prognostic surrogate for coronary artery disease
1743. Substrate stiffness regulates cholesterol efflux in smooth muscle cells
1744. Pharmacometric analyses to characterize the effect of CSL112 on apolipoprotein A‐I and cholesterol efflux capacity in acute myocardial infarction patients
1745. High-density lipoprotein cholesterol efflux capacity is not associated with atherosclerosis and prevalence of cardiovascular outcome: The CODAM study
1746. Impaired HDL cholesterol efflux capacity in systemic lupus erythematosus patients is related to subclinical carotid atherosclerosis
1747. GPR120 facilitates cholesterol efflux in macrophages through activation of AMPK signaling pathway
1748. FGF21 induces autophagy‐mediated cholesterol efflux to inhibit atherogenesis via RACK1 up‐regulation
1749. Persistent Effect of Advanced Glycated Albumin Driving Inflammation and Disturbances in cholesterol efflux in Macrophages
1750. HDL cholesterol efflux capacity is related to disease activity in psoriatic arthritis patients
1751. circDENND1B Participates in the Antiatherosclerotic Effect of IL-1β Monoclonal Antibody in Mouse by Promoting cholesterol efflux via miR-17-5p/Abca1 Axis
1752. Glucocorticoids impair HDL-mediated cholesterol efflux besides increased HDL cholesterol concentration: a proof of concept
1753. Exosome-mediated transfer of anti-miR-33a-5p from transduced endothelial cells enhances macrophage and vascular smooth muscle cell cholesterol efflux
1754. cholesterol efflux-independent modification of lipid rafts by AIBP (Apolipoprotein AI binding protein)
1755. cholesterol efflux and Collateral Circulation in Chronic Total Coronary Occlusion: Effect‐Circ Study
1756. Eicosapentaenoic acid membrane incorporation stimulates ABCA1-mediated cholesterol efflux from human THP-1 macrophages
1757. Functional pasta consumption in healthy volunteers modulates ABCG1-mediated cholesterol efflux capacity of HDL
1758. Design and Synthesis of a Compound Library Exploiting 5-Methoxyleoligin as Potential cholesterol efflux Promoter
1759. CTRP9 alleviates foam cells apoptosis by enhancing cholesterol efflux
1760. Nascent HDL (high-density lipoprotein) discs carry cholesterol to HDL spheres: effects of HDL particle remodeling on cholesterol efflux
1761. RAGE mediates cholesterol efflux impairment in macrophages caused by human advanced glycated albumin
1762. High-density lipoprotein cholesterol efflux capacity and cardiovascular risk in autoimmune and non-autoimmune diseases
1763. Incorporation of α-methylated amino acids into Apolipoprotein AI mimetic peptides improves their helicity and cholesterol efflux potential
1764. Shuttle/sink model composed of β-cyclodextrin and simvastatin-loaded discoidal reconstituted high-density lipoprotein for enhanced cholesterol efflux and drug uptake …
1765. cholesterol efflux capacity in coronary artery disease: a meta-analysis
1766. Astragalin retards atherosclerosis by promoting cholesterol efflux and inhibiting the inflammatory response via upregulating ABCA1 and ABCG1 expression in …
1767. Serum albumin modified by carbamoylation impairs macrophage cholesterol efflux in diabetic kidney disease
1768. … reductions in plasma ceramides after anthocyanin supplementation are associated with improvements in plasma lipids and cholesterol efflux capacity in dyslipidemia …
1769. Impaired cholesterol efflux in retinal pigment epithelium of individuals with juvenile macular degeneration
1770. Atrial natriuretic peptide inhibited ABCA1/G1-dependent cholesterol efflux related to low HDL-C in hypertensive pregnant patients
1771. Histone deacetylase 3 represses cholesterol efflux during CD4+ T-cell activation
1772. HDL-mediated cholesterol efflux and plasma loading capacities are altered in subjects with metabolically-but not genetically driven non-alcoholic fatty liver disease …
1773. Structure dynamics of ApoA-I amyloidogenic variants in small HDL increase their ability to mediate cholesterol efflux
1774. A meta-analysis of HDL cholesterol efflux capacity and concentration in patients with rheumatoid arthritis
1775. Reverse cholesterol Transport Pathway and cholesterol efflux in Diabetic Retinopathy
1776. Ovarian cholesterol efflux: ATP-binding cassette transporters and follicular fluid HDL regulate cholesterol content in mouse oocytes
1777. Setosphapyrone C and D accelerate macrophages cholesterol efflux by promoting LXRα/ABCA1 pathway
1778. cholesterol efflux capacity and its association with prevalent metabolic syndrome in a multi-ethnic population (Dallas Heart Study)
1779. Hematopoiesis is regulated by cholesterol efflux pathways and lipid rafts: connections with cardiovascular diseases: Thematic Review Series: Biology of Lipid …
1780. Gypenosides mediate cholesterol efflux and suppress oxidized LDL induced inflammation in retinal pigment epithelium cells
1781. Bionic receptor for atherosclerosis therapy: Molecularly imprinted polymers mediate unique cholesterol efflux and inhibit inflammation
1782. Comparison of a novel cholesterol efflux assay using immobilized liposome-bound gel beads with the conventional method
1783. TIGAR mitigates atherosclerosis by promoting cholesterol efflux from macrophages
1784. The association between impairment of HDL cholesterol efflux capacity and atrial remodeling in atrial fibrillation
1785. HDL cholesterol efflux capacity and lipid profile in patients with systemic sclerosis
1786. Dietary stearic acid and palmitic acid do not differently affect ABCA1-mediated cholesterol efflux capacity in healthy men and postmenopausal women: A randomized …
1787. Alisol B 23-acetate, a new promoter for cholesterol efflux from dendritic cells, alleviates dyslipidemia and inflammation in advanced atherosclerotic mice
1788. An octimibate derivative, Oxa17, enhances cholesterol efflux and exerts anti-inflammatory and atheroprotective effects in experimental atherosclerosis
1789. Prolonged bedrest reduces plasma high-density lipoprotein levels linked to markedly suppressed cholesterol efflux capacity
1790. THP-1 macrophage cholesterol efflux is impaired by palmitoleate through Akt activation
1791. Glycation of HDL blunts its anti-inflammatory and cholesterol efflux capacities in vitro, but has no effect in poorly controlled type 1 diabetes subjects
1792. ADAM17 Boosts cholesterol efflux and Downstream Effects of High-Density Lipoprotein on Inflammatory Pathways in Macrophages
1793. Lipoprotein (a) concentration, genetic variants, apo (a) isoform size, and cellular cholesterol efflux in patients with elevated Lp (a) and coronary heart disease …
1794. The influence of high-density lipoprotein (HDL) and HDL subfractions on insulin secretion and cholesterol efflux in pancreatic derived β-cells
1795. Site-specific 5-hydroxytryptophan incorporation into apolipoprotein AI impairs cholesterol efflux activity and high-density lipoprotein biogenesis
1796. Hesperetin inhibits foam cell formation and promotes cholesterol efflux in THP-1-derived macrophages by activating LXRα signal in an AMPK-dependent …
1797. High-density lipoprotein remodeling by phospholipid nanoparticles improves cholesterol efflux capacity and protects from atherosclerosis
1798. Supramolecular copolymer modified statin-loaded discoidal rHDLs for atherosclerotic anti-inflammatory therapy by cholesterol efflux and M2 macrophage polarization
1799. Artemisinin and Procyanidins loaded multifunctional nanocomplexes alleviate atherosclerosis via simultaneously modulating lipid influx and cholesterol efflux
1800. Pre-freezing equilibration for 22 h improves post-thaw sperm functions in cryopreserved ram semen by reducing cholesterol efflux
1801. Rosmarinic acid increases macrophage cholesterol efflux through regulation of ABCA1 and ABCG1 in different mechanisms
1802. Conformational Flexibility of Apolipoprotein AI amino-and carboxy-Termini is necessary for Lipid Binding but not cholesterol efflux
1803. Facile cholesterol loading with a new probe ezFlux allows for streamlined cholesterol efflux assays
1804. Lipid-Based Nutrient Supplementation Increases High-Density Lipoprotein (HDL) cholesterol efflux Capacity and Is Associated with Changes in the HDL …
1805. Differences in HDL-cholesterol efflux Capacity Between Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis.
1806. Myristica fragrans promotes ABCA1 expression and cholesterol efflux in THP-1-derived macrophages
1807. Methyl tertiary-butyl ether inhibits THP-1 macrophage cholesterol efflux in vitro and accelerates atherosclerosis in ApoE-deficient mice in vivo
1808. Midkine inhibits cholesterol efflux by decreasing ATP-binding membrane cassette transport protein A1 via adenosine monophosphate-activated protein kinase …
1809. Effects of Dietary Education Program for the Japan Diet on cholesterol efflux Capacity: A Randomized Controlled Trial
1810. Ezetimibe markedly reduces hepatic triglycerides and cholesterol in rats fed on fish oil by increasing the expression of cholesterol efflux transporters
1811. HDL-Mediated cholesterol efflux Associates with Incident Kidney Disease
1812. Perimenopausal transdermal estradiol replacement reduces serum HDL cholesterol efflux capacity but improves cardiovascular risk factors
1813. Photobiomodulation therapy promotes the ATP‐binding cassette transporter A1‐dependent cholesterol efflux in macrophage to ameliorate atherosclerosis
1814. Phospholipase A2 group IIA correlates with circulating high-density lipoprotein cholesterol and modulates cholesterol efflux possibly through regulation of …
1815. cholesterol efflux Capacity Associates with the Ankle-Brachial Index but Not All-Cause Mortality in Patients with Peripheral Artery Disease
1816. Combined LXR and RXR Agonist Therapy Increases ABCA1 Protein Expression and Enhances ApoAI-Mediated cholesterol efflux in Cultured Endothelial Cells
1817. A short peptide of the C-terminal class Y helices of apolipoprotein AI has preserved functions in cholesterol efflux and in vivo metabolic control
1818. Curcumin affects ox‑LDL‑induced IL‑6, TNF‑α, MCP‑1 secretion and cholesterol efflux in THP‑1 cells by suppressing the TLR4/NF‑κB/miR33a signaling …
1819. Increased ABCA1 (ATP-Binding Cassette Transporter A1)-specific cholesterol efflux capacity in schizophrenia
1820. Contrasting effects of membrane enrichment with polyunsaturated fatty acids on phospholipid composition and cholesterol efflux from cholesterol-loaded J774 mouse …
1821. Reduced Levels of ABCA1 Transporter Are Responsible for the cholesterol efflux Impairment in β-Amyloid-Induced Reactive Astrocytes: Potential Rescue from …
1822. Excess weight mediates changes in HDL pool that reduce cholesterol efflux capacity and increase antioxidant activity
1823. Nanoparticle-based “Two-pronged” approach to regress atherosclerosis by simultaneous modulation of cholesterol influx and efflux
1824. Crosstalk between LXR and caveolin-1 signaling supports cholesterol efflux and anti-inflammatory pathways in macrophages
1825. Correction to: Association between cholesterol efflux capacity and peripheral artery disease in coronary heart disease patients with and without type 2 diabetes: from …
1826. Connecting cholesterol efflux Factors to Lung Cancer Biology and Therapeutics
1827. Morroniside Promotes PGC-1α-Mediated cholesterol efflux in Sodium Palmitate or High Glucose-Induced Mouse Renal Tubular Epithelial Cells
1828. Lysis reagents, cell numbers, and calculation method influence high-throughput measurement of HDL-mediated cholesterol efflux capacity
1829. The Capacity of APOB-Depleted Plasma in Inducing ATP-Binding Cassette A1/G1-Mediated Macrophage cholesterol efflux—But Not Gut Microbial-Derived …
1830. The effect of transgender hormonal treatment on high density lipoprotein cholesterol efflux capacity
1831. The role of HDL-and non-HDL-related parameters in cell-cholesterol efflux capacity
1832. cholesterol uptake and efflux are impaired in human trophoblast cells from pregnancies with maternal supraphysiological hypercholesterolemia
1833. Atorvastatin enhances foam cell lipophagy and promotes cholesterol efflux through the AMP-activated protein kinase/mammalian target of rapamycin pathway
1834. Artesunate attenuates foam cell formation by enhancing cholesterol efflux
1835. Insulin Rescued MCP-1-Suppressed cholesterol efflux to Large HDL2 Particles via ABCA1, ABCG1, SR-BI and PI3K/Akt Activation in Adipocytes
1836. Novel cholesterol efflux assay using immobilized liposome-bound gel beads: Confirmation and improvement for application in clinical laboratory
1837. Correlates and Predictors of Cerebrospinal Fluid cholesterol efflux Capacity from Neural Cells, a Family of Biomarkers for cholesterol Epidemiology in Alzheimer’s …
1838. Probucol treatment is associated with an ABCA1-independent mechanism of cholesterol efflux to lipid poor apolipoproteins from foam cell macrophages
1839. PRMT2 inhibits the formation of foam cell induced by ox-LDL in RAW 264.7 macrophage involving ABCA1 mediated cholesterol efflux
1840. Impaired cholesterol efflux capacity in patients with Helicobacter pylori infection and its relation with inflammation
1841. MicroRNA-33-5p inhibits cholesterol efflux in vascular endothelial cells by regulating citrate synthase and ATP-binding cassette transporter A1
1842. Large HDL particles negatively associate with leukocyte counts independent of cholesterol efflux capacity: A cross sectional study in the population-based …
1843. Identification of novel lipid droplet factors that regulate autophagy and cholesterol efflux in macrophage foam cells
1844. Synergism between albumin, bicarbonate and cAMP upregulation for cholesterol efflux from ram sperm
1845. Recombinant Klotho protein enhances cholesterol efflux of THP-1 macrophage-derived foam cells via suppressing Wnt/β-catenin signaling pathway
1846. Inhibition of miR-200b-3p alleviates lipid accumulation and promotes cholesterol efflux by targeting ABCA1 in macrophage-derived foam cells
1847. Apolipoprotein M promotes cholesterol uptake and efflux from mouse macrophages
1848. Thematic Review Series: Biology of Lipid Rafts: Hematopoiesis is regulated by cholesterol efflux pathways and lipid rafts: connections with cardiovascular …
1849. Effects of pre-eclampsia on HDL-mediated cholesterol efflux capacity after pregnancy
1850. Characterization of cholesterol efflux capacity in diabetic and non-diabetic patients with coronary artery disease: comparison between acute coronary syndrome and …
1851. Differences in Capacity of High‐Density Lipoprotein cholesterol efflux Between Patients With Systemic Lupus Erythematosus and Rheumatoid Arthritis
1852. Endocytic recycling as cellular trafficking fate of simvastatin-loaded discoidal reconstituted high-density lipoprotein to coordinate cholesterol efflux and drug influx
1853. … inhibits PARP-1 and promotes LXR-mediated ABCA1 expression to protect pancreatic β-cells against cholesterol-induced toxicity through cholesterol efflux
1854. cholesterol efflux promoting function of high-density lipoproteins in calcific aortic valve stenosis
1855. CSL112 (APOLIPOPROTEIN AI [HUMAN]) SIMILARLY ENHANCES cholesterol efflux CAPACITY IN JAPANESE AND CAUCASIAN SUBJECTS: FINDINGS …
1856. Apolipoprotein AI carboxy-terminal domain residues 187–243 are required for adiponectin-induced cholesterol efflux
1857. Macrophage cholesterol efflux downregulation is not associated with abdominal aortic aneurysm (AAA) progression
1858. Ultrasound-targeted simvastatin-loaded microbubble destruction promotes OA cartilage repair by modulating the cholesterol efflux pathway mediated by …
1859. Advanced glycated apoA-IV loses its ability to prevent the LPS-induced reduction in cholesterol efflux-related gene expression in macrophages
1860. The myocardial infarction-associated transcript 2 inhibits lipid accumulation and promotes cholesterol efflux in oxidized low-density lipoprotein-induced THP-1-derived …
1861. The Heat Shock Protein 27 Immune Complex Enhances Exosomal cholesterol efflux
1862. A novel therapeutic strategy for atherosclerosis: autophagy-dependent cholesterol efflux
1863. Curcumin promotes cholesterol efflux by regulating ABCA1 expression through miR-125a-5p/SIRT6 axis in THP-1 macrophage to prevent atherosclerosis
1864. Targeting OSBPL7 restores cholesterol efflux
1865. High-Density Lipoprotein cholesterol efflux Capacity as a Surrogate Marker for Major Cardiac Adverse Events in Japanese Patients
1866. Interferon‐γ decreases ATP‐binding cassette subfamily G member 1‐mediated cholesterol efflux through small ubiquitin‐like modifier/ubiquitin‐dependent liver X …
1867. SAT0317 HDL-cholesterol efflux CAPACITY IS DOWNREGULATED IN PATIENTS WITH SYSTEMIC SCLEROSIS.
1868. ASSOCIATION OF cholesterol efflux CAPACITY WITH ADVERSE CARDIOVASCULAR OUTCOMES-A META-ANALYSIS
1869. The Improved Ability of ApoA-I Amyloidogenic Variants at Mediating cholesterol efflux Relies on their Increased Structural Flexibility
1870. Exenatide promotes cholesterol efflux in pancreatic tissue of obese diabetic rats
1871. cholesterol efflux is differently controlled by specific pathways and effectors
1872. Plasma high density lipoproteins phospholipds as an indirect indicator of their cholesterol efflux capacity-new suspected atherosclerosis risk factor
1873. Research progress on the association between cholesterol efflux capacity and coronary artery disease
1874. High-Sensitivity CRP is Independently Associated with HDL-Mediated cholesterol efflux Capacity and HDL Remodeling in Patients with Coronary Artery …
1875. Serum cholesterol efflux capacity is associated with coronary plaque progression in patients with coronary heart disease
1876. cholesterol efflux capacity is associated with inflammation level and monocyte-platelet aggregates in healthy men.
1877. HDL cholesterol efflux capacity and concentration in patients with rheumatoid arthritis: a systematic review and meta-analysis
1878. Contrasting effects of eicosapentaenoic acid (EPA) membrane enrichment on ABCA1-mediated cholesterol efflux from primary human macrophages or THP-1 human …
1879. Maternal and Child Supplementation With Small-Quantity Lipid-Based Nutrient Supplements Increases Child HDL cholesterol efflux Capacity
1880. Novel cholesterol efflux assay using immobilized liposome-bound gel beads: Comparison to conventional method
1881. Modulation of cholesterol efflux capacity (CEC) of high density lipoprotein (HDL) with bariatric surgery
1882. Niemann Pick C2 protein enables cholesterol transfer from endo-lysosomes to the plasma membrane for efflux by shedding of extracellular vesicles
1883. … and low phosphatidylcholine concentrations in HDL phospholipids are associated with atherosclerosis in relation to decreased cholesterol efflux capacity
1884. Impaired HDL cholesterol efflux capacity in subjects with metabolically-but not genetically-driven non-alcoholic fatty liver disease (NAFLD)
1885. Delivery of micrornas by reconstituted HDL enhances cholesterol efflux from foam cells in a triple-cell two-dimensional atheroma plaque model
1886. Tangshen formula promotes cellular cholesterol efflux in HG-induced mTECs by suppression of TGF-β1/Smad3 pathway
1887. Calpain inhibitor prevents atherosclerosis in apolipoprotein E knockout mice by regulating mRNA expression of genes related to cholesterol uptake and efflux
1888. Bmal1 Regulates Macrophage cholesterol efflux and Protects Against Atherosclerosis in Mice
1889. RELATIONSHIP BETWEEN cholesterol efflux CAPACITY, APOLIPOPROTEIN A1 AND NONCALCIFIED CORONARY BURDEN IN PSORIASIS
1890. Characterizing The Effects Of Fish Oil On High-density Lipoprotein Proteome And cholesterol efflux Capacity
1891. Abstract P291: Effects of a Multidisciplinary Lifestyle Intervention on HDL cholesterol efflux Capacities in Adolescents With Obesity
1892. Macrophage Specific IGF-1 Overexpression Decreases Atherosclerosis, CXCL12 Chemokine, And Increases cholesterol efflux In ApoE Deficient Mice
1893. Differential MicroRNA Expression Profiles in Extracellular Vesicles From Visceral Adipose Tissue and Urine: Affect of Varying cholesterol efflux Capacity
1894. Regulation of ATP-binding cassette transporters and cholesterol efflux by glucose in primary human monocytes and…
1895. Improvements in cholesterol efflux capacity of HDL and adiponectin contribute to mitigation in cardiovascular disease risk after bariatric surgery in a cohort …
1896. Expression of the circular RNAs in astaxanthin promotes cholesterol efflux from THP-1 cells based on RNA-seq
1897. Levels of High Density Lipoprotein-associated Proteins, Myeloperoxidase and Serum Amyloid A1, and cholesterol efflux Capacity in Heterozygous Familial …
1898. Acid-Sensing Ion Channel 1/Calpain1 Activation Impedes Macrophage ATP-Binding Cassette Protein A1-Mediated cholesterol efflux Induced by Extracellular …
1899. Epsins Regulate cholesterol Uptake and efflux in Macrophages
1900. … lipase deficiency affects the expression of SR-BI, LDLr, and ABCA1 receptors/transporters involved in cellular cholesterol uptake and efflux and disturbs fertility in …
1901. Activated macrophages displaying an M1 phenotype have a reduced capacity to efflux cholesterol
1902. DNA repair and cholesterol-mediated drug efflux induce dose-dependent chemoresistance in nutrient-deprived neuroblastoma cells
1903. … coffee and green tea extract inhibit foam cell atherosclerosis by lowering inflammation and improving cholesterol influx/efflux balance through upregulation of …
1904. ATP-binding cassette transporters G1 and G4 mediate cholesterol and desmosterol efflux to HDL and regulate stero…
1905. Tangshen formula improves cholesterol uptake and efflux of macrophages induced by high lipid via activating PGC-1α/LXR/ABCA1 pathway